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Diffuse Optical Cerebral Diagnostics For Real-Time Guidance During Pediatric
Surgery And Resuscitation
Abstract
Adequate oxygen and blood flow are vital for the developing pediatric brain. Herein, we apply quantitative
diffuse optical techniques, frequency-domain diffuse optical spectroscopy (FD-DOS) and diffuse
correlation spectroscopy (DCS), to non-invasively characterize cerebral oxygenation (StO2), blood flow
(CBF), and oxygen metabolism (CMRO2) in pediatric animal models of hypoxic-ischemic injury.
In a neonatal swine model (n=8) of congenital cardiac defect repair, we performed a two-part study which
validated non-invasive diffuse optical measurements and uncovered significant limitations in the
guidance of deep hypothermia using temperature during cardiopulmonary bypass. First, non-invasive
CMRO2 was validated against invasive methods over wide temperature ranges (18-37C). Non-invasive
measurements of CBF (p<0.001) and CMRO2 (p<0.001) were significantly associated with invasive
measurements. Furthermore, a significant hysteresis (p=0.001) of cerebral metabolic temperaturedependence during cooling versus rewarming with respect to NPT is “fixed” with the use of ICT (p>0.5).
Second, we compared non-invasively measured cerebral metabolic parameters between cohorts who
underwent deep hypothermia with or without circulatory arrest (DHCA; n=8). Cerebral metabolic
temperature-dependence with respect to ICT in DHCA animals demonstrated significantly diminished
temperature sensitivity during rewarming (p<0.001; i.e., following reperfusion) compared to during
cooling. Direct non-invasive CMRO2 measurement is an improved surrogate of cerebral status over
temperature and enables individualized management of deep hypothermia and circulatory arrest.
In another study of asphyxia-induced pediatric cardiac arrest and cardiopulmonary resuscitation (CPR),
non-invasive measures of StO2, oxy-hemoglobin concentration ([HbO2]) and total hemoglobin
concentration (THC) at 10-minutes of CPR were significantly associated with return of spontaneous
circulation (ROSC). The absolute change in [HbO2] from 1-minute of CPR ([HbO2]CPR) was the optimal
predictor of ROSC, with a mean (SD) AUC of 0.91 (0.07) across the first 10 minutes of CPR, evaluated at
1-minute intervals. Furthermore, separate high sensitivity and specificity threshold for ROSC were
established.
These results show, in several contexts, that non-invasive FD-DOS/DCS neuromonitoring provides unique
physiological information about the developing pediatric brain that enables individualized identification of
critical neurological risk periods and real-time guidance of clinical care.
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ABSTRACT

DIFFUSE OPTICAL CEREBRAL DIAGNOSTICS FOR REAL-TIME GUIDANCE
DURING PEDIATRIC SURGERY AND RESUSCITATION
Tiffany S. Ko
Arjun G. Yodh
Daniel J. Licht
Adequate oxygen and blood flow are vital for the developing pediatric brain.
Herein, we apply quantitative diffuse optical techniques, frequency-domain diffuse
optical spectroscopy (FD-DOS) and diffuse correlation spectroscopy (DCS), to noninvasively characterize cerebral oxygenation (StO2), blood flow (CBF), and oxygen
metabolism (CMRO2) in pediatric animal models of hypoxic-ischemic injury.
In a neonatal swine model (n=8) of congenital cardiac defect repair, we
performed a two-part study which validated non-invasive diffuse optical measurements
and uncovered significant limitations in the guidance of deep hypothermia using
temperature during cardiopulmonary bypass. First, non-invasive CMRO2 was validated
against invasive methods over wide temperature ranges (18-37°C). Non-invasive
measurements of CBF (p<0.001) and CMRO2 (p<0.001) were significantly associated
with invasive measurements. Furthermore, a significant hysteresis (p=0.001) of cerebral
metabolic temperature-dependence during cooling versus rewarming with respect to
NPT is “fixed” with the use of ICT (p>0.5).
Second, we compared non-invasively measured cerebral metabolic parameters
between cohorts who underwent deep hypothermia with or without circulatory arrest
(DHCA; n=8). Cerebral metabolic temperature-dependence with respect to ICT in DHCA
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animals demonstrated significantly diminished temperature sensitivity during rewarming
(p<0.001; i.e., following reperfusion) compared to during cooling. Direct non-invasive
CMRO2 measurement is an improved surrogate of cerebral status over temperature and
enables individualized management of deep hypothermia and circulatory arrest.
In another study of asphyxia-induced pediatric cardiac arrest and
cardiopulmonary resuscitation (CPR), non-invasive measures of StO2, oxy-hemoglobin
concentration ([HbO2]) and total hemoglobin concentration (THC) at 10-minutes of CPR
were significantly associated with return of spontaneous circulation (ROSC). The
absolute change in [HbO2] from 1-minute of CPR (∆[HbO2]CPR) was the optimal predictor
of ROSC, with a mean (SD) AUC of 0.91 (0.07) across the first 10 minutes of CPR,
evaluated at 1-minute intervals. Furthermore, separate high sensitivity and specificity
threshold for ROSC were established.
These results show, in several contexts, that non-invasive FD-DOS/DCS
neuromonitoring provides unique physiological information about the developing
pediatric brain that enables individualized identification of critical neurological risk
periods and real-time guidance of clinical care.
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CHAPTER 1: BACKGROUND AND SIGNIFICANCE
Few things in life are more vital or more complex than the human brain. Before
birth or sentience, our immature brain is already hard at work laying the foundations for
centralized processing hubs and the connecting neuronal signaling super highways
underlying our capacity for thought, sensation, memory and function. Innate primitive
reflexes and early structural differentiation of the auditory, visual and sensorimotor
cortices provide the means and the feedback necessary to begin to perceive and interact
with the world around us.
Early neuroprotection is critical to long-term quality of life. It is a particularly
urgent concern in populations of children with increased vulnerability to neurological
injury, as can arise during surgery or cardiac arrest. Unfortunately, non-invasive
diagnostic techniques for continuous and safe monitoring of the developing pediatric
brain during critical periods of risk are limited. The research in this thesis leverages the
relatively low absorption of biological tissue in the near-infrared (NIR) for non-invasive
monitoring of the brain. Specifically, diffuse optical monitoring and imaging with NIR light
enables non-invasive, continuous quantification of cerebral hemodynamics, i.e.,
quantification of cerebral blood volume, blood oxygenation, and tissue metabolism.
In this introduction, we first provide an overview of the theoretical basis and
instrumentation necessary for diffuse optical measurements (Chapter 1, Section A). We
next provide a brief review of the neurological outcomes and risk factors faced by
neonates with severe congenital heart disease. We then present a framework for how
diffuse optical measurements may be applied during intraoperative cardiac repair to
mitigate these risks (Chapter 1, Section B). Finally, we provide a similar overview for
pediatric cardiac arrest and resuscitation (Chapter 1, Section C). In subsequent
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chapters, the novel clinical diagnostic capabilities of this optical modality are validated
and are utilized to characterize brain alterations in pediatric swine models of neonatal
cardiac repair (Chapter 2 and 3) and in pediatric swine models of cardiac arrest and
cardiopulmonary resuscitation (CPR; Chapter 4). To conclude this work, we summarize
our findings, their limitations, and our future outlook (Chapter 5).

A. Diffuse Optical Monitoring of Cerebral Hemodynamics
In biological tissue, the propagation of NIR light (wavelengths from 650 to 1000
nm) is well-modeled as a diffusive process due to the predominance of tissue scattering
over tissue absorption. The resulting “transparency” permits photons to travel through
large chunks of tissue (e.g., 1 to 10 cm) in the infant head in reflectance geometry.1–5
Typically, a compact optical probe is used to place non-invasive NIR light sources on the
surface of the skin and to collect the photons that propagate from the source and
through the tissue at a separate detector position (e.g., 2.5 cm away from the source on
the tissue surface). As the photons travel through tissue, they are scattered and
absorbed. In this way, physiological information about the tissue is imprinted into the
transmitted NIR light. By examining the differential spectral changes of the detected light
with respect to wavelength, source-detector separation, and other factors, we can
characterize tissue properties.
Modeling tissue as a homogenous turbid medium, the photon fluence rate (Φ,
W/cm2) at a position, , is described by the Photon Diffusion Equation:6–10
DΦ( , )
= @2( , ) + ∇ Φ( , ) − @+ Φ( , ).
D

(1.1)

Here represents time, 2( , ) represents the source light distribution, @ is the speed of
light in the medium, +,- is the tissue reduced scattering coefficient, + is the tissue
2

absorption coefficient, and

is the tissue photon diffusion coefficient expressed, i.e.,

= @J3(+,- + + )LM!. A key assumption for this formulation is that the source light and

light radiance are predominantly isotropic, +,- ≫ + , and the typical photon path length

travelled through the tissue is significantly greater than the mean free path (
1/(+ + +,- ) ~1/+,- ; i.e., one random-walk step).

('

=

Thus +,- and + are the defining optical properties unique to the turbid medium

being measured. These parameters are the sources of information from which

physiologic information may be quantified. In essence, +,- and + correspond to the

distance traveled by a photon in tissue before it has had its direction randomized (1/+,- ,
by reduced scattering) or has been absorbed (1/+ ), respectively; more precisely, these
are “exponential” decay lengths for the above processes. Sources of scattering in
biological tissue are varied and largely delineated by composition rather than function;
significant scatterers include collagen and other fibrous tissues, bone, lipid and cells with
large concentrations of mitochondria or lysosomes.11 Sources of absorption (i.e., tissue

chromophores) are better-defined and limited to a few major contributors. Water is the
primary absorber, however, a substantial decrease in absorption between 300 to
1000nm permits spectroscopic examination of other chromophores. Importantly, in the
NIR window between 650 to 1000nm, oxy- and deoxy-hemoglobin are prominent
absorbers with differential spectral behavior that permits separation of their respective
contributions. By combining measurements of absorption (+ ) at multiple wavelengths
across this range, the concentrations of oxy- and deoxy-hemoglobin can be quantified,
and the relative oxygenation of cerebral tissue hemoglobin determined. All approaches
to derive these types of information involve “fitting” measured data to theoretical models.
To this end, solutions to the photon diffusion equation (Equation 1.1) are next
described.
3

A.1. Frequency-Domain, Infinite Homogenous Medium, Solution
In this work, frequency-domain techniques are employed to quantify the absolute

optical properties (+ , +, ′) of tissue. Assuming the existence of a stationary, sinusoidally

amplitude-modulated point source with angular frequency A in a highly scattering

medium, the fluence rate of resulting diffusing photon density waves in the medium can
be separated into DC and AC components
Φ( , ) = ΦTU ( ) + Φ<U ( )V &W( .

(1.2)

Substitution of the AC component into the Photon Diffusion Equation yields a closedform analytical solution for the fluence rate at position

in an infinite homogenous

medium with the point source placed at the origin:
Φ<U ( ) =

@2
4Z

The variable

X

V &[' ,

(1.3)

= | | and the real and imaginary components of the “wavevector,” $ =

$' + ]$& , are fully expressed as:

@+
A
`a1 + b
c − 1d ;
2
@+

(1.4)

@+
A
`a1 + b
c + 1d .
2
@+

(1.5)

$' = ^

$& = ^

The fluence rate can then be expressed as Φ<U ( ) = ( )V &f(') and real and imaginary

components determined by concurrent measurements of the amplitude ( ) and phase

( ). + and +,- at a single optical wavelength may be obtained by fitting the data using,

for example, multiple measurements of the fluence rate at varying

4

or A.

A.2. Frequency-Domain, Semi-Infinite Homogenous Medium, Solution
For clinical applications of the frequency-domain technique, a reflectance
geometry is often employed in order to perform measurements on the surface of the
skin.9,12–16 As a result, a boundary condition must be imposed and assumptions must be
made regarding propagation of diffuse light across the boundary (i.e., the surface of the
skin). Modeling underlying tissue as a semi-infinite homogenous medium with boundary
surface at B = 0, we must first account for the fact that our fiber source, in practice, is

usually not an isotropic point source. However, it is well approximated by a point source
at a depth within the medium of roughly the mean free path of a photon (B =

(' ),

directly

below the boundary location of the incident source. The boundary condition for light
fluence at the interface requires an additional so-called extrapolated-zero boundary

condition approximation where, at a certain distance (B = −BC ), the fluence rate from the
light source falls to zero:17
BC ~

2
3

('

h

1 + /011
i.
1 − /011

(1.6)

/011 is the effective reflection coefficient at the boundary to account for index of

refraction mismatches between tissue and air or a measurement probe. Given refractive
indices of the tissue (j) and the outside medium (jkl( ), /011 ~ − 1.440(j/jkl( )M +
0.701(j/jkl( )M! + 0.668 + 0.0636(j/jkl( ).18

With the extrapolated-zero boundary condition, the method of images (Figure

1.1) can be used to solve the semi-infinite medium problem. The “method of images”
introduces a “negative” light source with identical but opposite fluence to the point light
source within the medium but placed at a position B = −B, = −(2BC +

mirrored location of

('

(' )

that is the

across BC . Combining the fluence rate solutions for point sources
5

Figure 1.1 Extrapolated-Zero Boundary and the Method of Images: Modeling tissue
(shaded) as a semi-infinite homogenous medium, an extrapolated-zero boundary
condition is imposed at z = −z4 using the method of images. At a depth z = lyz (i.e., one
random-walk step) the source may be well-approximated as an isotropic point source
(blue star). The zero boundary is achieved by then placing a “negative” light source
(black star) of equal but opposite source fluence at z = −z , the mirrored location of z =
lyz across z = −z4 . This is used to solved for the detected fluence rate (Φ<U (r)) at a
distance r from the source on the surface of the medium.

in an infinite medium at both source locations yields the semi-infinite homogeneous
solution:
Φ<U ( ) =
where

!

@2 X V &['p V &['6
−
h
i,
4Z
!

=q

+

('

(1.7)

is the Euclidean distance from the detector position to the point

source in the medium, and

=q

+ (2BC +

(' )

is the Euclidean distance from the

detector position to the mirrored negative point source.
When the source-detector separation
Φ<U ( ) =

@2 X V M['
h
i r2$s
4Z

(' BC

+ BC tu.

≫

(' ,

the solution simplifies to:
(1.8)

Like the infinite solution, the fluence rate can then be expressed as Φ<U ( ) = ( )V &f(')

and the following linear expressions with respect to source-detector separation ( ) may
be derived:

ln( ( ) ) = −$& +

%;

(1.9)

6

{( ) = $' + {% .

These relationships provide the means to extract optical properties + and +, ′ by

(1.10)

measuring ( ) and {( ) at multiple source-detector separations and then performing
linear regression to determine slopes $& and $' , respectively. + and +, ′ are readily

determined from Equations 1.4 and 1.5 whereby.
+ =
+,- =

A $& $'
| − };
2@ $' $&

(1.11)

2@
$$ .
3A & '

(1.12)

It is fair to say that variants of this methodology are used for the majority of

“monitoring” measurements in the field. This methodology is a core part of the central
analyses performed throughout this thesis in order to extract the absolute tissue optical
properties of the brain in pediatric swine.
A.3. Calibration of Frequency-Domain Measurements
In practice, a calibration procedure must also be performed in order to
simultaneously measure at multiple source-detector separations.19 This is due to the
variability in coupling of different source and detection elements to the surface of the
skin. The calibration procedure calculates a correction factor for each source-detector
pair by using a tissue-mimicking calibration phantom with known optical properties. Due
to optical hardware issues that limit the dynamic range of detection, and the associated
increase in measurement error as limits of detection are reached, it is desirable for the
calibration phantom to have similar optical properties to the tissue being measured.
Amplitude and phase calibration coefficients must be individually calculated for

each wavelength of characterization. On a calibration phantom with properties +
7

,X ~

and

+,,X

~

for any given wavelength, $&,X

~

and $',X

and 1.5. Then, the expected amplitude
0( ) = V

•

h

{0 ( ) = $',X

V M[€,•‚ƒ '
~

i;

0(

~

may be calculated from Equation 1.4

) and phase {0 ( ) may be calculated as

(1.13)

+ {% .

Given the actual raw measurements of amplitude and phase ( ( ), {( ),

respectively), the amplitude and phase calibration coefficients
calculated as:

0(

( )=

%

( ) are

)
V • V M[€,•‚ƒ '
=
h
i;
( )
( )

( ) = {0 ( ) − {( ) = $',X

In theory

( ) and

~

(1.14)

(1.15)

+ {% − {( ).

(1.16)

and {% represent the amplitude and phase of the source light; in practice

these are typically calculated from the raw measurements of the first source-detector
separation

!,

such that the calibration coefficients

( ! ) = 1 and

( ! ) = 0.

To solve for optical properties from measurements of amplitude and phase ( ( ), {( ),

respectively) on tissue,

0(

) and {0 ( ) should be calculated by applying the calibration

coefficients and fitting a linear regression with respect to

to solve for $& and $' ,

respectively. Subsequently, + and +, ′ may be extracted as described above in
Equations 1.9-12.

A.4. Frequency-Domain Diffuse Optical Spectroscopy Analysis
Multi-distance, frequency-domain diffuse optical spectroscopy (FD-DOS) uses
the wavelength-dependent absorption and scattering coefficients, quantified above, to
determine concentrations of chromophores in tissue. The instrumentation and analysis
are described in detail throughout the work. In brief, using the well-known extinction
8

coefficients ( ) of water, oxy- and deoxy-hemoglobin (H2O, HbO2, and Hb,
respectively),20 and assuming a constant cerebral water volume fraction (often 0.75) and
negligible contributions from lipid, the measured absorption coefficients (+ ) across
multiple wavelengths ()) may be used to create a linear system of equations
where:9,13,14,21
+ ()) =

„C…6 ())J†

‡ L+

„C ())J†

L + 0.75+

,„6 … ()).

(1.17)

Absolute concentrations of oxy-hemoglobin ([HbO2], +mol/L) and deoxy-hemoglobin

([Hb], +mol/L) in cerebral tissue may then be resolved. The total hemoglobin

concentration (THC, +mol/L) and cerebral tissue oxygen saturation (StO2, %) are
subsequently calculated as:
>†‰ = J† ‡ L + J† L;
2 ‡ =

(1.18)

J† ‡ L
× 100%
>†‰

(1.19)

Validation of frequency-domain quantification of StO2 has been performed in both
animal models22 and in neonates.23 It has since been widely applied in vulnerable
pediatric populations to examine alterations in cerebral hemodynamics.24
A.5. Continuous-Wave Near Infrared Spectroscopy (CW NIRS)
The vast majority of clinical instruments that measure cerebral tissue oxygen
saturation are based on the diffuse optical technique called continuous-wave nearinfrared spectroscopy (CW NIRS). In this work this is referred to as CW NIRS. Note,
because the “continuous-wave” aspect is generally not discussed in clinical
communities, this technique is also known as just “NIRS.” Further, while the term “nearinfrared spectroscopy (NIRS)” is technically equivalent to the terminology “diffuse optical
spectroscopy (DOS),” NIRS is used almost exclusively to describe instrumentation which
9

employs a continuous-wave light source. (CW light sources have an intensity that is
constant in time; CW NIRS does not carry phase information.)
It is important to realize that the use of CW light sources to measure tissue
oxygen saturation (CW NIRS) requires assumptions about patient characteristics at
baseline. CW NIRS does not capture enough information to resolve both absorption and
scattering coefficients. As a result, in this work, the terminology “diffuse optical
spectroscopy (DOS)” has been reserved for reference to quantitative diffuse optical
techniques (i.e., more quantitative than CW NIRS), which permit calculation of absolute
optical properties from data. Herein, we describe some of the ways that CW NIRS data
is analyzed and its critical limitations.
Differential Pathlength Method
Due to the relatively low-cost barriers to adoption, early clinical cerebral
oximeters predominantly used what is known as the “differential pathlength method.”25 In
turbid (highly scattering) homogeneous medium, changes in the intensity may be
expressed using the so-called modified Beer-Lambert Law:

Ž( )
+ ,%
Δ‡ ( ) = − log |
} = ( ∙ •‘) ’Δ+ ( ) + h - i Δ+,- ( )“,
Ž%
+,,%

where Δ‡ is the change in optical density from baseline ( = 0),

detector separation, DPF is the differential pathlength factor, Ž% , +

(1.20)
is the source,% ,

and +,,%
are the

intensity, absorption and reduced scattering at baseline, respectively, and Ž( ) is the

intensity at time . For a semi-infinite homogenous medium, when
the “large r” approximation, the DPF may be expressed as26
•‘ =

3 +,-

2s q3+

,% +,

+ 1t

.

≫(

('

+ 2BC ), i.e.,

(1.21)
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This result essentially comes from a Taylor expansion of the optical density with
respect to small changes in absorption and scattering. By assuming that tissue

scattering remains constant over time (Δ+,- ( ) ≅ 0), all changes in intensity may be

equated to changes in absorption: Δ‡ ( ) = ∙ •‘ ∙ Δ+ ( ). This expression differs

from the traditional Beer-Lambert Law in “optically-thin” media because, in tissue, the
photon path becomes highly scattered and therefore cannot be measured in direct
transmission geometry from the source to the detector (distance ). To account for the
increase in photon pathlength due to scattering, the source-detector separation ( ) is
multiplied by the DPF to reflect the average photon pathlength in tissue for that particular
source-detector separation and background optical properties.
What makes the differential pathlength method attractive can also make it

inaccurate. Using baseline assumptions of + and +,- , a simple measurement of intensity
can resolve changes in + for determination of changes in [HbO2] and [Hb]. This method

is generally robust to changes in scattering, due to the +

,% /+,,%

≅ 0.01 multiplicative

term in Equation 1.20; the relative error in absorption due to scattering changes is thus
comparable to the relative change in scattering. Unfortunately, the DPF method cannot
quantify baseline optical properties. As will be discussed in this thesis, baseline
scattering and absorption properties can have significant inter-subject variability (with a
coefficient of variation between 10% and 20%). Furthermore, hypoxic-ischemic
conditions also significantly affect tissue scattering and absorption. Examining Equation

1.20 and 1.21, if a constant DPF and scattering coefficient (+,- ) over time are erroneously

assumed, when scattering does in-fact increase, a larger Δ+ is erroneously calculated.

Also, both expressions are dependent on the source-detector separation ( ) which is

sensitive to accurate positioning and coupling of these optical elements to the surface of
the skin. As a result, clinical oximeters which employed the DPF method will often
11

produce highly inconsistent trends across patients and are further impacted by
physiologic changes which affect scattering.27
Spatially-Resolved Spectroscopy (SRS)
The most recent generation of FDA approved cerebral CW NIRS oximeters
employ the technique of spatially-resolved spectroscopy (SRS).7,28,29 This techniques
relies on deriving a theoretical linear relationship between the detected diffuse
reflectance and source-detector separation from which optical properties may be
empirically resolved with linear fitting. The use of multiple separations partially mitigates
the influence of tissue-coupling errors and allows for improved cerebral sensitivity
compared to the DPF method.
To derive the CW diffuse reflectance, we start with the solution for the fluence
rate in a semi-infinite homogenous medium for continuous light instead of in the
frequency-domain (Equation 1.7). The same method of images (Figure 1.1) may be
employed to solve for the CW fluence rate (ΦU• , W/cm2) at a distance

from an

isotropic point source:7

1 V M–—˜˜ 'p V M–—˜˜ '6
ΦU• ( ) =
−
h
i,
4Z
!

(1.22)

where +011 = q3+ (+ + +,- ), and, as before,
=q

+ (2BC +

(' )

= @J3(+,- + + )LM!,

!

=q

('

+

, and

. Using Fick’s First Law of Diffusion, the CW fluence rate may be

used to derive the steady-state diffuse reflectance (R Xš ( ), W/cm2) measured at this

position from a source with intensity Ž% :7,28
R Xš ( ) =

Ž%
’
4Z

('

|+011 +

1 V M–—˜˜ 'p
}
+(
!

!

('

+ 2BC ) |+011 +
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1 V M–—˜˜ '6
}
“.

(1.23)

Assuming much greater source-detector separations than the mean transport free path
( ≫

(' ),

it follows that

!

≅

≅

. Adding the assumption of scattering predominance

over absorption (+,- ≫ + ), Equation 1.23 reduces to26
R Xš ( ) = ‰ ›|q3+

where ‰ = Ž% (

('

+,-

1 V
+ }

Mœ•–ž –Ÿ '

(1.24)

+ BC )/2Z becomes a scalar constant with respect to . The expression

may be rearranged as
ln(R Xš ( ) ∙

¡,

) = − q3+ +,- + ¢ln £

q3+ +,- + 1

¤ + ln(‰)¥.

(1.25)

Given typical optical properties of + in the range of 0.1-0.2 cm-1, +,- in the range of 5 to

15 cm-1, source-detector separations (SDS) >2cm, it follows that

q3+ +,- ≫ 1. This

assumption reduces the bracketed expression on the right-hand side of Equation 1.25
to a scalar constant that is independent of . Thus, a linear fitting of ln(R Xš ( ) ∙

) with

respect to , gives a fitted slope, 2 = −q3+ +,- , which can be used to solve for + (using

an assumed +,- ) according to the relationship
+ =

2
.
3+,-

(1.26)

For selected optical properties across the physiologic range, we show the

numerically-calculated percentage error in 2 for pediatric- and adult-sized probes (SDS
= 0.9 and 2.5cm; SDS = 1.5 and 5cm; respectively; see Figure 1.2) using the SRS

linear-fitting method. These errors were calculated by computing the slope 2 of

ln(R Xš ( ) ∙

), from Equation 1.25, with respect to

for each probe. The error of the

fitted 2 is then calculated with respect to the “true” 2 , computed as 3+ +,- . We see that,
for a subset of larger physiologic optical properties and larger source-detector
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Figure 1.2. Slope Error in Determination of μ using Spatially Resolved
Spectroscopy (SRS): Using continuous-wave SRS, absorption is equated to a fitted
linear slope μ ~ S by assuming rq3μ μ- ≫ 1, where r is the source-detector separation
(SDS). The percentage error in S is plotted with respect to two different probe layouts:
pediatric (SDS = 0.9 and 2.5 cm; black lines) and adult (SDS =1.5 and 5cm; blue lines).
We see retention of error (>1%) at all physiologic levels of scattering and absorption
(μ- = 5 − 15 cmM! , horizontal axis; μ = 0.05 − 0.2 cmM! , line thickness), with worse error
with the diminishing value of μ μ- .

separations, SRS can produce a fairly accurate (<10% error) extraction of the fitted
slope, which in turn translates into a fairly accurate extraction of absorption (+ ).

However, this result relies on the fact that scattering (+,- ) was accurately assumed. The

CW SRS assumption of a constant, population “average” scattering causes additional
errors in the quantification of + which may be attributed to inter-subject variability as

well as dynamic changes in +,- over time.

Errors in the assumption of +,- introduces additional errors in + . This magnitude

of error can be quickly deduced from Equation 1.26 whereby if we assume that
¦V(+ ) ∙

¦V(+,- ) = 2 =

SRS-calculated + follows as:

¦

V§(+ ) ∙ ¨¨¦©V§(+,- ), expression of the error of

¦ V§(+ )
¦V(+,- )
=
.
¦V(+ )
¨¨¦©V§(+,- )

(1.27)

Underestimation in baseline +,- properties results in an overestimation of + . An increase
in

¦V(+,- ) would result in an erroneous and proportional increased in
14

¦

V§(+ ).

Notably, this cursory scattering error assessment does not consider the additional
impact on the accuracy of SRS linear fitting with respect to source-detector separation
when scattering changes. We perform a more complete analysis of physiologic error with
respect to +,- in Chapter 4. With this understanding of error dependency in CW NIRS

instruments in clinical use, we can better identify when and how measurements of
cerebral hemodynamics by CW NIRS are most susceptible to error.
A.6. Diffuse Correlation Spectroscopy (DCS)

Diffuse correlation spectroscopy (DCS) is a time-domain diffuse optical technique
that derives a cerebral blood flow index (BFI, cm2/s) from quantification of the rapid
speckle intensity fluctuations of multiply scattered coherent NIR light induced by red
blood cell motion.30–32 With much similarity to the diffusion of photons, the temporal

electric-field ( ( , )) autocorrelation function (
diffuses through tissue.

!(

, ") = 〈

∗(

, ) ∙ ( , + ")〉 ) also

Its transport dynamics are described by the correlation diffusion equation:

−@2( ) = ¯∇° ∙ ( )∇ − @+ ( ) −

3

@+,- $% 〈Δ (")〉±

!(

, ").

(1.28)

Notice, this formulation is like the photon equation for CW light. However, the correlation
function is expressed as a function of position

and correlation delay-time ". $% is the

wavenumber (i.e., inverse of optical wavelength) in tissue,
scatterers to total scatterers in the optical cross-section,

is the ratio of moving

is the photon diffusion

coefficient from the photon diffusion equation, and + and +,- also appear as previously

defined. Interestingly, the factor 〈Δ (")〉 also appears as an absorption term which
contributes to decreased correlation; this factor is defined as the mean-square

displacement of the scatterers after a delay-time ". 〈Δ (")〉 is often set to be 6
15

",

where

is the effective diffusion coefficient of moving scatterers; this approach

assumes the movement of the scatterers in tissue (red blood cells) is well approximated
by an effective Brownian model. Using a similar method of an extrapolated-zero
boundary condition and the method of images discussed in Section A.2 (above), the
solution for
! ( , ") =

!(

, ") in a semi-infinite homogeneous medium may be expressed as:

3+,- 2% V M²(³)'p V M²(³)'6
−
h
i,
4Z
!

where ´(") =

µ
|¶ ¯+

+

· + $ ± (6
• , %

(1.29)

p
6

")} .

The blood flow index (BFI) measured by DCS is the combined coefficient

.

Using high-speed instrumentation to quantify the normalized intensity autocorrelation
function (# ( , ")) of arriving photons at the detector, the normalized electric field

autocorrelation function (#! ( , ")) can be calculated via the Seigert relation (# (") = 1 +

¸|#! (")| ). ¸ = Λ , where Λ is the speckle contrast of the intensity speckle fluctuations.
The calculated #! ( , ") curve may then be fit using a least-squares minimization

algorithm to empirically derive

~BFI.

Due to the direct dependence of the autocorrelation function on + and +,-

(Equation 1.29), the quantification of BFI is thus dependent, as was the quantification of
[HbO2] and [Hb], on accurate measurement of these optical properties. If + and +,- are

not quantified, then they must be assumed to derive a BFI. This results in significant

errors in both absolute BFI and its relative changes.33 In this work, concurrent FD-DOS

measurements are carried out to quantify + and +,- in the same tissue volume
measured by DCS for improved physiologic accuracy of BFI.

An example of the fitted #! curve as a function of delay time " demonstrates

(Figure 1.3) the effects of cooling to deep hypothermia and deep hypothermic circulatory
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Figure 1.3. Normalized electric field autocorrelation function (g 1 ) exhibits slower
decay as the blood flow in tissue declines. The fitted autocorrelation function is shown
for measurements acquired at baseline on cardiopulmonary bypass (red), during deep
hypothermia (blue), and during deep hypothermic circulatory arrest (DHCA; black).
Optical absorption and scattering properties (μ and μ- ) and fitted blood flow index (BFI)
values, which corresponds to cerebral blood flow, at each time-point are displayed.

arrest (DHCA) on #! , on the optical absorption and scattering coefficients, and on the

BFI (see Chapter 2 and 3). Examining BFI relative to baseline, we are able to show a

~50% decrease in cerebral blood flow as a result of cooling and >99% decrease during
DHCA when all blood has been vacuumed from the body and there are no sources of
cerebral perfusion. These results help demonstrate that, unlike measures of cerebral
blood velocity from transcranial Doppler ultrasound,34 DCS quantification of BFI is not
impacted by low flow; i.e., DCS is sensitive to very small flows.
BFI measured by DCS has been clinically validated against Xenon CT,35
transcranial Doppler ultrasound,36,37 phase-contrast,38,39 arterial spin labeling MRI,40 and
fluorescent microspheres.41 It has been repeatedly shown to be an accurate surrogate of
relative cerebral blood flow (rCBF). Moreover, quantitative relationships have been
explored in order to translate BFI into physiologic units (ml/min/kg) of cerebral blood flow
in children.38,39 The impact of deep hypothermia on quantification of BFI and validation
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Figure 1.4. Non-Invasive Measurement of Cerebral Metabolism: Combining
frequency-domain diffuse optical spectroscopy (FD-DOS) measures of cerebral tissue
oxygen saturation (StO 2 ) and diffuse correlation spectroscopy (DCS) measures of
cerebral blood flow (CBF), the cerebral metabolic rate of oxygen (CMRO 2 ) can be
calculated using the known O 2 carrying capacity of hemoglobin, the hemoglobin
concentration in blood ([Hgb]), the arterial oxygen saturation (SaO 2 ), and an
assumption of the optical venous fraction (γ).

against invasive measures of rCBF by laser Doppler flowmetry is an important aspect of
Chapter 2.
A.7. Diffuse Optical Measurements of Cerebral Oxygen Metabolism
Concurrent measures of cerebral oxygenation by FD-DOS and cerebral blood
flow (CBF) by DCS, permit the combined calculation of the cerebral metabolic rate of
oxygen (CMRO2). While the methodology is reviewed in detail later in the methods of
Chapter 2, here we provide a brief overview of it in Figure 1.4.
To perform FD-DOS measurements, our clinical diffuse optical instrument
(Figure 1.5, B) incorporates a commercially available frequency-domain instrument
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Figure 1.5. Clinical Diffuse Optical Instrumentation: Our diffuse optical instrument
features a custom, laboratory built DCS instrument (A), a commercial FD-DOS
instrument (B), an uninterruptible power supply to permit instrument portability (C), a
digital data acquisition board (D) and a desktop control computer (E). The portability of
instrumentation has permitted instruments at the bedside in the operating room and
intensive care units.

(Imagent; ISS Inc., Champagne, IL, USA) that has been customized with four laser
diodes at four distinct wavelengths in the NIR window (690nm, 725nm, 785nm, 830m).
Via customized fiber optic measurement probes, the source light is transmitted to the
tissue surface and detected photons are transmitted back to two high-sensitivity
photomultiplier tube (PMT) detectors. The emission of these lasers and the detector are
both sinusoidally intensity-modulated at 110MHz.
The duplicated sources for each wavelength of emission allows for placement at
up to four difference source positions. The lasers are multiplexed such that only one of
the sixteen sources is turned on at any given time. Time multiplexing of these sources
then permits separated measurements at each wavelength and source position. A full
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cycle of measurements from all sources is acquired at a rate of 10 Hz. The instrument
also features automated optimization of PMT gain which ensures that the PMT is
acquiring the highest sensitivity signal permitted without saturation.
The DCS instrumentation (Figure 1.5, A) employs long-coherence length (>10m)
lasers sources (RCL-080-785S; CrystaLaser, Inc, Reno, NV, USA) and single-photoncounting avalanche photodiode detectors (SPCM-AQ4C; Excelitas Technologies, Corp.,
Waltham, MA, USA), operating in Geiger mode, to detect and time the arrival of photons
in each “speckle.” These photons have traveled through the brain.
A high-speed correlator board (FLEX03OEM-8CH; Correlator.com, NJ, USA) is
used to measure the intensity autocorrelation function. It is computed for delay times
ranging from 200ns to 1s. This permits empirical computation of a cerebral BFI from
fitting to data (as described), which typically ranges from 1x10-9 to 5x10-8 cm/s2 under
normal physiologic conditions. However, during extreme physiological conditions such
as circulatory arrest, significantly lower values are measured.
The FD-DOS instrument and DCS instrument are both connected to a digital data
acquisition board and desktop computer which facilitate multiplexing of FD-DOS and
DCS measurements (Figure 1.5, D and E). Due to the overlapping sensitivity of FDDOS detectors to DCS sources and vice-versa, these different measurement modalities
must also be multiplexed in time. The tuning of timing parameters is often dependent on
study design. The DCS measurement is the more sensitive and “light-starved” due to the
need for single-mode detection fibers to maintain coherence of detected photons. Thus,
when allowable, it is beneficial to acquire more DCS measurements to increase signalto-noise of the measurement. When examining physiologic signals with slower temporal
components (>1 minute) the DCS instrument was allowed to integrate for 3 seconds per
frame before switching to a 1 second measurement frame of FD-DOS. However, in the
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context of rapid physiologic changes (i.e., cardiopulmonary resuscitation), the integration
time of the DCS signal was decreased to 500ms to permit increased time resolution.
Including delays for switching between the modalities, an approximate combined
FD-DOS/DCS sampling rate of 0.16Hz during cardiopulmonary bypass experiments
presented in Chapter 2 and 3. The sampling rate was 0.3Hz in the resuscitation work
presented in Chapter 4.
The technique of combining DOS and DCS to perform all-optical cerebral
metabolic measurements has the tremendous advantage of a compact patient
interface.42–44 This is critical when working with newborns and infants where not only is
the head small, the skull is still hardening, and in some cases, the skull has yet to cover
regions of the central fissure. Optical metabolic imaging has been applied with great
promise in a variety of clinical contexts. In Francescini et al., the measurement of
CMRO2 in infants demonstrated increasing THC and CMRO2 with age despite stable
StO2; this likely reflects increasing metabolic demands of brain maturation that could not
have been accessible without the concurrent DCS measurement of CBF.45 Using an
earlier version of our clinical instrument, Durduran et al., demonstrated a lack of change
in CMRO2 during hypercapnia in neonates with severe congenital heart defects. This
work verified the expected physiologic response and demonstrated that optical
measurements could be used to interrogate whether this proper autoregulatory response
was present. This technique has clearly demonstrated improved patient accessibility
over existing clinical modalities.
By extending this work to continuous monitoring during procedural interventions,
we demonstrate that, in addition to logistical benefits, the high temporal resolution of
optical methods allows for the development of novel diagnostic measures of cerebral
status. Cerebral status information, in turn, could facilitate real-time guidance during
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neonatal cardiac surgery and resuscitation and improve neurological outcomes in these
high-risk pediatric populations.
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B. Mitigating Pediatric Brain Injury During Hypothermic Cardiopulmonary
Bypass
B.1. Post-Operative Neurological Injury in CHD Neonates
Congenital heart defects (CHD) occur in approximately 8 of every 1,000 live
births worldwide and are the most common congenital birth defect.46 Approximately 1 in
3 of these newborns are affected by severe CHD, or life-threatening lesions requiring
immediate surgical intervention in the first weeks of life.47 Despite considerable
increases in survival over the last two decades, the ~40% incidence of newly acquired
post-operative neurological injury,48,49 specifically white matter injury, has remained
largely unchanged and poses a significant challenge to short-term morbidity and longterm neurodevelopment.47,50 In recent results, at 1 year of age, children who underwent
two-ventricle repair at less than 9 months of age continue to exhibit significant reductions
in white matter volume that accounted for 75% of total reduction in brain volume
compared to healthy age-matched controls.51 White matter volume was also significantly
associated with standardized measures of language and communication development
which were below the 50th percentile. Within the first 3 years of life, in absence of known
genetic syndrome, 35% experience significant neurodevelopmental delays,52 and at
school-age, 23% report impaired psychosocial functioning.53 Neuroprotective strategies
to identify and address operative risk factors for neurological injury in these neonates are
urgently needed to prevent early injury with potentially catastrophic long-term reductions
in quality of life.
Beca et al., identified that infants with severe CHD that required surgical repair of
the aortic arch had more than 4-fold increase in risk of acquired post-operative white
matter injury.54 In these patients, duration of cardiopulmonary bypass (CPB) and the use
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of deep hypothermic circulatory arrest (DHCA) were identified as operative risk factors;
(1) for each 1-minute increase in CPB duration, risk of injury increased by 2%, and (2)
risk of injury increased 5-fold with the use of DHCA.
While recent dialogue surrounding the association of perioperative risk factors
and long-term neurodevelopmental outcomes has emphasized the importance of nonmodifiable patient characteristics and socio-economic factors,49,54,55 the occurrence and
impact of severe hypoxic-ischemic insults56–58 during surgical correction remain
unquantified in increasingly vulnerable patients due to the lack of routine intraoperative
neuromonitoring.59 Moreover, the findings that intraoperative cerebral oxygen saturation
is associated with both white matter injury60 and neurodevelopmental outcomes at 1 year
of age61, and that deficits in both total brain volume and white matter volume are
significantly associated with cognitive, motor and executive function in adolescence,62
indicate the value of developing neuromonitoring strategies for individual optimization of
intraoperative risk factors to address discriminant neurological injury in high-risk
individuals.63
B.2. Intraoperative Risk Factors for Post-Operative Neurological Injury
Extracorporeal Cardiopulmonary Bypass (CPB) Support
Cardiopulmonary bypass (CPB) support provides perfusion, gas exchange, and
temperature management of the patient during surgical repair, but, in the process, it
exposes the perfusing blood to an artificial environment that contrasts starkly with the
smooth vascular endothelium in the body.64 The use of CPB in neonates inherently
causes 2 to 3-fold hemo-dilution due to the volume of blood in the CPB circuit compared
to the neonate’s corporeal volume; by contrast, in adults, the CPB circuit volume is only
1/3 to 1/4 of patient volume. Thus, it should not be surprising that placement of an infant
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on extracorporeal CPB support is associated with several well-documented physiologic
mechanisms which increase the risk of neurological injury.65 These include systemic
release of inflammatory mediators,66,67 hydropic degeneration of cellular membranes,68
tissue edema,69 and risks of cerebral hyperthermia70,71 and ischemia-reperfusion injury.72
Advances in management of CPB support have endeavored to address these
mechanistic risks, and routine neuromonitoring appears to be necessary in this context
to address the uncertainty of the effects on cerebral perfusion and oxygenation.
Deep Hypothermia & Temperature Management
Deep hypothermia (DH), or the profound lowering of body temperature to below
20°C is commonly used during CPB to improve vital organ tolerance to procedural
ischemia by suppressing metabolic demand.73,74 While this technique is largely
recognized to be beneficial and has been used in neonates for more than four
decades,75 standardized guidance about the management of cooling and rewarming to
prevent neurological injury was only released in 2015. This guidance focused on adult
care; pediatrics studies were only cited twice.76,77 For infants, both target temperature for
optimal neuroprotection and the site of temperature measurement remain
controversial.74,78 The most widely cited reports characterizing the temperature
dependence of cerebral metabolism (which is the primary therapeutic target of DH)
during CPB in children79 by Greeley et al., and in adults80,81 by Croughwell et al. and
McCullough et al., suffer from uncertainty due to lack of true brain temperature
determination.
In prominent surgical textbooks describing neonatal cardiac repair,74,82
nasopharyngeal and esophageal temperatures are used for guidance of deep
hypothermia. Indeed, these temperature measurement locations are the same at our
institution, wherein the target temperature is 18°C.83 Nasopharyngeal temperature is
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also commonly reported in studies to assess the depth of hypothermia.83–85 Both
nasopharyngeal and tympanic membrane temperatures are recommended over bladder
or rectal temperatures to avoid the potential of cerebral hyperthermia during
rewarming.74 However, even without exogenous temperature alterations, inconsistent
agreement with brain temperature has been reported for both anatomical locations in
children and animal models.86–89 Moreover, in the context of subsequent ischemia during
deep hypothermic circulatory arrest (DHCA), the extent of ischemic neuronal injury has
been shown to be highly brain temperature-dependent.90 Thus the precise determination
of brain temperature, or residual metabolism, is critical to ensure neuroprotection.
Unfortunately, the existing clinical modalities suitable for continuous intraoperative
monitoring are limited. This knowledge gap is and these limitations represent the primary
motivation for the work presented in Chapter 2. Feasible intraoperative modalities and
their limitations will also be discussed further below (Section B.3).
Deep Hypothermic Circulatory Arrest (DHCA)
Reconstruction of the aortic arch is an essential aspect of surgical intervention of
several neonatal cardiac defects. These include interrupted aortic arch, aortic arch
hypoplasia, and univentricular lesions (e.g., hypoplastic left heart syndrome, HLHS), the
lesion type with the greatest burden of post-operative neurological morbidity.82 Standard
cannulation techniques for cardiopulmonary bypass (CPB) require an intact aortic arch
to maintain cerebral and corporeal perfusion; however, this precludes the conduct of
surgical aortic arch reconstruction. In neonates where circulatory arrest is deemed
necessary for repair, deep hypothermia, as described above, is induced to mitigate
hypoxic-ischemic injury during circulatory arrest. Extended durations of DHCA
(durations > 41 minutes) have significantly worse neurodevelopmental outcomes at
school age.91 Alternatively, to provide continuous perfusion and cooling to just the brain,
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selective cerebral perfusion (SCP) may be established via the right innominate and
vertebral arteries after only a brief period (~15 minutes) of circulatory arrest.92,93 The
brain may then be continuously cooled and perfused at low flow (10-30 mL/min/kg) with
ongoing arch correction in the thoracic cavity. Selection between DHCA versus SCP, or
other similar “low-flow” perfusion strategies, remains a contentious topic among pediatric
cardiac surgeons and is largely determined by institution of practice.94 For DHCA
durations <40 minutes, rates of seizure were comparable to neonates and infants
wherein DHCA was not used.95 In fact, in a relatively recent prospective randomized
control study published by Algra et al., DHCA and SCP exhibited almost identical
incidence of post-operative neurological white matter injury.96 DHCA is currently used at
our institution and is the focus of Chapter 3. Intraoperative monitoring of cerebral
perfusion and metabolism has the potential to offer an objective measure of cerebral
health that will permit individual-level, rather than institutional-level, optimization of
management and neurological outcomes.
B.3. Intraoperative Neuromonitoring
The use of multimodal intraoperative neuromonitoring has provided substantial
evidence for positive impact on neurological outcomes following adult and pediatric
cardiac surgery.97,98 In a study of 250 children undergoing surgical repair of congenital
cardiac defects, Austin et al.97 used concurrent electroencephalography (EEG),
transcranial Doppler ultrasound (TCD), and continuous-wave cerebral near-infrared
spectroscopy (NIRS; i.e., a diffuse optical technique); in this study, an interventional
algorithm designed to address deficiencies in cerebral perfusion and oxygenation had a
beneficial impact on the incidence of postoperative neurologic sequelae and hospital
length-of-stay. Strikingly, NIRS cerebral oximetry and TCD measurement of blood flow
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velocity in the middle cerebral artery could account for 58% and 37% of abnormalities
detected, respectively, leaving only 5% EEG-related. Neuromonitoring-based
intervention resulted in significant improvement, from 26% incidence of neurological
complications to 6%. This result is comparable to the 7% seen in children where no
abnormalities were detected. Additional critical review has estimated that 90% of
cerebral abnormalities may be detected via NIRS and 10% via TCD.25 These and more
recent findings of predictive value in adverse neurological outcomes at 1 year of age
have led to increased adoption of intraoperative NIRS-derived cerebral regional oxygen
saturation (rSO2) monitoring;61,92,99,100 however, logistical difficulty with placement and
operation during the course of surgery has prevented similar adoption of TCD.101
While valuable for trend monitoring, intraoperative NIRS has both measurement
limitations and variability (see above, Section A.5). These issues are widely reported,
and the technology also precludes clinical interpretation based on absolute values of any
of the parameters it probes, particularly in the context of cardiopulmonary bypass and
circulatory arrest.27,102–104 Errors in NIRS quantification of rSO2 are introduced from
assumed baseline properties, which include a population-derived scattering coefficient
that may vary ~50% between neonatal subjects, especially in high-risk populations with
diverse presentations.5,45,105 Moreover, profound physiologic changes during CPB (e.g.,
hydropic degeneration in the brain leading to fluctuations in osmolarity68,106) and cooling
of the dermis and subdermis107 impact tissue scattering and cause additional errors in
this method of quantification. In many clinical systems, the limited optical power of lightemitting diode sources is susceptible to low optical signal at the limits of detection in the
presence of abnormally elevated hematocrit levels or darker skin pigmentation.108
Despite these shortfalls, rapid adoption of commercial NIRS systems has taken place
due to critical clinical needs and is encouraging for future acceptance of more advanced
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diffuse optical instrumentation that directly address existing limitations of NIRS (CW
NIRS).
B.4. Improved Clinical Accuracy Using Quantitative Diffuse Optical Monitoring
As described in Section A (above), frequency- and time-domain diffuse optical
spectroscopy, characterize scattering effects directly, and enable continuous absolute
quantification of oxy- and deoxy-hemoglobin concentration for calculation of cerebral
tissue oxygen saturation (StO2).53 Increased feasibility testing of DOS absolute
quantification in clinical pediatric settings has been reported since initial measurements
in 35 healthy newborn infants by Duncan et al., in 1995,3 over two decades ago, and
then in neonates undergoing surgical cardiac repair by Watzman and Kurth et al. in 2000
at our institution.23 Absolute quantification has enabled cross-sectional comparisons with
exciting new insights in this high-risk population by Lynch et al., regarding the critical
decline of StO2 in the pre-operative period and correlations with subsequent neurological
injury.109,110 The use of coherent laser sources, radio frequency-modulation, and more
sensitive optical detectors extend conventional NIRS limits of detection and permit more
accurate and sensitive spectroscopic analysis.27 Furthermore, frequency-domain DOS
(FD-DOS) quantification of StO2 does not exhibit temperature sensitivity during deep
hypothermia.111
However, even with improved quantification, intraoperative cerebral saturation
monitoring alone does not fully capture dynamic information regarding cerebral oxygen
delivery. This is important when identifying the cause of abnormal readings and for
determining the appropriate intervention, if any. In the context of deep hypothermic
cardiopulmonary bypass, depressed StO2, a result of increased oxygen extraction, may
reflect increased cerebral metabolism and cerebral inflammation when cerebral blood
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flow is concurrently elevated. Alternatively, if cerebral blood flow is depressed, the
condition may not be pathologic as long as total oxygen metabolism is comparable to a
healthy baseline. Quantification of cerebral blood flow enables more accurate
formulation of critical differential diagnoses.
TCD measures of blood flow-velocity have been effectively used as a surrogate
for cerebral blood flow (CBF) and for emboli detection in clinical research settings.
However the variable integrity of the developing neonatal skull is a significant challenge
for stable probe placement during the course of surgery.25,74
Diffuse correlation spectroscopy (DCS; see above Section A.6) is a relatively
novel technique for non-invasive measurement of CBF which has been cross-validated
against numerous clinical imaging modalities.35–41 As a stand-alone modality, DCS
measurements of CBF exhibit shortcomings which are comparable to those of
conventional NIRS and measurement of rSO2. It has been shown that DCS
measurement error of CBF is susceptible to assumption errors of optical scattering.33 As
a result, the use of concurrent absolute FD-DOS quantification of optical scattering and
absorption properties enables more accurate DCS measurement of CBF. These
advanced modalities may be combined into a single compact measurement probe,
equivalent in size to conventional NIRS forehead probes, but now equipped with the
capability of non-invasive cerebral metabolic monitoring in neonates.40,45 With adjunct
blood gas monitoring of arterial oxygen saturation (SaO2) and hematocrit (Hct),
continuous measurements of cerebral oxygen saturation via FD-DOS and cerebral blood
flow via DCS may be combined into a real-time measure of cerebral metabolic rate of
oxygen (CMRO2; Chapter 2, Section C.5). This is a significant logistical advantage for
using DCS over TCD monitoring in the operating room. Importantly, a good correlation
between DCS cerebral blood flow index and TCD blood flow-velocity have recently been
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reported in neonates during cardiopulmonary bypass and deep hypothermia.37 In this
thesis, we extend these novel techniques to validate continuous quantification of
cerebral oxygen metabolism during deep hypothermia to enable more accurate and
rapid identification of pathologic mismatches in oxygen demand and supply.
B.5. Significance & Innovation
Recent reports have demonstrated the feasibility of FD-DOS and DCS in the
neonatal cardiac intraoperative environment.37,112 However, the validity of DCS
quantification of cerebral blood flow or in the combined FD-DOS/DCS quantification of
CMRO2 has not been tested (or explored) during the profound physiologic changes
induced by deep hypothermia and subsequent rewarming to normothermia. In Chapter
2, titled “Non-invasive optical neuromonitoring of the temperature- dependence of
cerebral oxygen metabolism during deep hypothermic cardiopulmonary bypass in
neonatal swine,” we pursue two primary objectives. First, using concurrent measures of
non-invasive and invasive sampling of oxygen extraction fraction (OEF), CBF, and
CMRO2, we validate the non-invasive optical instrumentation during the induction of and
recovery from deep hypothermic cardiopulmonary bypass. Secondly, we examine the
sufficiency of conventional nasopharyngeal temperature guidance of deep hypothermia
to reflect intracranial brain temperature and metabolism. The combination of continuous
non-invasive nasopharyngeal and invasive intracranial temperature sampling, as well as
continuous non-invasive metabolic quantification, permits unprecedented high-resolution
characterization of the temperature-dependence of cerebral oxygen metabolism during
cooling and rewarming as well as examination of agreement with broadly-applied
Arrhenius-type models113–116 of reaction-rate dependence. Our results provide valuable
insights regarding the clinical variability of metabolism with respect to nasopharyngeal
31

temperature, as well as validation data to support the use of quantitative diffuse optical
measurement of cerebral metabolism to effectively address this variability.
We thus can move forward to the next step of our investigation, with improved
confidence in our quantitative metabolic measures, and the insight that accurate
characterization of metabolic temperature dependence necessitates the use of invasive
intracranial temperature. Further, individualized optimization of surgical management
requires quantification of expected effect sizes in order to determine diagnostic
thresholds which delineate those with increased risk. In Chapter 3, titled “Impact of deep
hypothermic circulatory arrest on non-invasive diffuse optical measurement of cerebral
oxygen metabolism in neonatal swine,” we extend our study to examine cerebral
metabolism in an additional cohort of neonatal swine (n=10) who were randomized to
receive 40 minutes of deep hypothermic circulatory arrest (DHCA) versus deep
hypothermic continuous perfusion (DHCP); note, animals who had been included in the
initial validation stage of the study were limited to those in the DHCP group.
Continuous metabolic quantification during circulatory arrest permitted novel
quantification of the timing of oxygen availability via the concentration of oxy-hemoglobin
[HbO2], the timing of oxygen extraction via the calculated oxygen extraction fraction
(OEF), and insights into the persisting impact of circulatory arrest on cerebral oxygen
metabolism during the rewarming period as reflected by comparison of metabolic
temperature-dependence in the cooling period, prior to arrest, versus the rewarming
period, following arrest. Quantification of the effects of DHCA on cerebral oxygen
metabolism provides improved understanding of the timing and magnitude of metabolic
shifts, including from aerobic to anaerobic respiration during prolonged arrest, as well as
the sufficiency of reperfusion to replenish depleted oxygen following circulatory arrest.
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Future examination of how these parameters are associated with neurological outcomes
may lead to the identification of critical thresholds to prevent neurological risk.
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C. Neurological Predictors of CPR Outcome following Pediatric
Respiratory-Mediated Cardiac Arrest
Children who suffer cardiac arrest face high rates of mortality and neurological
morbidity. Herein, we examine outcomes following pediatric cardiac arrest, risk factors,
and the potential role of non-invasive neuromonitoring to address these risk factors.
C.1. Neurological Morbidity and Mortality following Pediatric Cardiac Arrest, Risk
Factors, and the Role of Cardiopulmonary Resuscitation (CPR)
Over the last 15 years, survival has significantly improved from ~30% to over
45%117–120 for children of all ages (<19 years) who suffer in-hospital cardiac arrest
(IHCA). However, for those who suffer out-of-hospital cardiac arrest (OHCA), despite
improved CPR quality over time,121 there has been only limited evidence of improved
survival for adolescents (aged 12-18 years)122 but not for infants (<1 year) or for children
(1-11 years).122,123 Infants and children, who represent ~50% and 25%, respectively, of
all pediatric cardiac arrests,119,122–126 face bleak rates (~3.5 and 10%, respectively) of
survival to hospital discharge with little improvement in the last 5 years.127,128
The discrepancy between pediatric IHCA (pIHCA) and OHCA (pOHCA) also
extends to neurological outcomes and morbidity. Over 60% of pIHCA survivors achieve
favorable neurological outcomes, defined as a Pediatric Cerebral Performance Category
(PCPC) of 1 (normal age-appropriate neurodevelopmental function), 2 (mild disability) or
3 (moderate disability), as opposed to 4 (severe disability), 5 (comatose/vegetative), or 6
(death), with no significant differences across age groups.117,119,126,129 In comparison,
only one-third of pOHCA survivors achieve favorable neurological outcomes.124,130 In a
2015 report summarizing n=1980 children (<18 years) who experienced an OHCA and
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factors associated with their outcomes, 69.8% were young children (<7 years) who
constituted only 32.0% of survivors.123 A multivariate model accounting for sex, race,
historical timing, and first monitored rhythm showed a highly significant age group bias
(p<0.001) where children younger than 7-years of age were less than half as likely to
have favorable neurological outcomes compared to older children aged 13 to 17-years.
Critically, accounting for age group, the presence of a shockable first monitored rhythm
conveyed a 6.8-fold increase (p<0.001) in favorable neurological outcomes over nonshockable rhythms (e.g., asystole). The distinct and persisting risk factors of OHCA
highlighting young age and first-presentation with a non-shockable cardiac
rhythm121,123,125,130 strongly indicates that young children may have physiologically
discrepant mechanisms which affect their response to cardiac arrest as well as their
ability to recover from arrest. We carefully consider these characteristic features in the
selection of our physiological model to permit an accurate representation of this at-risk
population.
While beyond the immediate scope of the presented work, we highlight another
important, persisting and modifiable risk factor which distinguishes children who suffer
an OHCA in the United States and impacts both chances of bystander CPR and
subsequent neurologically intact survival: race. In a recent study examining pOHCA in
3,900 children occurring in 2013-2015 from the Cardiac Arrest Registry to Enhance
Survival (CARES) database of the US Centers for Disease Control and Prevention
(CDC), 56.3% of white children received bystander CPR compared to 39.4% of black
children and 44.0% of other racial backgrounds (i.e., black and other non-white children
were 30% and 22% less likely to receive bystander CPR, respectively).131 Receiving
bystander CPR translated into a 1.5-fold (95% CI: 1.2, 2) increase in survival with
favorable neurological outcomes. In total, even adjusting for the occurrence of bystander
35

CPR, age, sex, witnessed arrest, arrest location, rhythm type, and defibrillation, black,
Hispanic and other races/ethnicities were 32%, 9%, and 13% less likely than white
children to achieve survival with favorable neurological outcomes. Though a cursory
glance might suggest innate racial or genetic health disparities, these statistics do not
account for provider bias or timing characteristics critical to survival (e.g., time to
initiation of compressions). In comparison, a recent study of 29,577 children with IHCA
from 1997 to 2012 in the United States also observed a racial discrepancy where
survival was 8.8% and 12.8% less likely in black and other non-white children compared
to white children.120 In a smaller study of pIHCA in 3,701 children occurring in 2006,
adjustment for age, sex, hospital location, comorbidities, and cardiac factors resulted in
no racial disparities in incidence or survival.132 Racial disparities in the out-of-hospital
setting are not unique to children,133 and deserve continued attention by all communities
inside and outside of academia.134
Despite the many discrepant risk factors between pIHCA and pOHCA, a common
connection is timing. The 3-phase time-sensitive model of physiologic response following
cardiac arrest, as described by Weisfeldt and Becker,135 may underlie a striking U-curve
relationship, uncovered by Tijssen et al., between pOHCA scene time (i.e., the amount
of time spent by first-responders at the scene prior to departing towards a hospital) and
survival to hospital discharge.122 Both a scene time <10 minutes or >35 minutes
conveyed decreased chances of survival compared to 10-35 minutes. This was
attributed to the lack of intervention (e.g., defibrillation, intravenous fluid administration)
for a “scoop and run” encounter associated with <10 minutes, versus detrimental or futile
over-intervention (e.g., placement of an invasive airway) that delayed re-establishment
of perfusion when scene times exceeded 35 minutes. Given an average emergency
medical services (EMS) response time of 5 to 5.5 minutes121,122 following a 9-1-1 call, the
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timeline of survival risk is well-aligned with pIHCA. For pIHCA occurring in an intensive
care unit (ICU; 96% of pIHCA136), cardiopulmonary resuscitation (CPR) times exceeding
30 minutes had a decreased survival rate of 28% compared to 45% overall survival.119
The median [IQR] CPR time in survivors of pIHCA was found to be 15 [7-36] minutes
versus 29 [15-49] minutes in non-survivors within a cohort of 880 children.129 The
achievement of return of spontaneous circulation (ROSC; i.e., restarting of the heart)
within 30 minutes of arrest appears critical to survival, though not the only determinant.
Compared to the respective infant and children OHCA survival rates of ~3.5% and 10%
discussed above, infants and children who suffered OHCA but achieved ROSC prior to
hospital arrival had increased survival rates of 28.6% and 47.1%, respectively;121 these
statistics are more concordant with survival in pIHCA (~45%).
In addition to timing, quality of CPR is also divisive for survival, both in-hospital
and out-of-hospital, and, potentially, a more modifiable risk factor.121,137 Notably, the
pIHCA survival rate of subjects with CPR times ranging from 16-35 minutes appear
nearly identical to those with CPR times >35 minutes (17.8% versus 15.9%).126 In the
pediatric ICU setting, Berg et al. observed that though survival was lower with extended
CPR times >30 minutes, the rate of survival with favorable neurological outcomes (89%,
n=8/9) did not differ from survivors with only 1-3 minutes of CPR (90%, n=26/29).119 This
is evidence that, while in the pursuit of ROSC, high-quality CPR has the potential to
provide life-sustaining perfusion that is also adequate for neurological protection in
pediatric survivors of cardiac arrest. This is the foundation of the work presented in
Chapter 4 and central to our vision of improving upon existing physiologic indicators of
high-quality CPR.
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C.2. Pediatric CPR Guidelines and Quality Monitoring
With varied levels of emergency response training and interventions ranging from
the lay-graduate student performing hands-only CPR to the critical care attending
physician initiating extracorporeal life support (ECLS), we are compelled to inquire, what
defines “high-quality” CPR? How does one know if ongoing CPR is “high-quality”? And
critically, with persisting rates of >50% mortality in the hospital setting where trained
professionals administer CPR, what is the future of “high-quality” CPR? Every 5 years
the International Liaison Committee on Resuscitation (ILCOR), which includes
representative organizations from the US, Canada, Europe, Latin America, South Africa,
Asia, Australia and New Zealand, reviews previous guidelines and new literature and
consolidates evidence into a report detailing the Consensus on Science with Treatment
Recommendations (CoSTR). This is the core component of updated guidelines
published by the American Heart Association (AHA) for Pediatric Basic and Advanced
Life Support127,138 and Cardiopulmonary Resuscitation Quality.139 The current guidelines
are described in relation to recent advances in CPR quality monitoring.
What defines “high-quality” CPR?
High-quality CPR, summarized by the AHA catch phrase, “PUSH HARD and
PUSH FAST,” is explicitly defined as 1) ensuring chest compressions of adequate rate,
2) ensuring chest compressions of adequate depth, 3) allowing full chest recoil between
compressions, 4) minimizing interruptions in chest compressions, and 5) avoiding
excessive ventilation.139 Many aspects of the guidelines for basic life support (BLS) CPR
(see Table 1.1) in infants and children are consistent with those of adult CPR to permit
minimized teaching complexity and improved skill retention. These include initial scene
safety checks, pulse and breathing checks for a maximum of 10 seconds, identical chest
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compression rate recommendations of 100-120 compressions per minute, and the 2010
adoption of the C-A-B (“Circulation”-“Airway”-“Breathing”) sequence of initiating CPR
over the historic A-B-C (“Airway”-“Breathing”-“Circulation”) sequence to minimize time to
first compression, a well-established risk factor in adult OHCA,140 but, as of yet, has had
no demonstrated impact on survival in pediatric populations compared to the A-B-C
sequence. Recommendations specific to children (defined as before puberty) include, in
the event of an unwitnessed collapse, immediate initiation of 2-minutes of CPR with a
chest compression depth at least 1/3 of the anterior-posterior diameter of the chest (i.e.,
front-back distance of upper torso), which is approximately 4 cm in infants and 5 cm in
children, and an emphasis on using rescue breathing, either in a 30 compression-to-2
breath (30:2) ratio with a single rescuer or 15:2 with two rescuers; following 2-minutes of
CPR, the emergency response system should be activated and an automated external
defibrillator (AED) should be sought and used.
In comparison, for witnessed collapses, or in adolescents and adults where the
predominant arrest etiology is cardiac in origin,141 with a single rescuer, the emergency
response system should be activated and AED sought and applied immediately before
beginning, or with two-rescuers, concurrently to beginning CPR; CPR should be
provided until the AED is ready to use.141,142 In adolescents and adults, compression
depths should be at least 5 cm, but not exceeding 6 cm. Notably, while a trained rescuer
should initiate C-A-B CPR with rescue breathing in a 30:2 ratio, a new version of chest
compression-only CPR with no rescue breathing (i.e., “hands-only” CPR) was introduced
in the 2010 guidelines for the lay-bystander to improve low-rates of bystander
intervention (43.8% in adults143; 37.4% in children122). It has shown significant
improvements in adult survival when dispatcher-assisted, and no significant difference
from conventional C-A-B CPR when un-assisted.144 However, these findings have not
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translated to children where survival following the use of compression-only CPR (12%),
while better than survival with no CPR (9%), is significantly lower than conventional CPR
(17%).131,145,146 This resulted in a 2017 update of the 2015 AHA Guidelines147 to
emphasize, “against the convenience of aligning with adult recommendations for chest
compression-only CPR,” the necessity of rescue breathing in infants and children. These
findings and recommendations underscore that the majority of pediatric cardiac arrest
events with known etiology, either out-of-hospital (27%)130 or in-hospital (57%)129,132, are
asphyxial in nature and, in instances of unwitnessed collapse (>70% of pOHCA122,125,148),
should be treated distinctly from cardiac arrest in adults. To align the generalizability of
our work with these findings, the presented methodology utilizes a model of asphyxiainduced cardiac arrest.
How does one know if ongoing CPR is “high-quality”?
Adherence to the 2010 AHA CPR guidelines for over 60% of the duration when
chest compressions were performed by a trained professional during pediatric IHCA
conveyed a 10.3-fold increase in 24-hour survival over individuals where compressions
did not adhere.149 However, outside of the healthcare profession, it is often difficult to
imagine witnessing the cardiac arrest of a child and being able to perform CPR with an
innate sense of a 4 or 5 cm compression depth or 100 to 120 compressions-per-minute.
The advent of “feedback technology” in the last 15 years has, via force transducers and
accelerometers, begun to provide quantitative measures and both auditory and visual
feedback of CPR quality in real-time.121,150,151 This data has defined the guideline range
of chest compression rates152,153 and, in trained professionals, has helped identify and
correct methodological errors (e.g., leaning during the conduct of CPR154,155) as well as
improved guideline adherence in pediatric IHCA through the use of active feedback
during resuscitation.156
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However, the impact of active feedback on patient outcomes, either pediatric or
adult or during IHCA or OHCA, remains unclear121,157 and an ongoing area of
investigation. In the meantime, the positive impact on conduct of CPR by non-healthcare
providers is worthy of highlight. While previous studies identified a CPR quality
discrepancy between non-health care provider, lay-bystander CPR and trained
professional CPR during OHCA arrests,158 excitingly, two recent studies in the last year
have demonstrated that the activation of audio feedback on public AEDs has enabled
lay-bystanders to perform a comparable quality of CPR to trained EMS rescuers.159,160
Given that a bystander response incorporating both CPR and public AED use compared
to CPR-only has already shown a 3 to 5-fold improvement in survival with favorable
neurological outcomes in pediatric OHCA without active feedback,148,161 these findings
give promise that even further improvements in pediatric OHCA outcomes are possible
through the continued proliferation of public AED devices with feedback and overall
awareness of their benefit. In relation to the presented work, it is encouraging that realtime CPR monitoring of risk factors has helped define “high-quality” care142,152,153 and
holds the potential to significantly improve future outcomes for children.
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Table 1.1. 2015 Summary of High-Quality CPR Components for BLS Providers

Component
Scene Safety

Infants

Children

Adults and
Adolescents

(Age 1 Year to Puberty)

(Age < 1 Year,
Excluding Newborns)

Make sure the environment is safe for rescuers and victim
Check for responsiveness

Recognition of
cardiac arrest

Activation of
emergency response
systems

Compressionventilation ratio
without advanced
airway
Compressionventilation ratio with
advanced airway

No breathing or only gasping (i.e., no normal breathing)
No definite pulse felt within 10 seconds
(Breathing and pulse check can be performed simultaneously in less than 10
seconds)
Alone with no mobile
Witnessed collapse: Follow steps for adults and
phone: Leave the victim
adolescents on the left
to activate the emergency
Unwitnessed collapse:
response system and get
the AED before beginning
Give 2 minutes of CPR
CPR
Leave the victim to activate the emergency
Otherwise: Send
response system and get the AED
someone and begin CPR
immediately; use the AED Return to the child or infant and resume CPR; use
the AED as soon as it is available
as soon as it is available
1 or 2 rescuers

1 rescuer, 30:2

30:2

2 or more rescuers, 15:2

Continuous compressions at a rate of 100-120/min.
Give 1 breath every 6 seconds (10 breaths/min)

Compression rate
Compression depth

Hand placement

Chest recoil
Minimizing
interruptions

100-120/min
At least 2 inches (5 cm);
No more than 2.4 inches
(6cm)

At least 1/3 AP diameter
of chest; About 2 inches
(5 cm)

2 hands on the lower half
of the breastbone
(sternum)

2 hands or 1 hand
(optional for very small
child) on the lower half
of the breastbone
(sternum)

At least one third AP
diameter of chest;
About 1.5 inches (4
cm)
1 rescuer
2 fingers in the center
of the chest, just below
the nipple line
2 or more rescuers

2 thumb–encircling
hands in the center of
the chest, just below
the nipple line
Allow full recoil of chest after each compression; do not lean on the chest after
each compression
Limit interruptions in chest compressions to less than 10 seconds

Abbreviations: AED, automated external defibrillator; AP, anteroposterior; BLS, basic life
support; CPR, cardiopulmonary resuscitation. Reproduced with permission from the AHA. 162
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C.3. Future of “High-Quality” CPR: Physiologic Monitoring
In the continual pursuit of improved survival and neurological outcomes, novel
interventions and risk factors with greater specificity for outcomes are continually being
explored, identified and validated. Despite the demonstrated improvements in care, the
current application of force and depth sensors still suffer from inaccuracies dependent
on the surface of compression;163 without the use of a rigid backboard, sensors placed
on the body are unable to account for surface compression and inaccurately report
deeper compressions than truly applied. In an evolutionary path reminiscent of the
application of force transducers and accelerometers for compression depth and rate,
institutional-level advances in high-resolution physiological monitoring and data
recording at the bedside in the in-hospital setting have permitted unprecedented
understanding of the physiology underlying high-quality CPR, achievement of ROSC,
and neurologically intact survival.164,165 Real-time vitals data collection are a major
component of Pediatric Early Warning Scores (PEWS)166–168 and pivotal to a potential
methodological transition from “rescuer-centric” resuscitation guidance using exogenous
setpoints (e.g., compressions characteristics) to “patient-centric” resuscitation guidance
using the individual’s physiologic response.137 Given demonstrated improvements in
achievement of ROSC using physiologic-directed CPR during adult IHCA169 and updates
to the Pediatric Advanced Life Support (PALS) recommendations supporting the use of
invasive hemodynamic targets, when available, to guide pIHCA resuscitation,127 this
transition is underway and reflects the future of “high-quality” CPR.137
Hemodynamic Monitoring
In a landmark study by Paradis et al. in 1990, coronary perfusion pressure
(CoPP), defined as the difference between aortic arterial blood pressure and right atrial
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(central venous) blood pressure during diastole, was shown to be a highly specific
predictor of ROSC in adults, with no achievement of ROSC in subjects with maximal

CoPP ≤15mmHg.170 CoPP is a measure of the pressure gradient driving blood flow and

oxygenation to the myocardium and has been shown to be highly predictive of

successful defibrillation.171 However, due to the difficulty of inserting both invasive
arterial and central venous blood pressure monitors during an ongoing arrest, and the
lack of mathematical subtraction on vitals display devices, implementation of CoPP
guidance is often prohibitive; data regarding CoPP during CPR remains limited to
subjects where such monitoring is clinically necessary.172 To address this challenge,
arterial blood pressure (ABP) monitoring alone as well as monitoring of end-tidal carbon
dioxide (ETCO2) have been explored as surrogate measures of CoPP and were
identified as pertinent physiologic signals during CPR in a 2013 AHA Consensus
Statement137 as well as recent reviews of physiology-directed CPR173 and CPR practices
in pediatric and cardiac ICUs.174
The latest pediatric-related evidence regarding ABP monitoring during CPR
comes from a prospective study examining promising diastolic ABP (DBP) targets from
animal studies175–177 in 164 children (60% infants, <1 year old) where invasive ABP

monitoring was in place prior to IHCA. A mean DBP ≥25 mmHg in infants and mean

DBP ≥30 mmHg in children over 1 year old, during CPR, was associated with a 1.7-fold
(95% CI: 1.2, 2.6) improvement in survival to discharge with favorable neurological

outcomes. This study defines important thresholds for guidance that will now move
towards independent validation in a future cohort.
End-Tidal Carbon Dioxide (ETCO2)

A similar pediatric investigation was performed examining an ETCO2 ≥20 mmHg

target extrapolated from recommendations137 and studies in adults.178–182 In contrast to
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diastolic ABP thresholds, mean ETCO2 ≥20 mmHg over the first 10 minutes of CPR in
43 children with quantitative capnography in place prior to arrest, either in a pediatric

ICU or cardiac ICU, did not demonstrate improved rates of ROSC or survival to hospital
discharge. A recent review of studies in adults and children173 highlights the high
variability in measured ETCO2 across studies depending on the etiology of the arrest
(e.g., cardiac, respiratory, out-of-hospital) and ventilation rates. In addition, a few-minute
delay in prognostic value during the conduct of CPR during IHCA further limits the use of
ETCO2 for real-time guidance.183 However, there was significant support for alternative
recommended uses of ETCO2 monitoring as a marker of CPR futility, when ETCO2
remains <10 mmHg for over 20 minutes,179 or as an identifier of ROSC.184 The
independent identification of ROSC could potentially remove compression pauses for
cardiac rhythm checks and permit the ideal scenario of minimally interrupted chest
compressions.185,186 Reported data regarding ETCO2 during pediatric CPR remains
limited and deserves further examination as, in contrast to invasive ABP monitoring,
measurements of ETCO2 have been readily studied during IHCA and OHCA.179,187 While
still requiring an advanced life support EMS responder to place an advanced airway,
ETCO2 monitoring is relatively non-invasive compared to hemodynamic monitoring and
may potentially be applicable to a broader population of children outside of the hospital
setting.
C.4. Diffuse Optical Neuromonitoring: An Emerging Diagnostic of CPR Quality
Diffuse optical neuromonitoring, our modality of focus and more commonly
known as near-infrared spectroscopy (NIRS) in clinical CPR contexts, is a promising
emerging technology for monitoring CPR quality which, as repeatedly highlighted in this
work, provides truly non-invasive measurement of cerebral hemodynamics.173,188 Diffuse
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optical neuromonitoring may be performed with the simple application of a rubber probe
pad on the forehead and may be initiated with significantly reduced procedural barriers
compared to either ABP or ETCO2 monitoring. Magnetic resonance imaging,189–191
transcranial Doppler ultrasound,192,193 and electroencephalography (EEG)194–196 have
also been explored for neuromonitoring,197 but currently face prohibitive limitations for
out-of-hospital use; their discussion here is limited, but they remain interesting adjunct
modalities for further investigation.
Neuroprotection is Critical
The importance of cerebral physiology is innately emphasized during cardiac
arrest; in a pediatric animal model (6-12 kg, young mongrel dogs) of cardiac arrest by
ventricular fibrillation, evaluation of the regional distribution of blood flow by radioactive
microsphere injection, preceded by 30 seconds of CPR and followed by 2.5 minutes of
CPR and a single defibrillation, albeit a now outdated version of CPR (chest
compression fraction of 50%, chest compression rate of 62 compressions per minute,
and simultaneous compression to ventilation ratio of 5:1), demonstrated that, compared
to normal controls with sinus rhythm, 90% of cerebral blood flow was sustained versus
35% for the heart and 15% for the kidneys.198 This dynamic distribution reflects the
central role of brain and heart function to survival as well as identifies tradeoffs in
perfusion during resuscitation. Maintained perfusion to the heart versus the brain has
been more highly associated with ROSC following defibrillation,171 however neurological
injury accounts for 81% of subsequent deaths in resuscitated children following
OHCA.199 These compounded risk factors necessitate a multifactorial approach that
incorporates real-time assessment of both cardiac and cerebral status during CPR to
optimize survival with favorable neurological outcomes.
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Diffuse Optical Neuromonitoring: Current Progress
Prior to the presented work, the clinical application of diffuse optical
neuromonitoring of active resuscitation efforts have been limited to the use of
continuous-wave NIRS techniques. In 1995, Mullner et al. first reported on the diagnostic
potential of NIRS in the peri-arrest period in humans.200 Immediately after emergency
department arrival, a NIRS sensor was placed and cerebral oxygen saturation (rSO2)
was measured in adults following OHCA where 6 of 18 subjects had failed to achieve
ROSC prior to arrival. A significant difference was observed between subjects with 1week survival (rSO2 = 63%, 95% CI: 60%-68%) and non-survivors (rSO2 = 46%, 95% CI:
17%-51%; p=0.003); a similar examination of pulse oximetry did not demonstrate group
differences. This represented a promising new application for non-invasive
neuromonitoring which has since been reinforced in a 27-month-long, nationwide study
in Japan published by Nishiyama et al. in 2015. Patients (n=1921) who were
unresponsive (Glasgow Coma Score <9) upon hospital admission following OHCA, both
with (n=148) and without ROSC (n=1773), were measured by bilateral cerebral NIRS for
a minimum of 1 minute. The lowest NIRS value during measurement was found to have
significant correlation with incidence of favorable neurological outcomes (p<0.01).
Interestingly, a decorrelation in right-left NIRS rSO2 was observed in subjects without
ROSC (Pearson’s R=0.66) compared to those with ROSC (Pearson’s R=0.94). These
results confirmed the prognostic potential for neuromonitoring to inform long-term
neurological outcomes.
Recent reviews188,201–203 have documented the dramatic increase in the utilization
of NIRS during adult CPR over the last 10 years, in both the in-hospital and out-ofhospital setting. This, firstly, is a testament to the accessibility and ease-of-use of current
NIRS systems, and, secondly, holds promise for rapid translation of advances in diffuse
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optical neuromonitoring to healthcare providers. Three recent studies (reported in 2016
and after) represent the largest, prospective evaluations of the association of rSO2
measurements during CPR with outcomes, and are subsequently examined here.204–206
In the in-hospital setting, NIRS measurements of 183 adults by Parnia et al.
demonstrated a significant difference in mean rSO2 during CPR between individuals who
achieved ROSC versus those who did not (mean (SD): 51.8% (11.2) vs. 40.9% (12.3)).
Median and mean rSO2 in the last 5 minutes of CPR, as well as median and mean rSO2
over all CPR, and percentage of time with rSO2 above 50% in the last 5 minutes of CPR
and over all CPR were assessed as predictors of ROSC and neurologically intact
survival to discharge. Mean rSO2 in the last 5 minutes demonstrated highest predictive
value for ROSC with a receiver-operating-characteristic (ROC) area under the curve
(AUC) value of 0.76 (95% CI: 0.69, 0.83). Percentage time with rSO2 >50% best
predicted favorable neurological outcomes (AUC = 0.79, 95% CI: 0.70-0.88).
Furthermore, critical decision thresholds for ROSC prediction were identified as mean

rSO2 ≥25% (sensitivity = 100%) and mean rSO2 ≥65% (specificity = 100%). This study

provided critical assessments of potential diagnostic parameters that informed predictor
selection in a subsequent study in the out-of-hospital setting.
From the same authorship group, Singer et al. examined adults (n=100) with out-

of-hospital cardiac arrest upon hospital admission with both ETCO2 and rSO2
monitoring.205 The predictive value of mean ETCO2 and mean rSO2 values during
subsequent CPR were assessed and compared. Both mean ETCO2 and mean rSO2
were significantly higher in patients who achieved ROSC (mean (SD), ETCO2 = 41.1
mmHg (18.1), rSO2 = 45.8% (12.2)) versus those who did not (ETCO2 = 23.8 mmHg
(15.0), p<0.001; rSO2 = 36.4% (13.4), p=0.001). But while the AUCs were similar
(ETCO2: 0.77, rSO2: 0.69), the two measures were not significantly correlated.
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Furthermore, optimal prediction thresholds determined by maximal Youden index (ETCO
≥19mmHg, rSO2 ≥50%) had greater sensitivity with respect to ETCO2 (sensitivity =

100%, specificity 45%) but greater specificity with respect to rSO2 (specificity = 85%,
sensitivity = 48%). These findings confirm that the physiology reflected by each measure
are distinct but potentially complimentary and warrant further multivariate optimization.
The most recent report, by Genbrugge et al., also addressed OHCA following
hospital admission and represents the largest prospective multicenter study to-date with
continuous neuromonitoring during CPR.206 In 329 patients, both initial rSO2 values and
change in rSO2 during CPR were significantly higher in individuals who achieved
sustained ROSC (>20 minutes) versus those who did not (mean (SD) initial rSO2: 41%
(13) vs. 33% (13), p<0.001; median [IQR] change in rSO2: 9% [2,24] vs. 2% [-2.7],
p<0.001). A linear mixed-effects model was used to analyze the trajectory of rSO2 during
CPR as a function of time and found significant differences between ROSC and noROSC subjects (p<0.001). Change in rSO2 >15% during CPR was a highly promising
predictor identified during analysis; adjusting for sex, age, witnessed arrest, bystander
CPR, pre-hospital defibrillation, initial rhythm, EMS response time, and arrest etiology,
achieving a change in rSO2 >15% conveyed a 4.9-fold increase in chances of ROSC.
Given the study sample size, this result is noteworthy and highly relevant to the
methodology and findings of the presented work where both absolute and change in
cerebral hemodynamics are examined during CPR.
These studies provide substantial evidence that non-invasive monitoring of
cerebral hemodynamics during CPR may be prognostic of both ROSC and neurological
outcome. However, diffuse optical neuromonitoring during pediatric CPR has been
limited to animals studies207–215 and three descriptive case reports in children.216–218 Most
recently, Çağlar et al. reported on the largest group of children (n=10) who were
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monitoring by NIRS during CPR following OHCA. Three of ten children achieved
sustained ROSC (>20 minutes) with abrupt increases in measured cerebral oxygenation
at ROSC. With cautious interpretation due to sample size, minimum rSO2 values were
found to be significantly lower in children who did not achieve ROSC compared to those
who did (mean (SD), 20.7% (5.7) vs. 30.0% (1.0); p=0.02). Despite these limited reports,
the future holds promise for growth; the 2018 AHA Scientific Statement on CPR in
Infants and Children with Cardiac Disease has incorporated new recommendations for
NIRS neuromonitoring during pre- and post-arrest care219 following an expert consensus
assessment determining NIRS safe and effective for use in the pediatric critical care
setting.220 To further improve the diagnostic potential of diffuse optical neuromonitoring
during pediatric CPR, the presented work explores the use of more sophisticated diffuse
optical techniques8 to address existing limitations of continuous-wave NIRS in the
context of CPR.202
C.5. Significance and Innovation
Maintaining perfusion to the heart and the brain during pediatric cardiac arrest is
vital to resuscitation and neurologically intact survival. As the presented evidence has
shown, these outcomes are highly dependent on the administration of high-quality CPR.
Transitioning away from “rescuer-centric” guidance parameters, physiologic-directed
CPR is a novel frontier that permits optimization of high-quality CPR for the individual.
Non-invasive diffuse optical neuromonitoring techniques have demonstrated the
potential to extend the current bounds of physiologic-directed cardiopulmonary
resuscitation to include neurological resuscitation. However, the application of these
techniques to CPR are currently limited to continuous-wave (CW) NIRS measurements
of cerebral tissue oxygenation which suffer from high inter-subject variability and the lack
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of precision.221–223 At baseline in healthy volunteers, this has been attributed to tissue
heterogeneity224 and extracerebral contributions.225,226 Even greater variability is
introduced in the context of extreme values and dynamic changes seen during
resuscitation when the optical assumptions which underlie CW NIRS quantification are
violated (Chapter 1, Section A.5) and physiologic conditions deviate from the rSO2 =
50-90% range where commercial oximeters are validated in healthy individuals for FDA
approval.29,227 The use of continuous-wave light sources effectively limit CW NIRS
quantification to spectral and spatial changes in optical intensity which are equated
exclusively to changes in absorption; assumed optical scattering properties are used to
calculate these changes in absorption. These scattering properties have been shown to
have significant inter-subject variability in healthy infants 5 as well as significant changes
following cardiac arrest.26 The use of more sophisticated, quantitative diffuse optical
techniques provides the ability to limit this variability through absolute quantification of
dynamic absorption and scattering properties,8 resulting in greater individual physiologic
accuracy.
In Chapter 4, entitled “Prediction of Return of Spontaneous Circulation During
Cardiopulmonary Resuscitation using Non-Invasive Frequency-Domain Diffuse Optical
Spectroscopy”, we apply the quantitative diffuse optical technique of frequency-domain
(FD) diffuse optical spectroscopy (DOS) to provide physiologically accurate
measurements of cerebral hemodynamics during asphyxia, cardiac arrest by ventricular
fibrillation, and subsequent CPR. As described in Chapter 1, Section A.1-4, the addition
of sinusoidally amplitude modulated laser sources and high-sensitivity detectors permits
additional phase discrimination resulting in the resolution of tissue optical scattering
properties. These methods are applied in a high-fidelity pediatric swine model of
asphyxial cardiac arrest which has been incorporated in expert consensus statements127
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and widely regarded as an accurate model of physiologic response during high-quality
CPR in children approximately 1 year of age.228–230 With respect to the overall incidence
rates by age group presented, this reflects the approximate median age of a pediatric
cardiac arrest victim.120,128
In addition to cerebral tissue oxygen saturation, which we will abbreviate as StO2
when measured by FD-DOS and rSO2 when measured by CW NIRS, the accurate
resolution of variability in scattering by FD-DOS permits quantitative measurements of
absolute concentrations of oxy-, deoxy- and total hemoglobin in tissue ([HbO2]. [Hb] and
THC, respectively). This provides novel diagnostic measures of physiology related to
oxygen availability, via [HbO2], and blood volume, via THC,231 whose associations with
ROSC are reported. Secondly, the most comprehensive report of CW NIRS during CPR
to-date by Genbrugge et al. highlights the importance of additionally examining the
change in physiology during CPR; these trends and associations are also examined. In
total, these quantitative diagnostics reveal exciting new insights regarding the necessary
evolution of cerebral hemodynamic conditions for achievement of ROSC. Finally, to
address the time-sensitive nature of neuroprotection and successful achievement of
ROSC,135 the predictive power of significant cerebral hemodynamic parameters are
examined with respect to time within the first 10 minutes CPR. Using the novel
application of time-stability analysis to these parameters, the optimal ROSC predictor is
selected, considering both predictive power as well as predictive stability throughout
early CPR.
The predominant cause of death due to neurological injury in short-term survivors
of pediatric cardiac arrest199 warrants focused development of real-time physiologic
neuromonitoring to ensure high-quality CPR also addresses the needs of the vulnerable
pediatric brain. As evidenced by the neurological resilience of survivors after extended
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periods of CPR,119,126 high-quality CPR has the potential to provide adequate perfusion
for neurological protection. By elucidating the cerebral physiology necessary for ROSC
and providing promising, non-invasively measured, decision thresholds for guidance, the
presented work makes important strides towards the realization of high-quality cardio-,
pulmonary- and neurological resuscitation for all children both in and out of the hospital
setting.
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CHAPTER 2: NON-INVASIVE OPTICAL NEUROMONITORING OF THE
TEMPERATURE- DEPENDENCE OF CEREBRAL OXYGEN METABOLISM
DURING DEEP HYPOTHERMIC CARDIOPULMONARY BYPASS IN
NEONATAL SWINE
A. Abstract
Management of deep hypothermic (DH) cardiopulmonary bypass (CPB), a critical
neuroprotective strategy, currently relies on non-invasive temperature to guide cerebral
metabolic suppression during complex cardiac surgery in neonates. Considerable intersubject variability in temperature response and residual metabolism may contribute to
the persisting risk for postoperative neurological injury. To characterize and mitigate this
variability, we assess the sufficiency of conventional nasopharyngeal temperature (NPT)
guidance, and in the process, validate combined non-invasive frequency-domain diffuse
optical spectroscopy (FD-DOS) and diffuse correlation spectroscopy (DCS) for direct
measurement of cerebral metabolic rate of oxygen (CMRO2). During CPB, n=8 neonatal
swine underwent cooling from normothermia to 18°C, sustained DH perfusion for 40
minutes, and then rewarming to simulate cardiac surgery. Continuous non-invasive and
invasive measurements of intracranial temperature (ICT) and CMRO2 were acquired.
Significant hysteresis (p<0.001) between cooling and rewarming periods in the NPT
versus ICT and NPT versus CMRO2 relationships were found. Resolution of this
hysteresis in the ICT versus CMRO2 relationship identified a crucial insufficiency of
conventional NPT guidance. Non-invasive CMRO2 temperature coefficients with respect
to NPT (Q10 = 2.0) and ICT (Q10 = 2.5) are consistent with previous reports and provide
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further validation of FD-DOS/DCS CMRO2 monitoring during DH CPB to optimize
management.

B. Introduction
Deep hypothermia (DH) is an important neuroprotective therapy used during
cardiopulmonary bypass (CPB) in an attempt to mitigate hypoxic-ischemic brain injury by
suppressing cellular metabolic demand in neonates with congenital heart disease during
complex cardiac repairs.74 Over the last two decades, survival rates for these children
have substantially improved;232 however, the incidence of neurological injury has
remained constant and, in some cases, has resulted in developmental delays and
lifelong neurological deficits.47 Despite widespread use of DH CPB, uncertainty
predominates regarding optimal temperature management due to hitherto poorly defined
individual cerebral metabolic responses to hypothermia.
Real-time neuromonitoring is needed to address a key challenge for DH
protocols by confirming, on a patient-by-patient basis, that the suppression of
metabolism is sufficient to prevent adverse neurological sequelae during procedural
cerebral ischemia.73,74,91,233 Decreased cerebral blood flow, oxygen extraction, and
metabolism in response to deep hypothermia has been widely demonstrated, but
significant inter-subject variability in temperature-response has also been observed.234
Specifically, the use and value of conventional core temperature guidance for
assessment of the adequacy of metabolic suppression during DH has been
questioned.79,81,235–237 Systematic study of core temperature, brain temperature, and
residual cerebral metabolism as neurological risk factors are needed. Such studies are
hindered by a lack of noninvasive, cerebral metabolic monitoring tools suitable for the
operative environment. If this limitation can be ameliorated, then assessment of current
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neuroprotection strategies, and development of new personalized strategies to optimize
neurological outcomes, should be possible for these at-risk children.
Multimodal neuromonitoring, including clinical continuous-wave near-infrared
spectroscopy (CW NIRS) for cerebral oxygen saturation and transcranial Doppler
ultrasound (TCD) for cerebral blood flow-velocity, has shown evidence of improving
post-operative neurological complications.97 The quantitative uncertainty of CW NIRS
and the logistical difficulty of employing and interpreting TCD in the operating room has
prevented their combined use for routine metabolic monitoring and likely impacted
efficacy of goal-directed therapy.238 By contrast, the combination of frequency- or timedomain diffuse optical spectroscopy (FD-DOS, TD-DOS), to measure absolute cerebral
tissue oxygen saturation (StO2, %), with diffuse correlation spectroscopy (DCS) to
measure cerebral blood flow (CBF), enables a compact, all-optical method for
continuous non-invasive monitoring of cerebral metabolism. This approach has been
demonstrated in vulnerable pediatric populations outside the operating
room.24,39,40,105,109,110,112,239–245 Although recent work has established intraoperative
feasibility for some of this technology 37,112, non-invasive diffuse optical measurements of
CBF and metabolism have never been validated against invasive monitoring during the
profound physiologic and temperature changes induced by DH CPB and subsequent
rewarming.
Here we carry out an observational study of concurrent conventional monitoring
of nasopharyngeal temperature alongside invasive intracranial temperature and invasive
and non-invasive (i.e., diffuse optical) measurements of cerebral oxygen metabolism
during a simulated cardiac surgical procedure using DH CPB with subsequent
rewarming in neonatal swine. The sufficiency of nasopharyngeal temperature guidance
is examined with respect to intracranial temperature, and the temperature-dependence
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of cerebral oxygen metabolism is assessed with respect to both modalities using high
temporal resolution in vivo sampling methods. Non-invasive diffuse optical
measurements are compared directly with invasive measurements, and similarities and
differences of measured parameters are identified and understood.

C. Methods
Neonatal, female Yorkshire swine (n=8, 6-10 days old, 3-5kg) were continuously
monitored during cardiopulmonary bypass (CPB) from induction of deep hypothermia
(DH) through recovery to normothermia. All procedures were approved by the CHOP
Institutional Animal Care and Use Committee, performed in strict accordance with the
NIH Guide for the Care and Use of Laboratory Animals, and reported according to the
ARRIVE guidelines (https://www.nc3rs.org.uk/arrive-guidelines).
C.1. Selection of Animal Model
Pediatric large-animal model studies describing CMRO2 temperaturedependence during DH CPB have been reported in dogs246 and pigs using sparse
sampling methods.237,247–252 The neonatal swine model offers comparable anatomical
size and cortical maturation with the human neonate, as well as excellent intersection of
DH CPB and diffuse optical neuromonitoring literature.32,40,253,254
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Figure 2.1. Neuromonitoring: Head placement of non-invasive (green; left
hemisphere) and invasive (blue; right hemisphere) neuromonitoring technologies. A
diagram showing details about the FD-DOS/DCS optical probe is given on the lower left
(source positions, triangles; detector positions, circles).

C.2. Neuromonitoring
Non-invasive and invasive neuromonitoring were placed and secured following
anesthetic induction and intubation as detailed in the Appendix (Section F.1).255
Continuous non-invasive measurements comprised nasopharyngeal temperature (NPT,
°C), for guidance of hypothermic therapy, and frequency-domain diffuse optical
spectroscopy (FD-DOS) and diffuse correlation spectroscopy (DCS), which are detailed
below. FD-DOS/DCS measurements were acquired in the left frontal cortex via an
optical probe sutured to the left forehead (Figure 2.1). Continuous invasive
neuromonitoring was performed symmetrically on the contralateral hemisphere through
small burr holes made over the right frontal cortex (10mm paramedian; Figure 2.1).
Subcortical intracranial oxygen tension (PbtO2, mmHg) and cortical intracranial
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Figure 2.2. Temperature and Blood Gas Sampling Protocol: Each subject underwent
three stages of treatment: 1) Induction of deep hypothermia (“Cooling”); 2) Forty
minutes of continuous cold perfusion (“Deep Hypothermia”); 3) Recovery from deep
hypothermia (“Rewarming”). Arterial and jugular venous blood gas sampling was
performed at multiple time-points indicated by red droplets along the time-axis.

temperature (ICT, °C) were measured ~15 mm and ~5 mm, respectively, below the
cortical surface (Licox CC1-P1, Integra LifeSciences), and relative cortical cerebral blood
flow (rCBF LD, %) was measured with a laser Doppler probe (PeriFlux 5000, Perimed
Inc.) secured to the dura matter. A double lumen, 4Fr central venous catheter was
placed in the superior vena cava and advanced into the internal jugular bulb for invasive
discontinuous sampling of cerebral venous drainage.
C.3. Deep Hypothermia Protocol
Protocols for institution of DH CPB are detailed in the Appendix (Section F.1)
and closely mirrored clinical practice at our institution (Figure 2.2). Subjects were
stabilized on CPB at normothermia (NPT=37°C) and baseline measurements acquired
for five minutes. Guided by nasopharyngeal temperature, subjects were then cooled at a
target rate of 1°C per minute. Once 18°C was attained, subjects were maintained on
continuous DH perfusion for 40 minutes. Though continuous CPB with more mild
hypothermia is used at the surgeon’s discretion, here we aimed to characterize cerebral
metabolism across the full range of temperatures currently used in neonates (i.e., from
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normothermia to a low NPT of 18°C).83,85 Rewarming to normothermia occurred at a
target rate of 1°C per minute. Invasive arterial and venous blood gas sampling (0.3 cc of
blood per draw from the bypass arterial outflow and jugular bulb, respectively) occurred
at the start of cooling (i.e., baseline, 37°C), midpoint of cooling (27°C), end of cooling
(18°C), start of rewarming (18°C), midpoint of rewarming (27°C) and end of rewarming
(37°C; Figure 2.2). Immediate analysis was facilitated through a point-of-care blood gas
analyzer (GEM 3000, Instrumentation Laboratory). Blood pH was optimized by pH-stat
management during cooling. During rewarming and while normothermic, blood pH was
optimized by alpha-stat.
C.4. Diffuse Optical Techniques
Frequency-Domain Diffuse Optical Spectroscopy (FD-DOS)
Multi-distance FD-DOS was used to continuously measure cerebral tissue
oxygen saturation (StO2, %) and oxygen extraction fraction (OEF). FD-DOS employs
radio-frequency intensity-modulated near-infrared light to quantify wavelengthdependent absorption and scattering properties of tissue.9,10,256
A customized, commercial instrument (Imagent, ISS Inc.), equipped with four
690, 725, 785, and 830 nm intensity-modulated (110 MHz) diode laser sources and two
photomultiplier tube detectors, was coupled to the fiberoptic probe; source-detector
separations ranged from 0.75 cm to 3 cm (Figure 2.1, lower left). For each subject, the
source- and detector-fiber coupling coefficients to the tissue were estimated using a
phantom-calibration approach19 and used to correct continuous (10Hz) AC intensity and
phase data. Using a multi-distance linear fitting method, absolute absorption and
scattering coefficients were calculated for each wavelength from this data. Coefficients
were excluded if the linear fit Pearson correlation coefficient was <0.95, and the data60

point excluded if more than one of the four scattering or absorption coefficients were
excluded. Assuming a cerebral water volume fraction of 75%,257 the absolute cerebral
tissue concentration of oxy-hemoglobin ([HbO2], µmol/L) and deoxy-hemoglobin ([Hb],
µmol/L) was quantified from the absorption coefficient9 and StO2 calculated as:
2 ‡ (%) =

J† ‡ L
.
J† L + J† ‡ L

(2.1)

Importantly, the FD-DOS technique directly measures the tissue scattering
coefficient and eliminates optical absorption measurement errors introduced by
physiologic shifts in optical scattering,11,26 a parameter which cannot be determined by
commercial CW NIRS.
Diffuse Correlation Spectroscopy (DCS)
DCS is a photon correlation technique that derives a cerebral blood flow index
(BFI, cm2/s) from quantification of the rapid speckle intensity fluctuations of multiply
scattered coherent near-infrared light induced by red blood cell motion.30–32 DCS
measurements were made using a source-detector separation of 2.5 cm, wherein the
detected light fields were sensitive to blood flow at an average depth of ~1 cm below the
scalp surface.258
The DCS light source was a continuous-wave, long-coherence length (>10 m),
785 nm laser (RCL-080-785S, CrystaLaser, Inc). A bundle of eight single-mode
detection fibers coupled diffuse light emerging from the head onto two detection arrays
of four single-photon-counting avalanche photodiodes (SPCM-AQ4C, Excelitas
Technologies, Corp.). Calculation of the intensity autocorrelation curve for each detector
was accomplished using a commercial eight-channel correlator board (FLEX03OEM8CH, Correlator.com) with a fixed integration time of 3 seconds per measurement. The
tissue absorption and scattering coefficients, measured concurrently over the same
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tissue volume by FD-DOS, were used as inputs for the calculation of BFI from the
intensity autocorrelation curve, averaged across all co-located detection fibers; the
calculation was based on the semi-infinite homogeneous medium approximation of the
diffusion correlation equation.33 Individual measurements were rejected when the
average detected photon count rate (light intensity) was <5kHz, when the intensity
autocorrelation curve failed to decay below 1.01, or when the fit of the intensity
autocorrelation curve had greater than 10% error from the sampled curve.
For validation of DCS against invasive laser Doppler, relative CBF from DCS
(rCBF DCS, %) was computed from BFI normalized to the mean baseline BFI value.
C.5. Calculation of Cerebral Metabolic Rate of Oxygen (CMRO2)
Cerebral metabolic rate of oxygen (CMRO2) was calculated using the Fick
principle:259

‰¼/‡ = ‰ ‡ × ‡ ‘ × ‰½‘,

(2.2)

where CaO2 is the arterial blood concentration of oxygen and OEF is the cerebral
oxygen extraction fraction.
Invasive Calculation of CMRO2
Systemic arterial hematocrit (Hct, %), arterial oxygen saturation (SaO2, %) and
jugular venous oxygen saturation (SjvO2, %) were determined at each blood gas
sampling time-point and assumed to estimate cerebral arteriole and venule oxygen
content, respectively.260 Using the piglet-specific mean corpuscular hemoglobin
concentration (MCHC) of 32.2g/mL261 and a mammalian hemoglobin oxygen binding
capacity of 1.36mL O2/g Hgb,262 OEF and CaO2 were computed as:
‡ ‘=

2 ‡ − 2¾@‡
;
2 ‡

(2.3)
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(2.4)

Continuous laser Doppler measurements of relative CBF (rCBF LD, %) were
calculated with respect to the mean baseline value such that the baseline blood gas
draw at the start of cooling corresponded to an rCBF LD of 100%. For each subsequent
blood gas sample, the mean rCBF LD value in the 30 seconds preceding the time of
blood gas draw was used. CaO2 and OEF were also normalized to baseline and
combined into an invasive measure of relative CMRO2 (invasive rCMRO2, %):
Žj@ ¨]@V ‰¼/‡ =

‰ ‡
‡ ‘
‰½‘ ¿
×
×
.
‰ ‡ ,C ,0Á&Â0 ‡ ‘C ,0Á&Â0
‰½‘ ¿ C ,0Á&Â0

(2.5)

Non-Invasive FD-DOS/DCS Calculation of CMRO2

Non-invasive CMRO2 calculation utilized the baseline arterial blood gas oxygen
concentration (CaO2, baseline, %); this was assumed to remain constant. OEF was derived
from FD-DOS-measured cerebral tissue oxygen saturation (StO2, %), baseline arterial
oxygen saturation (SaO2, baseline, %), and an assumed cerebral arterio-venous mixing
fraction (γ) of 0.75:23,43,263
‡ ‘=

2 ‡ ,C ,0Á&Â0 − 2 ‡
.
× 2 ‡ ,C ,0Á&Â0

(2.6)

The DCS-measured BFI was used as a surrogate for CBF. As previously described in
Roche-Labarbe, et al., baseline CaO2, OEF, and BFI, were combined into an absolute
index of non-invasive CMRO2 (CMRO2,i), calculated continuously as:39,105,264
‰¼/‡

,&

=‰ ‡

,C ,0Á&Â0

× ‡ ‘ × ½‘Ž.

(2.7)

For comparison with invasive quantification, a relative non-invasive CMRO2 (non-

invasive rCMRO2, %) was also calculated for each blood gas sample. Corresponding
non-invasive OEF and BFI values were calculated as the mean value measured in the
30 seconds prior to blood gas draw. These values were then normalized to their
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respective baseline blood gas values and, assuming constant CaO2 and γ, were
combined to calculate non-invasive rCMRO2:
ÃÀj]j@ ¨]@V ‰¼/‡ =

‡ ‘
½‘Ž
×
.
‡ ‘C ,0Á&Â0 ½‘ŽC ,0Á&Â0

(2.8)

C.6. Modeling CMRO2 Temperature-Dependence
The van’t Hoff Equation has been widely applied in human and animal studies to
describe the relationship between temperature and cerebral metabolism.114,234 Here, the
van’t Hoff Equation, either reformulated as the empirical Arrhenius equation113,115
(Equation 2.9) or as the Q10 temperature coefficient (Equation 2.11), is employed as a
means to understand and quantify the temperature-dependence of cerebral oxygen
metabolism.
Arrhenius Equation Approach
In the Arrhenius relationship (Equation 2.9), a rate of reaction ($) depends on
temperature (>), the universal gas constant (/), an activation free energy barrier (

),

and a pre-exponential factor ( ) which is related to the reaction attempt frequency:
Äž

$ = V MÅÆ .

(2.9)

Here we assume this rate of reaction ($) to be the metabolic rate, CMRO2.

Rearrangement and substitution yields a linear expression (Ç = È + ) that models the
relationship between CMRO2 and temperature:
ln(‰¼/‡ ) =

1
| } + ln( ).
/ >

Model parameters,

=

Äž
,
Å

(2.10)

= ln( ), are obtained from data using linear regression.
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Assessment of Model Accuracy
Arrhenius-type approaches such as the version we utilize represent an
oversimplification of the physiology, since cerebral metabolism is known to depend on
many chemical reactions and other factors.234 The model selection we have made might
be valid, for example, if a single rate-limiting reaction exists for the metabolic process, or
if multiple important reactions had roughly the same Free Energy Barrier height. Dense
temperature sampling in vitro has shown good agreement,265 however, multiple reports
of in vivo characterization using sparse sampling methods have found non-Arrhenius or
multiphasic behavior, depending on temperature range.116,235,266 Thus, using continuous
quantification of non-invasive CMRO2,i and temperature, we evaluated model robustness
in vivo by goodness-of-fit of the linear regression (Equation 2.10).
Temperature Coefficient, Q10
Most commonly, the temperature-dependence of metabolism has been assessed
using the temperature coefficient, Q10. This metric is a reduction of the van’t Hoff
Equation for use under physiologic conditions (see Appendix, Section F.2). Q10 is
defined as the relative change in cerebral metabolic rate per 10°C change in
temperature. It can be calculated using an initial and subsequent measurement of
temperature and CMRO2:
.!%

!%

‰¼/‡ ,! Æp MÆ6
=h
.
i
‰¼/‡ ,

(2.11)

The Q10 for both invasive and non-invasive rCMRO2 measurements were quantified with
respect to nasopharyngeal and intracranial temperatures.
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C.7. Statistical Analysis
All statistical analyses were carried out using MATLAB 2014a. Summary
statistics were reported as mean and standard deviation, unless otherwise noted.
Continuous time-series data were synchronized using 15 second epoch averages.
The sufficiency of nasopharyngeal temperature guidance was assessed via the
relationship between non-invasive nasopharyngeal temperature and invasive intracranial
temperature, and especially via the functional relationship between non-invasive
CMRO2,i and each temperature source during cooling and rewarming (i.e., using the
linear form of the Arrhenius equation; Equation 2.10). These relationships were
individually examined using linear mixed-effects models that incorporated subjectspecific random intercept and slope effects to allow for variation in the intercept and
slope among individuals. To quantify the potential hysteresis between cooling and
rewarming periods, each model included period-specific (e.g., cooling, rewarming) fixed

slope, (É, ∆É), and intercept, (Ë, ∆Ë), effects reported as mean and standard error. The
modeled relationship during cooling is expressed as
Ç = ÉÈ + Ë,

(2.12)

Ç = (É + ∆É)È + (Ë + ∆Ë).

(2.13)

and the modeled relationship during rewarming expressed as
Parameters ∆É and ∆Ë should be interpreted as the incremental effects of rewarming on

the slope (É) and intercept (Ë), respectively, of cooling. The goodness-of-fit of these
models were evaluated using the coefficient of determination (R2) of a separate

generalized linear regression model with slope and intercept interaction terms for each
subject and period.
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Validation of non-invasive against invasive CMRO2 measures at discontinuous
blood gas sampling time-points was conducted by paired t-test, assuming equal
variances and evaluated at a pooled significance level of α=0.05 with Bonferroni
correction for multiple comparisons. Consequently, the five individual time-point t-tests
were evaluated at an adjusted significance level of α=0.01. Given a type II error rate of
β=0.2 and an assumed within-subject correlation of 0.875, the analysis was powered to
detect a 10% difference in paired observations. Secondarily, to assess the continuous
relationship between invasive rCBF LD versus non-invasive rCBF DCS and invasive
rCMRO2 versus non-invasive rCMRO2, linear mixed-effects models with random slope
effects were used to quantify the slope relating the change from baseline (ΔrCBF, %;
ΔrCMRO2, %; respectively) between modalities; slope are reported as mean and
standard error. To balance continuous rCBF data across the full range of temperatures
from normothermia to deep hypothermia, the synchronized time-series data was binaveraged by corresponding temperature in 1°C intervals from 18°C to 37°C. Linearity
was evaluated by the goodness-of-fit, as described above. Finally, agreement between
non-invasive measures versus invasive measures of rCBF and rCMRO2 was evaluated
by the bias and precision from repeated-measures Bland-Altman analysis.267,268
Calculated CMRO2 Q10 coefficients for both nasopharyngeal and intracranial
temperature-dependence were compared between modalities and to values reported in
the literature. Due to their non-normal sample distributions, these results were reported
as median and interquartile range (IQR), and intra-subject Q10 comparisons were made
using the Wilcoxon signed-rank test.
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Table 2.1. Summary Statistics
Start of
Cooling

End of
Cooling

Start of
Rewarming

End of
Rewarming

7.4 (0.1)
45.8 (17.2)
278.6 (92.7)
163.9 (56.1)
3.5 (1.2)
29.9 (2.8)
29.5 (3.1)
99.2 (2.5)

7.1 (0.1)
86.5 (16.9)
327.3 (58.5)
156.1 (45.7)
3.8 (1.2)
29.3 (6.4)
29.6 (3.2)
100.0 (0.0)

7.1 (0.1)
83.3 (20.5)
286.6 (34.8)
162.9 (37.7)
4.1 (1.4)
33.2 (7.5)
27.2 (5.0)
99.9 (0.2)

7.4 (0.1)
39.8 (8.4)
181.7 (80.5)
142.1 (36.7)
6.0 (4.9)
35.6 (7.0)
24.8 (2.9)
98.8 (2.3)

34.5 (2.4)
8.0 (2.7)
76.6 (13.2)
0.23 (0.13)
100.0 (-)
100.0 (-)

22.6 (2.1)
8.6 (4.9)
95.3 (5.3)
0.047 (0.053)
45.9 (18.1)
9.3 (9.9)

18.8 (1.1)
11.1 (8.7)
97.3 (2.2)
0.026 (0.022)
41.9 (21.2)
3.4 (3.2)

30.2 (3.1)
6.2 (4.9)
84.2 (7.3)
0.15 (0.06)
49.4 (9.9)
32.3 (7.9)

37.3 (0.5)

17.8 (0.3)

18.2 (0.5)

37.3 (0.5)

0.17 (0.02)
0.14 (0.02)
0.14 (0.02)
0.15 (0.02)

0.14 (0.02)
0.13 (0.02)
0.15 (0.03)
0.16 (0.03)

0.15 (0.02)
0.14 (0.01)
0.15 (0.03)
0.17 (0.03)

0.19 (0.03)
0.16 (0.02)
0.16 (0.03)
0.17 (0.02)

12.2 (1.7)
10.2 (1.5)
9.9 (1.5)
9.4 (2.0)
75.3 (9.3)
57.2 (5.3)
0.56 (0.07)
1.2 (1.2)
100.0 (-)
100.0 (-)

11.6 (1.6)
10.0 (1.4)
10.0 (1.5)
10.1 (2.1)
81.0 (14.0)
68.6 (8.7)
0.41 (0.10)
0.57 (0.55)
50.1 (17.5)
35.8 (8.7)

11.7 (1.3)
10.1 (1.2)
10.0 (1.4)
9.9 (1.8)
85.1 (14.9)
69.9 (11.4)
0.39 (0.14)
0.49 (0.51)
45.9 (28.9)
27.8 (11.4)

12.4 (1.6)
10.6 (1.6)
10.3 (1.7)
9.9 (1.7)
86.1 (12.6)
58.6 (6.7)
0.54 (0.08)
0.69 (0.73)
64.5 (31.6)
63.2 (35.5)

Arterial Blood Gas*
pH
pCO2 (mmHg)
pO2 (mmHg)
Glu (umol/L)
Lac (mmol/L)
Hct (%)
HCO3 (mmol/L)
SaO2 (%)

Invasive Neuromonitoring
ICT (°C)
PbtO2 (mmHg)
SjvO2 (%)*
OEF
rCBF LD (%)
rCMRO2 (%)

Non-Invasive Neuromonitoring
NPT (°C)
µa (1/cm)
λ = 690nm
λ = 725nm
λ = 785nm
λ = 830nm
µs’ (1/cm)
λ = 690nm
λ = 725nm
λ = 785nm
λ = 830nm
THC (µmol/L)
StO2 (%)
OEF
BFI (10-8 cm2/s)
rCBF DCS (%)
rCMRO2 (%)
*Values are corrected to 37°C
Abbreviations: Glu – Glucose; Lac – Lactate; Hct – Hematocrit; SjvO 2 – internal jugular venous
oxygen saturation; rCBF LD – relative cerebral blood flow measured using laser Doppler; ICT –
intracranial temperature; PbtO 2 – partial pressure of oxygen in brain tissue; StO 2 – cerebral
tissue oxygen saturation from FD-DOS; BFI – blood flow index measured using DCS; rCBF DCS
– relative cerebral blood flow measured using DCS; NPT – nasopharyngeal temperature; THC –
total hemoglobin concentration measured using FD-DOS.
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Figure 2.3. Temperature-dependence of non-invasive optical measures of cerebral
oxygen extraction fraction, flow, and metabolism during cooling (blue) from
normothermia to deep hypothermia, and during rewarming (red) from deep hypothermia
back to normothermia. Mean values across subjects (n=8) are plotted along with
standard deviation. Abbreviations: OEF, oxygen extraction fraction; rCBF DCS, DCS
measure of relative cerebral blood flow; rCMRO 2 , relative cerebral metabolic rate of
oxygen.

D. Results
Neonatal swine (n=8), with a mean (SD) weight of 4.1 (0.5) kg, were cooled to
deep hypothermia in 25.7 (5.3) minutes, maintained at deep hypothermia for 42.6 (1.1)
minutes, and subsequently rewarmed to normothermia in 27.2 (7.0) minutes. Summary
statistics of experimental parameters are listed in Table 2.1.
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Figure 2.4. (Left) Intracranial Temperature Hysteresis: Significant hysteresis of
intracranial temperature (ICT) with respect to nasopharyngeal temperature (NPT)
during rewarming (red) versus cooling (blue); rewarming slope p<0.001, intercept
p<0.001. Non-invasive CMRO 2,i Temperature-Dependence: (Center) CMRO 2,i, with
respect to (NPT) -1 , also demonstrates significant hysteresis in rewarming slope
(p=0.001) and intercept (p<0.001). (Right) CMRO 2,i, with respect to (ICT) -1 , has
improved concordance between rewarming versus cooling; rewarming slope p=0.647,
intercept p=0.585. Thick lines represent fitted linear mixed-effects models; unique
symbols connected by thin lines represent individual subject data (n=8).

D.1. Temperature-Dependence of Cerebral Oxygen Metabolism: Comparison of
Nasopharyngeal and Intracranial Temperature
Here we examine the impact of nasopharyngeal temperature (NPT) guidance on
cerebral metabolic parameters. An example of non-invasive optical time-series data is
available in the Appendix (Section F.3). The mean and standard deviation of the noninvasive optical measurements of OEF, rCBF DCS, and rCMRO2 with respect to NPT
during cooling and rewarming periods are plotted in Figure 2.3. Cooling to deep
hypothermia caused a decrease in all parameters. During rewarming, OEF values agree
with cooling, but a hysteresis in rCBF and rCMRO2 is apparent.
Characterization of the relationship of NPT and intracranial temperature (ICT)
provided additional insights regarding the hysteresis (Figure 2.4, left). A significant slope
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effect (É = 0.63 [0.06], p<0.001) confirmed an association between the two temperature
monitors with the effect size < 1 indicating a lag of ICT behind NPT (Figure 2.4, left).
Significant rewarming slope (∆É = -0.08 [0.01], p<0.001) and intercept (∆Ë = -5.0 [0.3],
p<0.001) effects demonstrated a hysteresis between the two temperature monitors with
an increased lag and offset in ICT. The mismatch in ICT between the end of cooling and
the beginning of rewarming indicated that, despite NPT indicating attainment of deep
hypothermia, the brain had not reached thermal equilibrium.
The NPT-dependence of non-invasive CMRO2,i exhibited a significant slope
effect (É = -3.7 [0.4] x103, p<0.001) which verified an association between metabolism
and temperature (Figure 2.4, center). Confirming the observed hysteresis, rewarming
had a significant and dampening effect on slope (∆É = +1.4 [0.4] x103, p=0.001), which
suggests metabolism had diminished sensitivity to NPT. Linear regression resulted in a
strong coefficient of determination (R2 = 0.87) and affirms use of Arrhenius-type models
for examining cerebral metabolic temperature-dependence at physiologic temperatures.
The ICT-dependence of non-invasive CMRO2,i also demonstrated a strong coefficient of
determination with linear regression (R2 = 0.90) and had a significant slope effect (É = 5.2 [1.0] x103, p<0.001; Figure 2.4, right). Surprisingly, rewarming did not have a
significant effect on slope (∆É = +0.3 [0.6] x103, p=0.647) or intercept (∆Ë = -1.1 [2.1],
p=0.585).
These results highlight critical insufficiencies of NPT guidance to accurately
reflect ICT or metabolic status during DH CPB. Furthermore, they suggest that the
presence of cerebral metabolic hysteresis with respect to temperature may be an artifact
resulting from use of NPT to approximate ICT.
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Figure 2.5. Comparison of invasive versus non-invasive tissue sampling at each
blood gas time-point demonstrate validity of optical assumptions of arterial
concentration of oxygen (CaO 2 ), agreement of relative cerebral blood flow (rCBF)
measurements, but a discrepancy in relative oxygen extraction fraction (rOEF) and
relative metabolic rate of oxygen (rCMRO 2 ). Paired data at each time-point are
displayed with a unique symbol for each subject (n=7) colored by modality (i.e., noninvasive, green; invasive, blue), and the x-axis labeled by respective nasopharyngeal
temperature with stage designated by color (i.e., cooling, blue; rewarming, red).
Asterisks (*) denote significant differences (p<0.01) in paired t-tests between invasive
and non-invasive sampling.

D.2. Validation of Non-Invasive Quantification of Cerebral Oxygen Metabolism
The results of models examining discontinuous and continuous repeated
measures of CMRO2 parameters to assess differences between invasive and noninvasive modalities are reported. Blood gas analysis was hampered by a machine
malfunction in a single animal, resulting in the inclusion of 7 of 8 animals.
Arterial Concentration of Oxygen (CaO2)
CaO2 quantified discontinuously from invasive blood gas samples, were used to
examine the non-invasive assumption that CaO2 remained constant through deep
hypothermia and recovery to normothermia. Importantly, no significant differences from
baseline were observed in relative CaO2 (rCaO2; Figure 2.5, top left). From these
72

results, we conclude that the assumption of constant CaO2 for non-invasive
quantification during deep hypothermia was reasonable.
Oxygen Extraction Fraction (OEF)
Significant differences between non-invasive versus discontinuous invasive
measures of relative OEF (rOEF; Figure 2.5, top right) were found at the end of cooling
(difference = +53.9% (24.3), p=0.001), start of rewarming (difference = +62.4% (22.6),
p<0.001), midpoint of rewarming (difference = +50.8% (20.4), p=0.002), and end of
rewarming (difference = +34.2% (17.2), p=0.005). Non-invasive sampling demonstrated
consistently greater rOEF across all time-points.
The non-invasive calculation of OEF is derived from baseline blood gas SaO2
and from continuous non-invasive measurement of cerebral tissue oxygen saturation
(StO2; Equation 2.6). Given the limited range in SaO2 (98.0-100.0%) during cooling and
rewarming, significant differences in non-invasive and invasive OEF must be attributed
to a disagreement between non-invasive StO2 and invasive sampling of jugular venous
oxygen saturation (SjvO2). Additional analysis of the relationship of StO2 and SjvO2 is
included in the Appendix (Section F.4).
Cerebral Blood Flow (CBF)
Non-invasive, continuous rCBF DCS measurement demonstrated good
agreement with invasive, continuous rCBF LD. Significant differences were not found at
all discontinuous blood gas sampling time-points (Figure 2.5, bottom left). Examination
of the continuous relationship between modalities demonstrated that the change from
baseline (ΔrCBF, %) of non-invasive DCS significantly predicted (Figure 2.6, left)
invasive laser Doppler with a slope effect of 1.26 [0.15] (p<0.001). Linear regression with
subject-specific slope interactions resulted in a good coefficient of determination (R2 =
0.73), suggesting a strong linear relationship between modalities. Using Bland-Altman
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Figure 2.6. Validation of Non-Invasive Diffuse Correlation Spectroscopy (DCS,
left) and CMRO 2 (right): Data from individual subjects are indicated by a unique
symbol. Measurements of change in relative cerebral blood flow using laser Doppler
(rCBF LD, %) and DCS (rCBF DCS, %) are compared using a linear mixed-effects
model (n=8; left). DCS measurements demonstrate a good linear correlation (fixed
slope effect p<0.001; R 2 =0.73) against laser Doppler measurements. Similarly, invasive
and non-invasive measurements of rCMRO 2 (%) are compared using a linear mixedeffects model (n=7; right). Non-invasive rCMRO 2 quantification demonstrates a
significant association but limited linearity (fixed slope effect p<0.001; R 2 =0.53) against
invasive sampling. Fitted linear relationships (solid line) with 95% confidence intervals
(dotted line) are plotted in blue.

analysis, the comparison of mean rCBF (%) between modalities was found to have a
bias of -10.0% and precision of 13.1% (Appendix, Section F.5). These findings support
the use of DCS for non-invasive measurement of rCBF during DH CPB.
Cerebral Metabolic Rate of Oxygen (CMRO2)
Non-invasive versus invasive relative CMRO2 measured discontinuously
exhibited significant differences at the end of cooling (difference = +26.9% (9.7),
p<0.001), start of rewarming (difference = +25.1% (11.7), p=0.001), and midpoint of
rewarming (difference = +18.3% (8.1), p=0.003; Figure 2.5, bottom right). Due to the
dependence of CMRO2 on OEF, significant differences in rOEF directly contributed to
differences in rCMRO2 whereby non-invasive sampling reflected higher levels of
metabolism versus invasive sampling.
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Examination of the continuous relationship between modalities by linear mixedeffects model analysis demonstrated that non-invasive ΔrCMRO2 (%) significantly
predicted (Figure 2.6, right) invasive ΔrCMRO2 (%) with a slope effect of 1.31 [0.07]
(p<0.001); however linear regression resulted in only a fair coefficient of determination
(R2 =0.53) suggesting underlying non-linearity. Using Bland-Altman analysis, agreement
of rCMRO2 between modalities was found to have a bias of -25.8% and precision of
12.5% (Appendix, Section F.4). Despite modest quantitative agreement, these findings
show a highly significant association between non-invasive and invasive rCMRO2
measurements; this association, in turn, supports use of non-invasive measurements as
an indicator of cerebral status.
CMRO2 Temperature Coefficient (Q10)
Computed CMRO2 temperature coefficient Q10 derived from invasive sampling
differed significantly from that of non-invasive sampling, whether assessed with respect
to nasopharyngeal temperature (non-invasive versus invasive median [IQR]: 2.0 [1.6,
2.3] versus 4.9 [3.6, 6.3], p=0.016) or intracranial temperature (non-invasive versus
invasive median [IQR]: 2.5 [2.0, 3.5] versus 9.0 [6.9, 11.0], p=0.016). This finding further
affirms our discrepant findings at individual blood gas sampling time-points. As may be
expected from the presence of significant temperature hysteresis, Q10 based on
intracranial temperature was significantly different from Q10 based on nasopharyngeal
temperature, i.e., whether measured non-invasively (NPT versus ICT median [IQR]: 2.0
[1.6, 2.3] versus 2.5 [2.0, 3.5], p=0.016) or invasively (NPT versus ICT median [IQR]: 4.9
[3.6, 6.3] versus 9.0 [6.9, 11.0], p=0.016). Regardless of metabolic sampling method,
sensitivity to nasopharyngeal temperature was lower than to intracranial temperature.
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E. Discussion
Continuous, non-invasive optical metabolic neuromonitoring using FD-DOS
combined with DCS permits understanding of the physiologic alterations of cerebral
metabolism that occur during therapeutic hypothermia. This approach has the potential
to address critical shortfalls in conventional temperature guidance of hypothermia, as
well as to enable individualized neuroprotective strategies. The present study takes
important steps towards this goal.
E.1. Temperature-Dependence of Cerebral Oxygen Metabolism: Comparison of
Nasopharyngeal and Intracranial Temperature
Nasopharyngeal temperature is an established source of guidance for DH CPB
management74 and has been found, among other non-invasive sites of core temperature
measurement, to best approximate cerebral temperature.87 However, our data adds to
mounting evidence that nasopharyngeal temperature does not adequately reflect
intracranial temperature, nor the metabolic state of the brain.269,270 This finding is evident
from the metabolic hysteresis with respect to nasopharyngeal temperature between
cooling and rewarming periods, and in the significantly different temperature coefficients
exhibited by nasopharyngeal versus intracranial temperature. The finding that
intracranial temperature has more concordant metabolic temperature-dependence
between cooling and rewarming periods is supported by prior in vitro observations of the
reversibility of hypothermic metabolic inhibition.265 The continued decline of intracranial
temperature following cooling indicates the clinical cooling interval used was insufficient
for thermal equilibrium and underscores the importance of directly measuring the
metabolic state of the brain in lieu of using nasopharyngeal temperature as a surrogate.
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By coupling continuous FD-DOS/DCS measurements of cerebral oxygen
metabolism with continuous temperature measurements during deep hypothermia, we
were additionally able to examine the validity of temperature-dependent models for the
metabolic rate based on the Arrhenius equation. These models were consistent with our
data, whether using nasopharyngeal temperature (R2=0.87) or intracranial temperature
(R2 = 0.90). Our results support the continued use of Q10 to characterize the
temperature-dependence of cerebral oxygen metabolism.
E.2. Validation of Non-Invasive Quantification of Cerebral Oxygen Metabolism
Non-invasive rCMRO2 significantly predicted invasive rCMRO2 (p<0.001).
However, we found significant discrepancies in measured values with a bias of -25.8%
and precision of 12.5%. This mismatch is discussed, and rationalized, with respect to
each component of the CMRO2 calculation below.
Arterial Concentration of Oxygen (CaO2)
A critical assumption of non-invasive CMRO2 quantification is that CaO2 remains
constant from baseline. While increases in CaO2 are expected during hypothermia,271
avoidance of hyperoxia during cardiopulmonary bypass has been established.272
Fortuitously, oxygen administration is intentionally adjusted during hypothermia to
maintain constant arterial blood oxygen tension. In-line with these recommendations, we
found that only the last sampling time-point after recovery to normothermia
demonstrated a significant difference from baseline. Thus, the assumption of constant
CaO2 for non-invasive quantification during deep hypothermic cardiopulmonary bypass
seems reasonable and is concordant with invasive sampling.
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Oxygen Extraction Fraction (OEF)
Absolute oxygen extraction fraction (OEF) was found to differ significantly
between invasive and non-invasive sampling methods at all time-points. We determined
that this effect resulted from a disagreement between optically-measured cerebral tissue
oxygen saturation (StO2), and the compartment model computation of StO2 via StO2 =
(1- γ)SaO2 + γSjvO2, wherein an arterio-venous mixing fraction of γ = 0.75 was
assumed.43,263 In fact, StO2 was consistently lower than SjvO2, thus violating a
necessarily positive γ. This phenomenon has been reported in the context of CW NIRS
instruments and FD-DOS measurements in animals models19,273 and human
subjects,23,239 and remains to be further explored in future studies. Our findings support
the reproducibility of this phenomenon and sheds further light on the issue.
The use of jugular venous sampling in this study was based on its wide utilization
in pediatric cardiac surgery for this purpose79,274 and for comparison with non-invasive
cerebral oximetry.23,275–277 Prior reports of jugular venous sampling in swine models of
cardiopulmonary bypass agree with our observations. In Sasaki et al., SjvO2 were
calculated from reported OEF as 74.5±7.1% at normothermia and 89.5±4.2% at 18°C in
comparably-aged neonatal piglets.273 In slightly older (3-4 wk) and larger piglets
(9.4±0.8kg), Walther et al. reported SjvO2 of 86-88% at normothermia, 91% at a body
temperature of 25°C, and 93% at a body temperature of 18°C.252 While these values are
in the range of our SjvO2 measurements at normothermia (76.6±13.2%) and at deep
hypothermia (95.3±5.3%), further comparison with sagittal sinus sampling suggests
these measurements may have been affected by reported limitations of jugular venous
sampling to access cerebral venous saturation.278
Animal studies wherein sagittal sinus oxygen saturation (SssO2) was directly
sampled during hypothermic cardiopulmonary bypass show consistently lower values
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than reported SjvO2. Two observations in moderately larger piglets (5-13 kg) reported an
SssO2 of 75±10% at normothermia and 85±5% at deep hypothermia (18-20°C).237,251
While normothermic values are comparable to our observations, hypothermic saturations
are markedly lower . These comparisons indicate that internal jugular venous sampling
overestimates sagittal sinus saturations, resulting in an underestimation of true cerebral
OEF in pediatric swine models. We believe this to be the primary source of error in our
invasively quantified OEF and, subsequently, CMRO2.
Probable physiologic mechanisms that could elevate SjvO2 with respect to SssO2
include systemic venous contamination of jugular venous sampling due, in-part, to the
logistical difficulty of advancing a catheter into small neonatal vessels. Contributions
from the external jugular vein or superior vena cava would reflect higher saturations due
to lower somatic oxygen utilization rates compared to the brain. This hypothesis is
corroborated by central venous saturations of ~75% at normothermia and 98±2% at
18°C in Cavus et al.;251 our SjvO2 agrees at baseline and is only ~3% lower at deep
hypothermia. Future studies conducted in neonatal swine should be wary of systemic
contributions with this sampling method that may inaccurately diminish cerebral OEF.
Cerebral Blood Flow (CBF)
Significant agreement was observed between invasive laser Doppler (LD) and
non-invasive DCS measurement of cerebral blood flow throughout deep hypothermia.
Our invasive data, in particular, advances recent cross-validation of DCS with
transcranial Doppler ultrasound.37 In principle, quantitative variation between LD and
DCS can be attributed to regional variability in metabolic and cerebrovascular response
to hypothermia, which has been previously reported,279–281 and can also result from
extracerebral contributions to the optical signal.282–284 Measuring tissue thickness postmortem, we found ~0.5 cm of superficial tissue (e.g., skull, scalp) above the brain. The
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potential contribution from this tissue should be explored in future studies using
advanced multi-layered optical extraction.
Cerebral Metabolic Rate of Oxygen (CMRO2)
Taken in total, non-invasive optical measurement of CMRO2 demonstrated lower
temperature-sensitivity and higher residual metabolic rates at deep hypothermia than
invasively sampled CMRO2. As discussed above, we believe this to be a direct result of
systemic contributions to invasive jugular venous sampling. For further validation,
calculated Q10 temperature coefficients were compared to those reported in the
literature.
In studies utilizing non-invasive temperature methods and jugular venous
sampling, Greeley et al. reported an average Q10 of 3.65 in neonates and children, and
McCullough et al. reported a Q10 of 2.3 in adults.79,81 While these measurements are
potentially confounded by pathologic conditions necessitating the use of hypothermic
cardiopulmonary bypass, plausibility is provided for our non-invasive (Q10 = 2.0) versus
invasive (Q10 = 4.9) measurements with respect to nasopharyngeal temperature.
In healthy animal models with invasive intracranial temperature and sagittal sinus
sampling, Michenfelder, et al. saw a Q10 of 2.23 for mild hypothermia (ICT between 37°C
and 27°C) and 4.53 for deep hypothermia (27 to 14°C) in canines; CBF was measured
using a flow-through electromagnetic flow probe placed in the sagittal sinus.235 Using
both radioactive and fluorescent microspheres for CBF determination, Erlich et al.
observed a Q10 of 2.46 with a 95% CI of 2.1 to 2.9 (38°C to 8°C) in piglets ranging in
weight from 7-13kg.237 These values support the validity of our non-invasive metabolic
measurements, which exhibited a Q10 of 2.5 with respect to intracranial temperature,
versus our invasive measurements (Q10 = 9.0) which incorporated jugular venous
sampling. In sum, despite significant differences between our non-invasive and invasive
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sampling methods, we are confident that our non-invasive metabolic measurements are
in agreement with prior studies of cerebral metabolic temperature-response and hold
tremendous clinical promise to measure an individual patient’s CMRO2.
E.3. Limitations of Animal Model
Several considerations affect the interpretation of our animal model results for
application to neonatal cardiac patients. First, we utilized only female animals; in light of
reported sexual dimorphisms with respect to brain development285 and tolerance to
neurological injury,286,287 further study is required to understand potential sex differences
in metabolic temperature-dependence. Additionally, piglet resting core temperatures are
slightly higher than human neonates (38.5°C vs. 36.5°C).280,288 The impact of relative
hypothermia in the animal model may have resulted in lower metabolic values than an
animal at natural baseline. Variation in anesthetic management, rate and duration of
temperature derangement, and the use of circulatory arrest among pediatric cardiac
surgical practices may also impact generalizability.248,289,290 Notably, the oxygen binding
affinity of swine hemoglobin has been shown to be significantly lower than that of human
hemoglobin.291 This effect could account for the lower baseline cerebral oxygen tissue
saturations measured versus baseline values in human subjects. Furthermore, there is
less impact of cooling on oxygen binding affinity.292 Therefore, greater changes in
cerebral metabolism (i.e., larger temperature coefficients) may be observed in humans
than those measured here.
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E.4. Clinical Applications of Cerebral Metabolic Monitoring during Therapeutic
Hypothermia
Clinical imaging modalities that permit access to cerebral metabolism include
stand-alone PET, which typically requires the injection or inhalation of radioactive tracers
such as 15O-H2O and 18F-FDG for glucose metabolism293 or 15O2 gas for oxygen
metabolism,294 and stand-alone MRI,295 which uses a combination of arterial spin
labeling or phase-contrast mapping for CBF and calibrated blood-oxygen-leveldependent T2* signal mapping for oxygenation. More recently, integrated PET/MRI
paradigms that decrease the invasive vascular access requirements of stand-alone PET
have been demonstrated.296 These modalities have profoundly impacted clinical care, as
well as our understanding of developmental and pathologic alterations in cerebral
metabolism; however, extensive patient transport and operating room requirements, the
incremental ionizing radiation exposure of PET, and the prolonged durations and limited
throughput associated with MRI data acquisition prohibit real-time, intraoperative
monitoring, particularly in neonates.
FD-DOS/DCS sacrifices spatial resolution and sensitivity for temporal resolution
and portability that, as specifically demonstrated in the present work, permit real-time
guidance during procedural hypothermia. Frequently, neonatal surgical protocols utilize
deep hypothermia for neuroprotection during subsequent circulatory arrest. Temperature
of initiation and what duration of circulatory arrest is safe remain controversial.74,91,95
Precise determination of residual cerebral metabolism using diffuse optics could be used
to individually guide cooling to adequate levels of cerebral metabolic suppression as well
as provide a subject-specific estimate of safe arrest duration based on rate of [HbO2]
depletion in cerebral tissue. Alternatively, mild hypothermia has also demonstrated
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therapeutic potential to improve mortality297,298 and neurological299 and
neurodevelopmental outcomes300 in infants with hypoxic-ischemic encephalopathy. Noninvasive optical CW NIRS and FD-DOS/DCS have already been used at the bedside in
these infants to examine alterations in cerebral autoregulation301 and metabolism.302 We
anticipate that our findings will enable and motivate closer examination of the magnitude
and rate of hypothermia-induced cerebral metabolic suppression and neurological
outcomes in these patients.
E.5. Conclusions
This study identifies critical limitations in conventional nasopharyngeal
temperature guidance during deep hypothermic cardiopulmonary bypass in neonates,
and it provides strong evidence for the validity and utility of non-invasive diffuse optical
measurements of cerebral oxygen metabolism to address these limitations. Continuous
measurements throughout cooling and rewarming enabled novel high-fidelity
determination of metabolic temperature-dependence in vivo and validation of Arrheniustype models (i.e., the van’t Hoff Law and Q10). The relationship between non-invasive
CMRO2 and nasopharyngeal temperature demonstrated a problematic hysteresis
between cooling and rewarming periods. The finding that intracranial temperaturedependence improved concordance suggests that nasopharyngeal temperature
inadequately reflects cerebral metabolic state and may be a significant source of
uncertainty in the clinical guidance of hypothermia for brain protection. The application of
non-invasive FD-DOS/DCS for direct quantification of cerebral oxygen metabolism thus
offers promise for improved guidance of therapeutic hypothermia and for mitigation of
neurological injury in vulnerable pediatric populations.
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F. Appendix
F.1. Neonatal Swine Model
One-week-old, healthy female Yorkshire piglets (n=8; Meck Farms, Lancaster,
PA) were included in this study. Animals were housed in the Abramson Research Center
Large Animal Facility for a maximum of 7 days prior to study with daily care monitoring
by a trained Division of Veterinary Resources technician. All animals underwent identical
care and study procedures as described.
Anesthesia
On the morning of study, animals were fasted a minimum of 2 hours prior to
receiving a pre-medicated intramuscular injection of ketamine (20 mg/kg) for comfort
followed by weighing and transport to operating room within the same facility. Prior to
intubation, piglets were administered 4% inhaled isoflurane in 100% FiO2 via snout
mask until abolishment of response to reflexive pinch stimulus. Animals were then
intubated with a 3mm endotracheal tube with in-line capnometer; placement was
confirmed by normative end-tidal CO2 tracings. Subsequently, a maximum of 1.5%
inhaled isoflurane was used for maintenance of anesthesia with depth of anesthesia
confirmed by heart rate, blood pressure, mandibular jaw tone, and absence of
withdrawal response to toe pinch. Ventilator settings were maintained within a peak
expiratory pressure of 6cm H2O, and tidal volumes (8-12 ml/kg) and respiratory rate
titrated to maintain end-tidal CO2 between 38-42 mmHg.
Surgical Preparation
Piglets were initially positioned prone. Then neuromonitoring and rectal and
nasopharyngeal temperature probes for guidance of hypothermic therapy were placed

84

and secured. A heating pad and blanket were placed along the dorsum and ventral
aspects and were used as needed to maintain normothermia.
Piglets were then positioned supine, neuromonitoring probe placements
optimized, and limbs secured. The right femoral artery and vein were exposed and
cannulated to permit pressure transduction and vascular access, respectively.
Intravenous fentanyl (25-200 µg/kg/min) and dexmetetomidine (0.5-2.0 µg/kg/min) were
initiated and titrated as needed for depth of anesthesia. A standard median sternotomy
incision was performed, along with thymectomy, pericardiotomy, and exposure of the
great vessels for cannulation. Systemic heparin 200 IU/kg was then administered directly
into the right atrium. Additional heparin was used as needed to ensure an activated
clotting time (ACT) greater than 400 seconds prior to establishment of cardiopulmonary
bypass.
Cardiopulmonary Bypass (CPB)
The cardiopulmonary bypass circuit was primed with 200 ml of Plasmalyte and
300 ml of donor swine whole blood added to establish a hematocrit level of 30%. The
prime volume was treated with 500 units of heparin, 1 mEq + 5 mEq/kg of sodium
bicarbonate, 1mg/kg of Lasix, and 450 mg of calcium gluconate and swept at 0.5L/min
for 2 minutes. Circuit lines were connected via two 3/16” x ¼” connectors and de-aired.
The ascending aorta and right atrial appendage were cannulated with a 10-Fr arterial
cannula and a 20-Fr single stage venous cannula, respectively. Cardiopulmonary
bypass flows were steadily increased to target baseline flows of 150 ml/kg/min and
continuously monitored via an ultrasonic flow probe affixed to the arterial outflow. The
cardiopulmonary bypass heater/cooler unit was used as necessary to stabilize
nasopharyngeal temperature at normothermic baseline (37°C) and for all subsequent
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periods of cooling and warming as described in the following protocol for deep
hypothermia.
Deep Hypothermia (DH) Protocol
Therapeutic deep hypothermia (DH) protocol closely mirrored clinical practice at
our institution (see Methods; Figure 2.2). DH was directed using nasopharyngeal
temperature. Following stable normothermia for a minimum of 5 minutes, subjects were
cooled to 18°C at an approximate rate of 1oC per minute by maintaining an 8-10°C
gradient between the cooling bath and venous return temperature. Subjects remained
under DH with continuous perfusion for a total of 40 minutes, at which point rewarming
to normothermia occurred at an approximate rate of 1°C per minute.
Arterial and jugular venous blood sampling (0.3 cc of blood per draw), as
described (see Methods; Figure 2.2), were analyzed for pH, pCO2 (mmHg), pO2
(mmHg), Na+ (mmol/L), K+ (mmol/L), Ca++ (mmol/L), glucose (mg/dL), lactate (mmol/L),
and hematocrit (%) and derivation of HCO3- (mmol/L), base excess (mmol/L), and SO2
(%) using the point-of-care blood gas analyzer (GEM 3000, Instrumentation Laboratory,
Blauvelt, NY, USA). Per clinical protocol at the Children’s Hospital of Philadelphia
(CHOP), blood pH was optimized by pH-stat management during cooling, whereby
increased concentrations of carbon dioxide were added to the oxygenator as necessary
to maintain a temperature-corrected pCO2 of 40 mmHg resulting in a blood pH of 7.4;
during rewarming and while normothermic, the blood pH was optimized by alpha-stat
(i.e., maintenance of pCO2 at 40 mmHg without temperature correction).
Mean arterial pressure was maintained between 40-70 mmHg with titration of
intravenous nitroglycerin (0.25-20 µg/kg/min), milrinone (50 µg/kg bolus, 0.25-0.75
µg/kg/min infusion), or nicardipine (0.5-3.0 µg/kg/min) as necessary for hypertension.
Significant changes in blood pressure, blood gas analytes, hyperglycemic status and any
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evidence of subject discomfort were treated immediately. At the conclusion of the study,
animals were euthanized using 20 mEq/kg of potassium chloride.
F.2. Derivation and Interpretation of Q10
The temperature coefficient, Q10, can be expressed as:
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Calculation of Q10 requires only two measurement points (i.e., knowledge of a

temperature change and corresponding relative change in CMRO2), and intuitively it
describes the relative impact of temperature change on metabolism. This scalar
coefficient formulation can be directly derived from the definite integral of the van’t Hoff
Equation or from simple substitution per the Arrhenius Equation. By the Arrhenius
Equation,
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a rate of reaction ($) depends on temperature (>), the universal gas constant (/),

an activation free energy barrier (

), and a pre-exponential factor ( ) which is related to

the frequency (i.e., incidence) of reaction. Using CMRO2 as the rate of reaction (k), the
relationship between the measured CMRO2 at two different temperatures, T1 and T2, is
easily shown to be exponentially related to the product of a scalar constant (
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the difference of the inverse of the two temperatures:
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Simple algebraic rearrangement yields the following expression incorporating the

constants

, /, and the temperatures, >! and > :
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Figure 2.A1: Continuous Cerebral Hemodynamics During Deep Hypothermia:
Continuous measurements of cerebral tissue oxygen saturation (StO 2 , %) measured
using FD DOS, relative cerebral blood flow (rCBF) measured using DCS, and the
combined measure of relative cerebral metabolic rate of oxygen (rCMRO 2 ) during
cooling, forty minutes of continuous deep hypothermic perfusion, and rewarming.
Decrease in temperature causes an increase in StO 2 , decrease in rCBF, and decrease
in rCMRO 2.
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Assuming a metabolic system is accurately modeled by the Arrhenius equation,

this result implies that .!% may be interpreted as a scalar constant, as long as the

temperature difference between >! and > is relatively small compared to the absolute

baseline temperature, >! , in Kelvin (i.e., |>! − > | ≪ >! such that Æ Æ Í Æ 6). These are
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reasonable assumptions for studies of cerebral metabolism given the narrow range of
normative baseline body temperatures 288. As a result, even without measurement of
absolute metabolism, comparison of the Q10 between such studies provides direct
insight regarding differences in activation energy

of each respective metabolic

system.
F.3. Example Cerebral Hemodynamic Time-Series Data
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Table 2.A1. Oxygen Saturation Sampling and Calculated OEF

SaO2, %
SjvO2, %
StO2, %
eqSbtO2, %
OEFoptical
OEFblood gas
p-value*

Cooling
Start

Cooling
Mid

Cooling
End

Rewarm
Start

Rewarm
Mid

Rewarm
End

98.9 (3.0)
74.1 (14.8)
55.7 (4.2)
11.0 (9.0)
0.58 (0.06)
0.25 (0.15)
<0.001

100.0 (0.0)
88.3 (6.6)
63.3 (5.5)
10.8 (3.9)
0.48 (0.07)
0.12 (0.07)
<0.001

100.0 (0.0)
93.7 (5.7)
66.1 (8.0)
20.0 (11.3)
0.44 (0.09)
0.06 (0.06)
<0.001

99.9 (0.2)
97.2 (2.6)
67.9 (12.3)
37.6 (28.8)
0.42 (0.16)
0.03 (0.03)
<0.001

99.8 (0.4)
92.0 (4.8)
62.9 (7.6)
23.9 (29.5)
0.48 (0.10)
0.08 (0.04)
<0.001

98.3 (2.7)
82.5 (8.5)
56.4 (6.1)
12.4 (14.3)
0.57 (0.08)
0.16 (0.07)
<0.001

*p-value of two-sample t-test between OEF optical and OEF blood-gas

Non-invasive frequency-domain diffuse optical spectroscopy (FD DOS) and
diffuse correlation spectroscopy (DCS) enables concurrent and continuous
measurement of cerebral hemodynamics and metabolism. A case example of these
measurements in shown in Figure 2.A1 with corresponding nasopharyngeal
temperature (NPT) during induction of deep hypothermia, continuous deep hypothermic
perfusion, and rewarming back to normothermia.
F.4. Examination of Cerebral Oxygenation
Cerebral tissue oxygen saturation (StO2) is expected to be higher than cerebral
venous oxygen saturation. However, at all blood gas sampling time-points, SjvO2, our
invasive surrogate measure of cerebral venous saturation, was consistently higher than
non-invasively measured StO2 (Table 2.A1).
A linear mixed-effects model (Figure 2.A2, left) was used to quantify the
relationship between the repeated measures of SjvO2 and StO2. A significant (p<0.001)
and positive slope effect illustrates a strong positive association between the two values;
however, the mean +27.4% bias between the two modalities from Bland-Altman analysis
(Figure 2.A2, right) with the zero-difference line outside the 95% limits of agreement
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([+10.5%, +44.4%]) are evidence of a discrepancy from the theoretical compartment
model computation of StO2.43,263

Figure 2.A2: Linear Mixed-Effects Model (left) and Bland-Altman Analysis (right) of
Invasive versus Non-Invasive Oxygen Saturation Measurements – Invasive oxygen
saturation derived from jugular venous blood gas sampling (SjvO 2 ) and non-invasive
tissue oxygen saturation derived from FD-DOS sampling (StO 2 ) in n=7 subjects
demonstrates a significant (p=0.003) and positive (slope [95% CI] = 0.46 [0.13, 0.79])
association and a bias and precision of +27.4% and 8.7%, respectively.

To further elucidate cerebral oxygen status, our secondary invasive measure of
oxygen, PbtO2, was used in combination with invasive intracranial temperature, pH,
HCO3, and base excess, analyzed from corresponding blood gas sampling, to estimate
equilibrated vascular saturation of brain tissue (eqSbtO2, %).303,304 This data is listed in
Table 2.A1 and mean and standard deviation plotted alongside non-invasive and
invasive saturation data in Figure 2.A3). Interestingly, the response to hypothermia and
the absolute value of StO2 during hypothermia is more comparable to eqSbtO2 than the
response and absolute value of SjvO2. This observation suggests that non-invasive StO2
measurements may reflect brain oxygen content better than blood gas sampling from the
jugular vein.
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Figure 2.A3: Comparison of Invasive and Non-Invasive Oxygen Saturation
Measurements: Mean and standard deviation across subjects (n=7) of oxygen
saturation measurements derived from arterial (red) and jugular venous (blue) blood
gas sampling (SaO 2 and SjvO 2 , respectively), FD-DOS sampling (StO 2 ; purple), and
invasive PbtO 2 measurements (eqSbtO 2 ; cyan), are presented for each blood gas
sampling time-point.

F.5. Bland-Altman Repeated-Measures Analysis

Figure 2.A4: Bland-Altman Analysis of Non-Invasive Diffuse Correlation
Spectroscopy (DCS; left) and rCMRO 2 (right): Data from individual subjects is
indicated by a unique symbol. DCS measurements of relative cerebral blood flow (rCBF
DCS) demonstrated a mean bias of -10.0% and precision of 13.1% (95% limits of
agreement = [-35.7%, 15.6%]) against laser Doppler (rCBF LD; n=8). Non-invasive
rCMRO 2 quantification demonstrated a mean bias of -25.8% and precision of 12.5%
(95% limits of agreement = [-50.3%, -1.4%]) against invasive rCMRO 2 measurements
(n=7).
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CHAPTER 3: IMPACT OF DEEP HYPOTHERMIC CIRCULATORY ARREST
ON NON-INVASIVE DIFFUSE OPTICAL MEASUREMENT OF CEREBRAL
OXYGEN METABOLISM IN NEONATAL SWINE
A. Abstract
Extended durations of deep hypothermic circulatory arrest (DHCA) during
complex surgical repair of congenital heart defects in neonates is used to improve
tolerance to hypoxic-ischemic injury. However, ~50% of infants still exhibit post-operative
neurological injury. Using real-time non-invasive diffuse optical monitoring techniques,
we aimed to perform novel quantification of the impact of DHCA on cerebral oxygen
metabolism, and the persisting effects following reperfusion in healthy neonatal swine.
Twenty-four piglets (3-5 kg) were placed on cardiopulmonary bypass and were
randomized to undergo deep hypothermia with continuous perfusion (DHCP; n=10) or
with circulatory arrest (DHCA; n=10) for 40 minutes; in addition four piglets comprised a
normothermic control group (n=4). Oxygen extraction fraction (OEF) and an index of
cerebral metabolic rate of oxygen (CMRO2,i) were derived from the optical
measurements continuously. During DHCA, we determined that OEF reached a
maximum at a mean (SD) time of 19.6 (6.7) minutes, indicating complete oxygen
utilization. After 40 minutes of deep hypothermia, the arrested DHCA group
demonstrated significantly increased OEF over the DHCP group (p<0.001). During
rewarming following reperfusion, the DHCA group also demonstrated a significant
hysteresis in the CMRO2,i temperature-dependence; i.e., metabolism exhibited
diminished temperature sensitivity compared to cooling (p<0.001). The findings present
novel continuous quantification of cerebral metabolic status both during and after DHCA
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that demonstrates the diagnostic potential of non-invasive diffuse optical monitoring;
moreover, this information may offer a prognostic indicator of neurological injury.

B. Introduction
The optimal cerebral perfusion strategy for infants requiring aortic arch
reconstruction remains a contentious topic across pediatric cardiac centers. Specifically,
the ability of the infant brain to tolerate deep hypothermic (DH) cardiopulmonary bypass
(CPB) and circulatory arrest during the course of aortic arch repair is not well
understood.78,94 Deep hypothermic circulatory arrest (DHCA) is a strategy characterized
by an extended period of circulatory arrest following venous vacuum-assisted
exsanguination and perfusion-supporting CPB cannula removal. This approach
facilitates a bloodless surgical field and thus improved visualization, factors which can
potentially lead to decreased surgical times and overall CPB support times. Prior to
circulatory arrest, deep hypothermia (DH) is induced, wherein core body temperature is
commonly decreased to 18°C to decrease metabolic demand and permit extended
cerebral tolerance to circulatory arrest. Optimization of strategies and neurological
outcomes in neonates and infants must thereby address a complex interplay of
compounded risk. The use of extracorporeal CPB support is associated with incremental
release of inflammatory mediators.66,305,306 Deep hypothermia causes a loss of cerebral
autoregulation,237,307 and extended durations of deep hypothermia have been associated
with transient post-operative choreoathetosis;308 moreover, duration of circulatory
arrest >40 minutes conveys an increased risk of seizures95 and adverse
neurodevelopmental outcomes at school-age.91 Currently, none of the routinely
employed intraoperative neuromonitoring methods characterize the evolution of these
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compounding risks in real-time. Thus, a knowledge gap for development and
implementation of neuroprotective strategies persists.
To date, one intraoperative intervention strategy, based on combined noninvasive neuromonitoring of cerebral tissue oxygen saturation (StO2) via continuouswave (CW) near-infrared spectroscopy (NIRS) and cerebral blood flow velocity via
transcranial Doppler (TCD) ultrasound, has shown that individualized intraoperative
feedback about cerebral oxygen metabolism can facilitate improved neurological
outcomes in children following their cardiac operation.97 Specifically, interpretation of
concurrent CW NIRS and TCD trends in cerebral oxygen utilization and cerebral
perfusion, respectively, permitted estimation of cerebral metabolic rate of oxygen
(CMRO2) and identification of vulnerable periods of cerebral hypoxia and ischemia. In
another recent prospective study, wherein DHCA was performed in 65 (87%) patients, a
lower cerebral tissue oxygenation index (<58%) measured by CW NIRS in combination
with blood lactate levels > 7.4mmol/L at 24 hours post-operation; this study showed a
sensitivity of 95% to poor outcome defined as death, or a BSID < 70 (Bayley Scales of
Infant Development, II).309 Together, these findings contribute to the limited evidence
that alterations in perioperative cerebral metabolism are prognostic of neonatal brain
injury.
Unfortunately, few clinical modalities are suitable for continuous intraoperative
neuromonitoring in neonates, and even fewer permit direct quantification of cerebral
metabolism. Following Austin et al.’s landmark study with CW NIRS and TCD, the only
other neuromonitoring modality for pediatric congenital heart surgery that has persisted
in the last two decades25,101,310–314 is electroencephalography (EEG). EEG is
recommended for postoperative seizure monitoring,315 but it has not been found to be an
accurate indicator of cerebral metabolism.316,317 Thus the combination of CW NIRS and
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TCD remains the only modality based on “conventional” methods that has proven
feasible for intraoperative metabolic monitoring.37,97,318,319 Yet, this multimodal strategy
has thus far seen limited clinical use.312,320 This limited use could be due to the
continuing susceptibility of TCD to motion artifacts and cautery interference, difficulties
maintaining TCD probe positioning on the small neonatal head, and small blood flow
velocities during low-flow cardiopulmonary bypass.25,34,101,215
Per optical techniques, intraoperative stand-alone CW NIRS has experienced
growing clinical adoption,321–323 in part because the instruments are FDA approved.
However, CW NIRS represents a class of diffuse optical spectroscopy (DOS) with
comparatively limited information.9,324 It does not quantify oxy- and deoxy-concentration
absolutely, and it fails to quantify cerebral blood flow or metabolism; thus its benefits
remain controversial.103,313 Ultimately, quantification of oxygenation relies on accurate
separation and assignment of tissue absorption and scattering properties (see
“Methods”), and even the most advanced, spatially resolved, multi-wavelength CW NIRS
systems rely upon baseline assumptions about the subject’s tissue optical scattering
properties. Furthermore, in CW NIRS, the changes in light intensity are equated to
changes in tissue optical absorption properties, without considering potential changes in
scattering. Consequently, the accuracy of CW NIRS suffers during perioperative
monitoring and, specifically, during DHCA, i.e., it suffers whenever tissue optical
properties can be significantly impacted by the profound physiological changes325, by
ATP depletion326, and by changes in tissue composition11 that result from deep
hypothermia, exsanguination via venous cannula vacuum, or extended hypoxiaischemia. These issues, along with the lack of cerebral perfusion monitoring, lead to
challenges for defining specific quantitative targets based on CW NIRS as part of goal-
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directed therapy. Thus, CW NIRS has failed to show a clear benefit on overall outcomes
in pediatric critical care.238
On the other hand, more sophisticated diffuse optical techniques exist that permit
all-optical, continuous non-invasive quantification of cerebral oxygen metabolism by
combining absolute measures of cerebral oxygenation, via time-domain (TD) or
frequency-domain (FD) diffuse optical spectroscopy (DOS), and via direct measurement
of blood flow by diffuse correlation spectroscopy (DCS).30–32 Recent proof-of-principle
demonstrations of intraoperative metabolic monitoring feasibility in infants37,112 have
been carried out. In these studies, the all-optical techniques show promise to address
the shortfalls of conventional clinical imaging modalities (including CW NIRS). Indeed, in
a subset of neonatal swine of the present study, invasive validation data based on these
techniques during DH CPB through cooling and rewarming have been reported
(Chapter 2); these data provide reason for improved confidence per the use of these
novel tools to inform clinical care during congenital heart surgery.
In this work, we employ these sophisticated non-invasive all-optical
hemodynamic methods to better understand the factors that contribute to cerebral
metabolic vulnerability. Specifically, the present study reports on characterization of the
incremental impact of circulatory arrest on cerebral oxygen metabolism with respect to
time during DHCA, and with respect to temperature following DHCA. The data are
derived using continuous non-invasive FD-DOS/DCS measurements in a neonatal swine
model of cardiac surgery.

C. Methods
The results in the present paper utilize unreported data from a prospective,
observational cohort study whose methods have been previously described.255 Briefly, in
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this work, twenty neonatal, female Yorkshire swine (6-10 days old, 3-5kg) were
continuously monitored through cardiopulmonary bypass (CPB) and were randomized,
following induction of deep hypothermia, to receive either continuous perfusion (DHCP;
n=10) or circulatory arrest (DHCA; n=10) for 40 minutes; these management scenarios
were followed by reperfusion of the DHCA group and rewarming to normothermia in both
groups. An additional control cohort (n=4) underwent CPB for a duration matching the
timing of the DHCP and DHCA cohorts, but without deep hypothermia or circulatory
arrest. All procedures were approved by the CHOP Institutional Animal Care and Use
Committee, performed in strict accordance with the NIH Guide for the Care and Use of
Laboratory Animals, and reported according to the ARRIVE guidelines
(https://www.nc3rs.org.uk/arrive-guidelines).
C.1. Selection of Animal Model
Neonatal swine models have provided foundational data contributions to our
understanding of the impact of circulatory arrest on the brain.250,255,327–330 This statement
is also true for the clinical translation of diffuse optical techniques for pediatric
neuromonitoring,19,22,26,41,324 due to comparability in the anatomical thickness of
superficial tissue (i.e., scalp, skull). The animal model used here was developed based
on surgical practices at our institution. The investigation builds upon and connects with
these two bodies of literature.
C.2. Neurological Monitoring
The methods for neurological monitoring have been previously detailed (Chapter
2, Section C.2 and C.4)331,332 but will be briefly summarized herein. Following,
anesthetic induction and intubation, and prior to initiation of cardiopulmonary bypass
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support, neurological monitoring modalities were placed. These monitoring modalities
included nasopharyngeal temperature (NPT, °C) for guidance of hypothermic therapy,
intracranial brain temperature (ICT, °C; CC1-P1, Integra LifeSciences; Plainsboro, NJ,
USA), and non-invasive frequency-domain diffuse optical spectroscopy (FD-DOS) and
diffuse correlation spectroscopy (DCS). Invasive measures of ICT were acquired in the
right frontal cortex, symmetrically contralateral to non-invasive FD-DOS/DCS
measurements over the left frontal cortex. Following placement, measurements from all
instruments were recorded continuously for the duration of the protocol.
Diffuse Optical Monitoring of Cerebral Oxygen Metabolism
Optical indices of cerebral metabolic rate of oxygen (CMRO2,i, mL O2/dL*cm2/s)
and relative CMRO2 (rCMRO2, %) were continuously quantified according to models
based on Fick’s Law 259. The resulting model, which is given below, uses the
combination of tissue oxygen extraction fraction (OEF) from FD-DOS, cerebral blood
flow index (BFI; cm2/s) from DCS, and baseline arterial blood gas sampling for the
arterial concentration of oxygen (CaO2, mL O2/dL):9,31,43,44,240,333
‰¼/‡

,&

= ‰ ‡ × ‡ ‘ × ½‘Ž .

(3.1)

CaO2 was assumed to remain constant throughout deep hypothermia. Validation data
regarding this assumption is reported in Chapter 2, Section D.2.331,332 Relative cerebral
metabolic rate of oxygen, rCMRO2, at a given time-point, t, was computed as:
‰¼/‡ ( ) =

‰¼/‡ ,& ( )
× 100% ,
‰¼/‡ ,&,C ,0Á&Â0

(3.2)

where the baseline value of CMRO2,i was calculated as the mean CMRO2,i measured
during the baseline period prior to cooling.
Using a customized commercial FD-DOS instrument (Imagent, ISS Inc.,
Champaign, IL, USA) with radio-frequency (110MHz) intensity-modulated near-infrared
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light sources and two photomultiplier tube detectors, the AC intensity and phase were
measured as a function source-detector separation. These data were then used to

derive absolute tissue absorption and scattering properties (+ and +, ′, respectively) at

four wavelengths () = 690, 725, 785, and 830 nm). Assuming constant cerebral tissue

water content 257, these measured absorption coefficients were used to quantify cerebral
tissue concentration of oxy- and deoxyhemoglobin ([HbO2] and [Hb], respectively;

+mol/L) 9,10,256. Subsequently, total hemoglobin concentration (THC, +mol/L), and tissue
oxygen saturation (StO2, %) were computed as:
>†‰ = J† L + J† ‡ L ;
2 ‡ (%) =

J† ‡ L
× 100% .
J† L + J† ‡ L

Assuming an optical venous fraction of

(3.3)
(3.4)
= 0.75 and using the arterial oxygen saturation

(SaO2) obtained from baseline blood gas sampling, OEF was determined as:
‡ ‘=

2 ‡ −2 ‡
.
×2 ‡

(3.5)

DCS measurements were performed using custom instrumentation with a

continuous-wave, long-coherence length (>10 m), ) =785 nm laser source (RCL-080-

785S; CrystaLaser, Inc, Reno, NV, USA), and two detection arrays of four single-photoncounting avalanche photodiode detectors (SPCM-AQ4C; Excelitas Technologies, Corp.,
Waltham, MA, USA). The DCS calculations of blood flow index (BFI) incorporated the
concurrent measurements of tissue absorption and scattering properties from FD-DOS.
BFI was derived from fitting the average (i.e., across all detectors) hardware-calculated
(FLEX03OEM-8CH; Correlator.com, NJ, USA) intensity temporal autocorrelation function
with the homogenous solution for the semi-infinite diffusion correlation equation 33.
Measures of relative cerebral blood flow (rCBF; %) at a given time-point (t) were
computed as:
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‰½‘( ) =

½‘Ž( )
× 100% ,
½‘Ž C ,0Á&Â0

(3.6)

where the baseline BFI value was calculated as the mean BFI measured during the
baseline period prior to cooling.
CMRO2 Temperature-Dependence
The Arrhenius Equation (Equation 2.7)113,115 was used to quantify the
temperature-dependence of cerebral metabolism during cooling and rewarming in DHCP
and DHCA groups. For example, the model for CMRO2,i (i.e., a rate of reaction) is
dependent on intracranial temperature (Ž‰>), the universal gas constant (/), an
activation free energy barrier (

), and a pre-exponential factor ( ) which is related to

the attempt frequency associated with the reaction:
‰¼/‡

,&

Äž

= V MÅ∙ÎXÆ .

This equation may be rearranged into a linear form (Ç = È + ) such that model

parameters,

=

j(‰¼/‡ ) =

Äž
Å

and

(3.7)

= ln( ), may be derived from linear regression of the data:

1
| } + j( ) .
/ >

(3.8)

C.3. Cardiopulmonary Bypass and Deep Hypothermia
The procedure and timing for institution of cardiopulmonary bypass, deep
hypothermia and circulatory arrest are illustrated in Figure 3.1 and have been described
in Mavroudis et al.255 All subjects (n=24) were stabilized on CPB (flow rate = 150
ml/kg/min) at normothermia (NPT = 37°C), and baseline measurements were acquired
for five minutes. Subsequently, DHCP and DHCA animals were cooled to deep
hypothermia (NPT = 18°C) at a target rate of 1°C per minute. After attainment of 18°C,
the subjects were randomized to either DHCA (n=10) or DHCP (n=10) for a duration of
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Figure 3.1. DHCA versus DHCP Experimental Protocol: Study subjects (n=24) were
randomized to three treatments. The control group (grey; n=4) received continuous
normothermic perfusion. Remaining animals were cooled to deep hypothermia
(nasopharyngeal temperature = 18°C) and received either continuous perfusion (DHCP,
n=10; green) or circulatory arrest (DHCA, n=10; blue).

40 minutes. To initiate DHCA, the CPB arterial outlet flow was turned off and clamped,
with venous drainage remaining open for patient exsanguination (i.e., removal of blood
from the body). Once the lack of venous return became apparent, the venous drainage
was also clamped. Donor blood was added as needed to ensure a minimum hematocrit
of 30%; similarly, 2 meq/kg of sodium bicarbonate and 0.5 g/kg mannitol were added
immediately prior to reinitiating CPB. Following reperfusion of DHCA animals, DHCA and
DHCP groups were rewarmed to normothermia (NPT = 37°C) at a target rate of 1°C per
minute. The normothermic control group (n=4) were maintained on CPB for a total of 70
minutes, i.e., 15 minutes for simulated cooling, 40 minutes for simulated deep
hypothermia, and 15 minutes for simulated rewarming.
C.4. Statistical Analysis
All statistical analyses were carried out using MATLAB 2014a. Summary
statistics are reported as mean and standard deviation (SD), unless otherwise noted.
Primary analyses comprised examination of the timing of oxygen utilization during
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DHCA, differences in cerebral metabolic parameters at 40 minutes of DHCA versus
DHCP. Additionally, we carried out a comparison of CMRO2,i temperature-dependence
during rewarming, following DHCA, versus during cooling. The latter analysis has been
described in DHCP animals in Chapter 2. Section D.1.
Timing of oxygen utilization during DHCA was characterized by a time-tomaximal oxygen extraction (
(

„C…6 ,ÐÎÒ ).

averages.

…ÄÏ,Ð Ñ ),

and a time-to-minimal [HbO2] depletion

Continuous time-series data were synchronized using 15 s epoch
…ÄÏ,Ð Ñ

and

„C…6 ,ÐÎÒ

were determined as the earliest time-point at which the

absolute change in the subsequent five-minutes became less than 0.5% of baseline
OEF and [HbO2], respectively. To examine the temporal characteristics of the change,
discrete differential time-series were also calculated from the continuous data as a
function of time by computing the difference in values recorded between adjacent 15 s
epochs.
Cerebral metabolic parameters were compared between DHCA versus DHCP
groups at 40 minutes of deep hypothermia. Secondary comparisons were conducted at
baseline and end of cooling, as well as comparisons of changes (Δ) from baseline at end
of cooling and at 40 minutes of deep hypothermia. All single-parameter comparisons
between groups were made using a two-sample t-test, assuming equal variances, and
evaluated at a pooled significance level of =0.05. A Bonferroni correction was applied
to adjust the significance level for the five multiple comparisons to =0.01. Assuming a

type II error rate of ¸=0.2, the two-sample t-test comparisons between DHCP and DHCA

groups were powered to identify a minimum effect size of 1.67*SD of each parameter at
a two-tailed significance level of =0.01.
In the control group, within-group paired t-test comparisons between baseline
and end values were conducted to examine the presence of significant changes as a
102

result of 70 minutes of normothermic CPB support. Assuming a type II error rate of
¸=0.2, and a within-subject correlation of 0.875, this test was powered to identify a

minimum effect size of 0.67 times the SD of each parameter at a two-tailed significance
level of =0.05.
Linear mixed-effects models were used to quantify differences in the relationship
between CMRO2,i and intracranial temperature (Equation 3.6). i.e., during cooling

versus rewarming in DHCA animals. The model included fixed and random slope and
intercept effects, with a period-specific (i.e., cooling or rewarming) interaction term.
Random effects were included to allow for subject-specific slope and intercept variations.
The goodness-of-fit of these models were evaluated using the coefficient of
determination (R2) of a generalized linear regression model, including subject
interactions and excluding random effects.

D. Results
Twenty-four neonatal swine (mean weight = 3.6 kg) underwent CPB with
neurological monitoring. Successful diffuse optical monitoring was achieved in 8 of 10
DHCP animals, 8 of 10 DHCA animals, and 3 of 4 control animals with fallout of
remaining animals due to incidental obstruction of optical signal by cutaneous bleeding.
Following adjustments in sample size, two-sample t-test comparisons between DHCP
and DHCA groups were powered to identify a minimum effect size of 2*SD and paired ttest within-subject comparisons in the control group were subsequently powered to
identify an effect size of 0.75*SD in each parameter.
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Table 3.2. Summary of Temperature and Cerebral
Metabolic Parameters in the Control Group (n=3)
Parameter

Baseline

70 Minutes

p-value

NPT
ICT
[HbO2]
[Hb]
THC
StO2
OEF
BFI*108
CMRO2,i*108
rCBF, %
rCMRO2, %

37.2 (0.3)
36.0 (1.4)
53.7 (10.8)
42.2 (6.0)
95.9 (14.4)
55.9 (4.6)
0.59 (0.06)
1.42 (0.67)
12.6 (6.3)
100.0 (-)
100.0 (-)

37.2 (0.3)
36.0 (1.8)
58.8 (21.4)
44.3 (10.5)
103.1 (30.0)
56.4 (6.5)
0.58 (0.09)
1.35 (0.54)
12.0 (5.6)
98.1 (9.2)
96.3 (5.6)

1.000
0.954
0.505
0.592
0.529
0.685
0.685
0.468
0.285
0.757
0.375

Abbreviations: See Table 1.

The mean baseline arterial concentration of oxygen (CaO2) across all animals
(n=19), measured by blood gas sampling, was 14.3 (1.8) mL O2/dL blood. On average,
DHCP (n=8) and DHCA (n=8) animals were cooled to deep hypothermia in 26.5 (4.9)
minutes. DHCP animals were maintained with continuous deep hypothermic perfusion
for 42.6 (1.6) minutes while DHCA animals underwent circulatory arrest for 41.0 (1.4)
minutes. These animals were subsequently rewarmed to normothermia in 27.5 (5.8)
minutes. No differences in timing, temperature, or other cerebral metabolic parameters
were found between groups at baseline or at the end of cooling (Table 3.1). We
examined the impact of prolonged cardiopulmonary bypass support alone within the
control group animals (n=3), who underwent normo-thermic CPB support for 72.6 (1.5)
minutes; they exhibited no differences in cerebral metabolic parameters from baseline
after this time (Table 3.2).
D.1. Timing of Cerebral Oxygen Utilization During DHCA
Mean oxygen extraction fraction (OEF) as a function of time from start of DHCP
or DHCA is depicted in Figure 3.2 for each group. In the control group, OEF remains
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Figure 3.2. Oxygen Extraction Fraction (OEF) during Deep Hypothermia: The mean
and standard deviation of OEF within each group is shown with respect to time from the
start of deep hypothermia, in DHCP animals (green), or from the start of circulatory
arrest, in DHCA animals (blue). For comparison, data is also shown from normothermic
control animals (gray) following 15 minutes of cardiopulmonary bypass support. DHCA
induces an increasing OEF over time; the mean (SD) time-to-maximal OEF (t 5:;,7<= )
was 19.6 (6.7) minutes after the start of DHCA. Notice, OEF recovers following
reperfusion and aligns with values of the DHCP group within 20 minutes.

stable for the entire period. The DHCP group also exhibits a stable, but depressed OEF
throughout the 40-minute period; this is followed by recovery during rewarming with
values trending towards the control group. The DHCA and DHCP group both begin at
lower OEF in comparison to the normothermic group (note, this is a qualitative
observation; no statistical testing was performed), but in both cases there is an
immediate and rapid increase in OEF with time. Mean time-to-maximal OEF (

…ÄÏ,Ð Ñ )

in

DHCA animals was determined to be 19.6 (6.7) minutes after the start of DHCA.
Further examination of absolute [HbO2], [Hb], THC (Figure 3.3, left), and StO2
(Figure 3.3, right) and their change from baseline (ΔBaseline) during DHCA shows
expectedly similar timing trends. Decreasing [HbO2] and increasing [Hb], resulted in
decreased StO2 and demonstrates rapidly increasing oxygen utilization. The mean timeto-minimal [HbO2] (

„C…6 ,ÐÎÒ )

was determined to be 18.4 (6.8) minutes after start of

DHCA.

105

Table 3.1. Summary of Temperature and Cerebral Metabolic Parameters in DHCP
and DHCA Groups
ABSOLUTE VALUES

Cooling Time
Rewarm Time

CHANGE FROM BASELINE

DHCP,
n=8

DHCA,
n=8

p-value

25.7 (5.3)
27.2 (7.0)

27.3 (4.7)
27.7 (4.7)

0.538
0.878

37.2 (0.6)
34.1 (2.4)
42.3 (7.7)
33.3 (4.3)
75.6 (10.7)
55.7 (4.2)
0.58 (0.06)
0.75 (0.30)
5.6 (2.7)

37.4 (0.8)
36.5 (0.9)
47.1 (15.7)
37.7 (6.7)
84.8 (21.8)
54.8 (4.4)
0.60 (0.06)
1.04 (0.44)
9.7 (5.0)

0.593
0.068
0.480
0.174
0.339
0.719
0.529
0.192
0.084

17.7 (0.4)
22.7 (2.3)
52.0 (13.4)
26.0 (5.6)
78.0 (14.1)
66.1 (8.0)
0.44 (0.09)
0.39 (0.24)
2.1 (1.1)

18.6 (1.7)
23.2 (1.7)
64.2 (23.2)
26.7 (7.1)
90.9 (28.5)
70.1 (5.7)
0.40 (0.08)
0.63 (0.45)
3.5 (2.2)

0.206
0.724
0.261
0.852
0.313
0.325
0.365
0.258
0.163

18.1 (0.5)
18.8 (1.1)
58.0 (18.4)
24.8 (6.0)
82.8 (15.0)
68.6 (11.1)
0.41 (0.15)
0.43 (0.38)
1.9 (1.3)

18.9 (0.5)
19.4 (1.3)
21.8 (15.3)
45.6 (10.0)
67.4 (24.9)
29.4 (10.6)
0.94 (0.14)
0.01 (0.01)
0.2 (0.2)

0.007*
0.369
<0.001**
<0.001**
0.155
<0.001**
<0.001**
0.008*
0.003*

DHCP,
n=8

DHCA,
n=8

p-value

-19.5 (0.7)
-11.4 (3.2)
+9.7 (8.9)
-7.3 (3.5)
+2.4 (7.9)
+10.4 (5.5)
-0.14 (0.07)
-48.9 (18.7)
-62.8 (8.4)

-19.0 (1.9)
-13.3 (2.7)
+16.6 (8.5)
-10.8 (4.0)
+5.8 (6.3)
+15.0 (6.0)
-0.20 (0.08)
-40.4 (23.4)
-61.2 (16.3)

0.509
0.360
0.184
0.122
0.408
0.175
0.175
0.500
0.823

-19.1 (0.8)
-15.2 (2.7)
15.2 (15.0)
-8.1 (7.2)
7.0 (11.5)
12.3 (9.4)
-0.16 (0.14)
-49.9 (32.7)
-70.2 (12.1)

-18.4 (0.8)
-16.4 (1.2)
-27.0 (7.1)
7.4 (4.7)
-19.5 (7.7)
-27.0 (9.9)
0.36 (0.13)
-98.8 (0.5)
-98.1 (1.0)

0.131
0.358
<0.001**
<0.001**
<0.001**
<0.001**
<0.001**
0.004*
<0.001**

Baseline
NPT
ICT
[HbO2]
[Hb]
THC
StO2
OEF
BFI*108
CMRO2,i*108

End of Cooling
NPT
ICT
[HbO2]
[Hb]
THC
StO2
OEF
BFI*108
CMRO2,i*108

ÓNPT
ÓICT
Ó[HbO2]
Ó[Hb]
ÓTHC
ÓStO2
ÓOEF
ÓrCBF, %
ÓrCMRO2, %

End of DH
NPT
ICT
[HbO2]
[Hb]
THC
StO2
OEF
BFI*108
CMRO2,i*108

*p<0.01; **p<0.001.

ÓNPT
ÓICT
Ó[HbO2]
Ó[Hb]
ÓTHC
ÓStO2
ÓOEF
ÓrCBF, %
ÓrCMRO2, %

Abbreviations (Units): Δ, change from baseline; Cooling Time (min); Rewarm Time (min); NPT,
nasopharyngeal temperature (°C); ICT, intracranial temperature (°C); [HbO2], concentration of
oxy-hemoglobin (+mol/L); [Hb], concentration of deoxyhemoglobin (+mol/L); THC, total
hemoglobin concentration (+mol/L); StO2, tissue oxygen saturation (%); OEF, oxygen extraction
fraction; BFI, blood flow index (cm2/s); CMRO2,i, optical index of cerebral metabolic rate of
oxygen (mL O2/dL * cm2/s); rCBF, relative cerebral blood flow (% baseline); rCMRO2, relative
cerebral metabolic rate of oxygen (% baseline).
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Figure 3.3. Effect of DHCA on Cerebral Hemoglobin Concentration and Tissue
Oxygenation: The mean (solid line) and standard deviation (shaded region) of absolute
values of oxy- and deoxy- hemoglobin concentration ([HbO 2 ], red; and [Hb], blue;
respectively), total hemoglobin concentration (THC; black), and cerebral tissue oxygen
saturation (StO 2 , purple) are shown as a function of time from the start of deep
hypothermic circulatory arrest through the first 20 minutes following reperfusion (DHCA;
n=8). Absolute values are displayed in the adjacent top panels alongside changes-frombaseline (Δ) values in the adjacent bottom panels. Rapid depletion and recovery of
oxygenation and total hemoglobin are seen at the onset of DHCA and upon reperfusion,
respectively. Mean (SD) time-to-minimal [HbO 2 ] (t 3456 ,789 ) was after 18.4 (6.8) minutes
of DHCA.

Supplemental analyses of the first and second discrete differentials of the OEF
and [HbO2] time-series identified a distinct initial period of rapid rate change in the first
six minutes (Figure 3.4) of DHCA. Subsequently, the first differential continued to
decline for the remainder of circulatory arrest, but it declined at a stable rate, as
indicated by the zero-value of the second differential. Given that changes in oxygen
utilization are often indications of changes in the magnitude of underlying cellular
metabolism, these distinct periods are suggestive of underlying alterations in cellular
metabolism.
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Figure 3.4. Timing of differential changes in OEF, [HbO 2 ], rCBF and THC: The
mean first (1st, dotted line) and second (2nd, solid line) differential time-series is
plotted for oxygen extraction fraction (OEF, top left) and oxyhemoglobin concentration
([HbO 2 ], bottom left) in DHCA subjects. The first differential is normalized to the change
in the first 15 seconds of DHCA. The second differential identifies an initial 6-minute
period (yellow) of rapid change, which subsequently stabilizes as the second
differential goes to zero. This analysis identifies distinct periods with differential rates
of change which may reflect changes in cellular metabolism during onset of hypoxia.
The agreement of timing between OEF and [HbO 2 ] confirms that depletion of available
oxygen is tightly linked to oxygen utilization. In the differential times series of relative
cerebra blood flow (rCBF; top right) and total hemoglobin concentration (THC; bottom
right), rapid declines are likely the result of exsanguination during the first two minutes
(blue) of DHCA.

Interestingly, THC also demonstrated progressive depletion with an average loss

of 19.5 (7.7) +mol/L at the end of DHCA. In addition to progressive hypoxia as a result of

oxygen metabolism, this observation identifies a compound effect of progressive

ischemia which further diminishes tolerance to DHCA. Another notable observation was
made regarding the change from baseline in [Hb], [HbO2] and THC; these tissue
properties exhibited substantially smaller inter-subject variability (i.e., standard deviation)
compared to their absolute values. This adjustment in inter-subject variability is not
observed between absolute values of StO2 and its difference from baseline. This effect
potentially indicates that, regardless of the varying amounts of blood volume in the
region of optical light penetration, the absolute value of oxygen that is either utilized or
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accessible for extraction is relatively homogenous across subjects. This finding also
holds true during reperfusion and subsequent rewarming, which suggests that
differences from baseline should be taken into consideration to provide a more
discriminating measure of oxygen utilization.
D.2. Impact of Prolonged DHCA on Cerebral Oxygen Metabolism
Following 40 minutes of DHCA versus DHCP, significant differences (p<0.01)
were detected in all cerebral metabolic parameters except intracranial temperature
(Table 3.1, “End of DH”). Nasopharyngeal temperature was significantly greater in
DHCA animals (18.9 (1.7)°C) than in DHCP animals (18.1 (0.5)°C). Given the lack of
cold perfusion to maintain stable deep hypothermia in DHCA animals, mild rewarming is
plausible due to equilibration with room temperature and due to residual cellular
metabolism.
Additional significant differences between DHCA and DHCP groups were seen in
[HbO2], [Hb], THC, StO2, OEF, BFI, and CMRO2,i. Inter-subject variability observed in the
time-series analysis of THC affected comparability of absolute values between DHCP
and DHCA groups (p=0.155). However, examination of differences in THC changes from

baseline (ΔTHC) between groups revealed a highly significant difference (DHCP ΔTHC =

+7.0 (11.5) +mol/L, DHCA ΔTHC = -19.5 (7.7) +mol/L; p<0.001). Significant differences

in all other variables were confirmed in comparisons of changes from baseline. As

expected from earlier examination of the OEF, [HbO2], and [Hb] time-series, in DHCA
animals, OEF was significantly higher (DHCA: 0.94 (0.14), DHCP: 0.41 (0.15); p<0.001),
[HbO2] was significantly lower (DHCA: 21.8 (15.3) +mol/L, DHCP: 58.0 (18.4) +mol/L;
p<0.001), [Hb] was significantly higher (DHCA: 45.6 (10.0) +mol/L, DHCP: 24.8 (6.0);
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p<0.001), and StO2 was significantly lower (DHCA: 29.4% (10.6), DHCP: 68.6% (11.1);
p<0.001) than in DHCP animals.
While both DHCA and DHCP groups saw similar depression of CBF (DHCA

ΔrCBF = -40.4% (23.4), DHCP ΔrCBF = -48.9% (18.7); p=0.500) and CMRO2 (DHCA

ΔrCMRO2 = -61.2% (16.3), DHCP ΔrCMRO2 = -62.8% (8.4); p=0.500) following cooling,

the overall changes from baseline at the end of deep hypothermia reflected a significant
difference resulting from lack of perfusion in DHCA animals (DHCA ΔrCBF = -98.8%

(0.5), ΔrCMRO2 = -98.1% (1.0)) as compared to continuous perfusion in DHCP animals

(DHCP ΔrCBF = -49.9% (32.7), ΔrCMRO2 = -70.2% (12.1)) on rCBF (p=0.004) and

rCMRO2 (p<0.001). This observation provides clear evidence that non-invasive FD-

DOS/DCS monitoring enables quantification of the impact of DHCA on cerebral oxygen
metabolism; the corresponding variation of hemodynamic parameters reflects the
hypoxic and ischemic conditions of the brain.
D.3. CMRO2,i Temperature-Dependence Following DHCA
A comparison of CMRO2,i temperature-dependence during cooling and
rewarming in DHCP animals (Figure 3.5, left) has been previously reported in Chapter
2, Section D.1.331,332 A primary objective of the previous study was to characterize the
adequacy of current non-invasive nasopharyngeal temperature guidance of deep
hypothermia through comparisons to true brain temperature and to cerebral metabolism.
A significant finding was that the use of nasopharyngeal temperature introduced
discrepancies in CMRO2,i temperature dependence due to mismatch with brain
temperature. As a result, in the present study, we exclusively examined intracranial brain
temperature-dependence, and we compared our previous findings in DHCP animals to
the results of an identical analysis conducted in DHCA animals.
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Figure 3.5. Temperature-Dependence of CMRO 2,i , Cooling versus Rewarming: The
fitted slope and intercept effects during cooling and rewarming are reported in tabular
form above the plotted individual data (unique symbols for each subject) and modeled
relationships (solid lines). The fitted model (thick solid line) is depicted with 95%
confidence intervals (thin solid lines) for cooling (blue) and for rewarming (red).
Concordance of the temperature-dependence of the optical index of cerebral metabolic
rate of oxygen (CMRO 2,i ) between cooling and rewarming, with respect to intracranial
temperature (ICT), in DHCP animals has been previously reported in Chapter 2,
Section D.1 (left). 331,332 In contrast to DHCP animals, the DHCA animals (right) exhibit
a significant hysteresis between cooling, prior to circulatory arrest, and rewarming,
following circulatory arrest, whereby the effect of rewarming adjusts the slope of the
temperature-dependence relationship towards zero; this indicates diminished sensitivity
of metabolism to temperature.

In a linear mixed-effects model of the CMRO2,i temperature-dependence with
respect to intracranial temperature (ICT) during cooling and rewarming in DHCA animals
(Figure 3.5, right), a significant slope (Mean [SE] = -5427.6 [435.1], p<0.001) effect
during cooling was found. This confirms a strong association between temperature and
CMRO2,i in DHCA animals. Moreover, while rewarming did not exhibit a significant effect
on slope or intercept in DHCP animals, in DHCA animals, both a significant rewarming
slope (Mean [SE] = +2078.7 [579.8], p<0.001) and intercept (Mean [SE] = -6.9 [1.9],
p<0.001) were found. This observation indicates that circulatory arrest significantly
impacted the relationship of temperature and metabolism, and in this case, metabolism
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exhibited diminished temperature sensitivity. Examination of individual subject data
suggests that, immediately following circulatory arrest, CMRO2,I appears heightened with
respect to pre-arrest CMRO2,i at deep hypothermia. This effect is likely secondary to
prolonged hypoxia, such that once oxygen availability is restored, oxygen metabolism
rapidly increases to replenish hypoxic tissue. Furthermore, the R2 of the temperaturedependence in DHCA animals is markedly lower (R2 = 0.73) than that seen in DHCP
animals (R2 = 0.90). The latter finding indicates that the variability in cerebral oxygen
metabolism explained by temperature has decreased, which may be plausibly explained
by the added variability of hypoxia. In sum, these findings demonstrate the novel
continuous characterization of CMRO2,I temperature-dependence by non-invasive FDDOS/DCS which may eventually be used to more accurately quantify and compare
alterations in cerebral metabolism following DHCA in alternative study populations.

E. Discussion
We have quantified the impact of deep hypothermic circulatory arrest (DHCA) on
cerebral oxygen metabolism during and following DHCA in a neonatal swine model. The
measurements employed continuous, non-invasive diffuse optical techniques which
advance substantially beyond conventional continuous-wave NIRS. Continuous
sampling methods permitted new quantification of the magnitude and the timing of
hemodynamic and metabolic variations during circulatory arrest, as well as cerebral
metabolic temperature-dependence following reperfusion. These findings complement
other reports of intraoperative monitoring in human neonates undergoing complex
cardiac repair37,112 by providing reference data in healthy neonatal animals of
comparable size and development. Moreover, our comparison with animals who
received deep hypothermia continuous perfusion (DHCP) enabled the independent
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effects of circulatory arrest to be separated from those of deep hypothermia.
Generalization of this work to intraoperative guidance of DHCA in children appears
feasible.
E.1. Timing of Cerebral Oxygen Utilization During DHCA
During DHCA, non-invasive optical measurements of oxygen extraction fraction
(OEF) from oxy-hemoglobin concentration ([HbO2]) permitted decoupling of oxygen
utilization (OEF) from oxygen availability ([HbO2]). The average (standard deviation) of
the time-of-minimal [HbO2], 18.4 (6.8) minutes, was comparable to time-of-maximal
OEF, 19.6 (6.7) minutes. These delays are shorter than the mean (SD) nadir time for
[HbO2] reported in a study by Sakamoto, et al. of 51.3 (12.3) minutes in moderately older
animals (mean weight = 9.36kg) who were similarly maintained at a hematocrit of
30%.328 The differences may be attributed to a longer cooling protocol (40 minutes) and
to a lower target temperature (esophageal, 13-14°C) in Sakamoto, et al., which could
lead to more homogenous brain cooling and lower residual metabolism with slower
oxygen utilization. Our average rate-of-change in StO2 was mean [range] = 1.0% [0.7,
1.7] per minute; it is calculated as the total StO2 change during DHCA divided by total
DHCA time. This number overlaps well with the range of 0.5-1.6% reported by Tobias et
al. in eight children, aged 2 weeks to 6 months, which showed a mean (SD) DHCA time
of 43.4 (8) minutes.334 Importantly, our findings confirm the wide inter-subject variability
in timing of oxygen depletion observed. From our data the mean absolute change in
StO2 during DHCA was 40.0%. Assuming an, albeit crude, constant consumption rate
ranging from 1.6% to 0.5% per minute, the time to deplete StO2 by 40% ranges from 2580 minutes; inadequate cooling would lower initial saturations and further decrease
timing of depletion. These uncertainties (or range of variation) underscore the
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importance of neuromonitoring during DHCA to individually characterize the timing of
oxygen depletion and prevent extended periods of hypoxia.
Examination of the differential OEF and [HbO2] time-series uncovered a matching
time period of rapid rate-change at the start of DHCA. A similar observation of [HbO2]
variation was made by Abdul-Khaliq, et al. and was attributed to blood loss due to
exsanguination following DHCA.335 From review of our operative notes, the period of
exsanguination, between clamping of the arterial outflow and venous inflow lines, was
always less than 2 minutes and was typically 30-40 seconds. In the first 2 minutes of
DHCA, we observed a rapid decline in both the THC (-8% to -17%) and the BFI (-2% to 12%) time-series which corroborates contribution from the exsanguination effect. By
combining the first differential THC time-series (Figure 3.4) with the StO2 time-series, we
find that this loss of THC in the first two minutes of DHCA results in a loss of 14-21% of
the total [HbO2] loss during the 40 minutes of DHCA. Mitigating strategies to maintain or
limit this loss could potentially result in extended tolerance to DHCA.
Exsanguination, however, is unable to account for the period of rapid rate change
extending beyond two minutes. Thus, the changes in rate of oxygen utilization we have
observed, without rapid volume loss, suggest that alterations in cellular metabolism
might also be occurring. Cerebral metabolic response and tolerance to hypoxia in
developing mammals has been observed to be markedly different than in more mature
individuals.336,337 From studies performed in developing mammals, two promising
metabolic mechanisms potentially underlie the observed effect are: 1) a shift in energy
substrate usage from oxygen to glucose, and/or 2) a hypometabolic neuroprotective
response during hypoxia whereby total energy utilization decreases during periods of
extended hypoxia.
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In Pigula et al., children with a median age of 5 months demonstrated a decrease
in the ratio of oxygen-to-glucose utilization during deep hypothermia.338 Two additional
studies, using invasive cerebral microdialysis sampling in piglets, also support the
presence of this substrate shift because lactate/pyruvate ratios were significantly
elevated during DHCA.251,255 However, their use of discontinuous sampling methods
prevented further insights regarding the timing of this shift. A critical clue was found in
fetal sheep wherein Hunter et al. observed an exponential increase in the cerebral
glucose/oxygen utilization ratio when oxygen availability dropped below 50% of baseline
during severe hypoxia induced by cord occlusion.339 The timing of this metabolic shift
aligns well with depletion of [HbO2] in our experiments; across all DHCA subjects, [HbO2]
decreased to the midway point between baseline [HbO2] and end-of-DHCA [HbO2] in 5.2
(2.8) minutes. The second differential [HbO2] time-series (Figure 3.4) rapidly decays to
zero after this time, which corresponds to stabilization of the slope of the first differential
until complete depletion of [HbO2]. In the future, the association between the timing and
magnitude of decreased [HbO2] utilization should be examined for its potential as
surrogate measure of anaerobic metabolism.
Hypometabolic response in newborns, which have been reviewed in detail by
Rogalska et al., offers another explanation for the decreasing rate of oxygen utilization
during hypoxia.337 A compelling example of hypometabolism was the significant
decrease in oxygen utilization seen by Cross et al. in infants ventilated by air with 15%
oxygen as opposed to the customary 21% oxygen in room air.340 Furthermore, neonatal
rat neurons have exhibited significantly lower energy utilization during prolonged hypoxia
compared to adult rat neurons.341 Methods of diminished energy utilization include
suppression of non-essential cellular processes such as pathways for thermogenesis,
repair and growth.342 Supporting the potentially concurrent and complimentary action of
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both identified mechanisms, Cavus et al. reported significantly lower cerebral pyruvate
and lactate production (measured invasively by cerebral microdialysis) which, in
combination, demonstrated an increased lactate-pyruvate ratio in 5-11 kg piglets during
DHCA compared to those who received continuous cerebral perfusion.251 Therefore, an
approach based on examination of the timing of cerebral oxygen utilization during DHCA
by continuous diffuse optical methods together with quantification of key cerebral tissue
metabolites offers a new route to elucidate these mechanisms.
In the setting of complex neonatal cardiac repair, varying degrees of cerebral
metabolic derangement may be observed due to persisting pre-operative hypoxia109,110
and diminished cerebral perfusion.343 Thus, improved understanding of the correlation
between temporal characteristics of oxygen availability and utilization, and about the
underlying mechanisms facilitating hypoxic tolerance, should enable continuous
intraoperative monitoring to provide precise, subject-specific estimates of the rate of
metabolic substrate depletion to inform neuroprotective care strategies.
E.2. Impact of Prolonged DHCA on Cerebral Oxygen Metabolism
The reported effects of 40-minutes of DHCA on all cerebral metabolic parameters
represent novel data which could not have been obtained simultaneously without
application of advanced, quantitative diffuse optical techniques. The effects of cooling to
deep hypothermia in DHCA animals showed no significant differences from DHCP
animals. These findings are consistent with the summary results reported in Chapter 2,
Section D.1,331,332 as well as with prior studies in comparable neonatal swine
models.249,273 Following 40 minutes of deep hypothermia, however, significant
differences in all measured cerebral metabolic parameters were observed. Herein, our
results are interpreted in the context of the physiology and are compared to
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measurements by CW NIRS, and FD-DOS/DCS measurements in related hypoxicischemic conditions.
Trends in StO2, THC, [HbO2], and [Hb] during DHCA were consistent with
reported changes measured by CW NIRS in piglet models328,335,344 and
infants.37,57,61,317,323,334,338,345,346 This data corroborates well-known effects of severe
hypoxia in the brain resulting from DHCA. However, the absolute values of CW NIRS
parameters (when reported) vary across the different studies. This is likely due, at least
in part, to variability in physiologic baseline assumptions across CW NIRS systems, to
the changes in scattering during deep hypothermia and circulatory arrest that occur and
are not accounted for, and to general intra-subject variability.27,276
To examine the variability of scattering we reviewed the measured optical
scattering coefficients through cooling, DHCA, and rewarming. Depending on
wavelength, the scattering coefficients showed a 2.5 to 5-fold increase in the coefficient
of variation (COV) with respect to baseline measurements. This COV finding indicates
that there are substantial shifts in scattering associated with temperature changes and
circulatory arrest.
In related physiologic contexts, our FD-DOS StO2 quantification at baseline
(54.8% (4.4)) and during DHCA (29.4% (10.6)) agree well with previous FD-DOS
measurements at baseline (56.5 ± 0.5%), post-sacrifice (~32%),26 and during severe
hypoxia as indicated by a sagittal sinus oxygen saturation < 5% (StO2 ranged from 2040%)22 in neonatal piglet models. Thus, our results demonstrate that the addition of deep
hypothermia and ischemia do not to dramatically impact the physiologic values of StO2
found in severe hypoxia.
The physiology underlying the significant decreases of THC in DHCA animals
compared to DHCP animals remains unclear. THC has been used as a surrogate
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measure of cerebral blood volume.109,112,231 The significant rCBF changes we observed,
in the early period of rapid change during DHCA, provides plausibility for blood volume
(THC) changes during exsanguination; however, THC continues to decline rapidly for
another few minutes with a more gradual but persistent decline till the end of DHCA.
Similar drops in THC have been reported following animal sacrifice, however, these
declines appear to reach a minimum by 12 minutes. A persistent decline could be
caused by continued blood vessel leakage and vascular collapse secondary to
exsanguination, as well as by cellular swelling secondary to ATP depletion resulting in
increased tissue water content and decreased tissue hemoglobin concentration.337 DCS
measurements of BFI would provide an indication of the former, and clearly combined
BFI and THC measurements should be explored in the future in conjunction with
measures of brain water to elucidate changes in tissue composition. This information
would be complementary to the present diagnostics of oxygen availability and utilization.
E.3. CMRO2,i Temperature-Dependence Following DHCA
Significant hysteresis was found between the metabolic temperaturedependence during cooling and during rewarming with respect to intracranial
temperature in DHCA animals. Specifically, CMRO2,i exhibited an early increase at low
temperatures following reperfusion, and it had diminished temperature sensitivity during
rewarming. The identical analysis in DHCP animals did not demonstrate hysteresis
(Chapter 2, Section D.1).332 Additionally, previous assessment of the adequacy of
nasopharyngeal temperature guidance in the DHCP group showed limited agreement
with cerebral metabolism; here, metabolism was assessed with respect to intracranial
temperature to mitigate this uncertainty. Given decreased variability with use of invasive
intracranial temperature, the clinical use of non-invasive temperature measurements to
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approximate cerebral metabolic status during rewarming should be increasingly
interpreted with caution following DHCA. Further, to mitigate the hysteresis, alternative
strategies, such as a period of continuous cold re-perfusion following DHCA, could be
explored to allow recovery of tissue oxygen content before metabolic demand is
increased during rewarming.
E.4. Limitations of Animal Model
The limitations of our measurements should be carefully considered in the
extrapolation of our neonatal swine model results to human neonates. RF modulation
affords the FD-DOS technique additional information over CW NIRS; however, other
assumptions in our calculations of CMRO2,i could deviate during DHCA and should be
explored.
The concentration of arterial oxygen is assumed to remain constant and also to
be a good approximation of arteriolar oxygen concentration. While the former
assumption has been validated during DHCP (Chapter 2, Section D.2),331,332 it is
impossible to draw a representative blood gas sample from the brain during DHCA
following exsanguination without significantly perturbing metabolic substrate availability.
This is a limitation. Additional invasive studies combining microscopy for vessel
identification347 with fluorescence or phosphorescent oxygen content imaging348,349 could
potentially clarify these temporal changes.
The tissue water volume fraction is also assumed to remain constant. Brain water
is believed to change in response to CPB and during cellular injury. Thus
additional/alternative techniques which permit continuous quantification of brain water
concentration should be explored, e.g., wideband optical spectroscopy.11,350
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Finally, Fick’s Law applied to CMRO2 assumes a steady state between the
vascular compartment and the tissue compartment. This is often a good approximation
which has led to extensive use in cerebral metabolic literature. However, a reformulation
of this model to incorporate the effects of dynamic blood volume changes which may
perturb both the concentration and volume of these compartments is possible and
should be explored.241,351–353
Per comparison to human neonates undergoing cardiac repair, we consider a
recent feasibility study by Ferradal et al. that employed discontinuous FD-DOS/DCS
monitoring in nine neonates undergoing DH CPB during cardiac surgery.112 This study
measured identical cerebral hemodynamic parameters as in the current study during DH
CPB; they are reported here as an estimated mean and standard deviation from plotted
data. In comparison to our measurements at 18°C, a higher StO2 (~80% (6) vs. 68%
(7)), lower THC (~40 (-) vs. 68 (7) +mol/L), lower OEF (~0.25 (-) vs. 0.42 (0.09)),

comparable BFI (~0.9 (0.6) vs. 0.5 (0.4) *10-8 cm2/s), and comparable CMRO2,i (~3.5
(3.0) vs. 2.7 (1.7) *10-8 mL O2/dL*cm2/s) were observed in human neonates at a
nasopharyngeal temperature of 20.5°C (2.4). The differences in StO2 and OEF may be
attributed to the lower impact of cooling on oxygen binding affinity in swine compared to
humans.292 Another consideration is that our flow rates were maintained at 150
mL/min/kg. Clinically, the CPB flow rates ranged between subjects from 111 to 173
mL/kg/min during deep hypothermia. Pump flow modulation is often a technique used to
expedite cooling to deep hypothermia. Its impact on cerebral metabolism and recovery
following DHCA should be explored further.
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E.5. Conclusions
In this study we perform novel, continuous quantification of the effects of 40
minutes of deep hypothermic continuous perfusion (DHCP) and deep hypothermic
circulatory arrest (DHCA) on cerebral oxygen metabolism in healthy neonatal piglets
who underwent simulated cardiac surgery. The advanced diffuse optical imaging
techniques represent a significant improvement over CW NIRS, which is more
commonly employed. This permitted continuous characterization of the absolute value
and changes in critical physiologic parameters during circulatory arrest as a function of
time. Specifically, timing to maximal oxygen extraction and minimal concentration of oxyhemoglobin in tissue were reported. The comparison between DHCA and DHCP groups
provided quantification of differences in cerebral metabolic parameters specific to the
effects of circulatory arrest which may be used as references values for related
measurements in human neonates. Following re-perfusion in DHCA animals, a
significant hysteresis in metabolic temperature-dependence during rewarming compared
to cooling identified a period of increased neurological risk whereby oxygen metabolism
demonstrated diminished sensitivity to temperature. These results demonstrate the utility
of non-invasive optical monitoring to individually quantify the effects of DHCA on
cerebral oxygen metabolism. These parameters, in turn, may now be explored as
potential diagnostics of neurological outcomes for human neonates undergoing DHCA.
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CHAPTER 4: PREDICTION OF RETURN OF SPONTANEOUS CIRCULATION
DURING CARDIOPULMONARY RESUSCITATION USING NON-INVASIVE
FREQUENCY-DOMAIN DIFFUSE OPTICAL SPECTROSCOPY

A. Abstract
Standardized non-invasive neuromonitoring tools with prognostic value during
cardiopulmonary resuscitation (CPR) are desirable to help optimize resuscitation
strategies for improved neurological outcomes, especially in pediatric cardiac arrest
which has very high rates of mortality (>50%) and neurological morbidity. Here, we take
steps towards this goal by examining the association between return of spontaneous
circulation (ROSC) and cerebral hemodynamics measured non-invasively using
frequency-domain diffuse optical spectroscopy (FD-DOS).
One-month old swine (n=31) underwent asphyxia for seven minutes followed by
ventricular fibrillation. Resuscitation was conducted for a maximum of 20 minutes, or
until ROSC, with pauses for cardiac rhythm check every two minutes and with eligibility
for external defibrillation after 10 minutes. FD-DOS measurements of cerebral oxy- and
deoxy-hemoglobin concentration ([HbO2], [Hb], respectively), tissue oxygen saturation
(StO2) and total hemoglobin concentration (THC) were acquired continuously beginning
10 minutes prior to asphyxiation. Associations between FD-DOS measurements and
ROSC were determined at 10-minutes of CPR. These parameters, measured from 1minute into CPR, were assessed for optimal prediction of ROSC and for possible
sensitivity and specificity thresholds throughout early CPR (i.e., 2-10 minutes of CPR)
using univariate ROC curve analysis at 1-minute intervals.
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ROSC was achieved in 74% of the subjects (23/31). At 10 minutes of CPR,
absolute and relative values of [HbO2], StO2, and THC, with respect to baseline and with
respect to the value after 1-minute of CPR, showed significant differences (p<0.05)
between subjects who attained ROSC compared to those who did not. Absolute change
in [HbO2] from 1-minute of CPR demonstrated the highest mean (SD) AUC of 0.91
(0.07), as well as a stable sensitivity and specificity threshold across 1-minute intervals
from 2-10 minutes of CPR. No significant associations between [Hb] and ROSC were
found.
Our results demonstrate an early association between non-invasive optical
measurement of cerebral hemodynamics during the conduct of CPR and subsequent
achievement of ROSC. The work provides proof of concept data for the definition of
treatment thresholds for real-time optimization of resuscitation strategies and
demonstrates a novel tool for rapid assessment of cerebral health in the event of
pediatric cardiac arrest.

B. Introduction
Children who suffer cardiac arrest, both in and out of the hospital, face a
mortality rate of over 55%117,123,129 and, among survivors, many do not achieve favorable
neurological outcomes.125,126,354 Current pediatric guidance for cardiopulmonary
resuscitation (CPR) incorporates a basic life support strategy comprising chest
compressions combined with rescue breathing;138,355,356 additionally, high-quality CPR
includes monitoring of chest compression rate, chest compression depth based on age,
and permitting full recoil of the chest between subsequent compressions. This approach,
however, neglects individual physiologic response to resuscitative efforts. Indeed,
individualized optimization of resuscitation strategies for improved neurological
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outcomes has been hindered by a lack of standardized neuromonitoring with
demonstrated prognostic value. Recent work along these lines has identified the
potential of non-invasive cerebral near-infrared spectroscopy (NIRS) to improve
guidance of resuscitation for cardiac arrest in adult populations.201,204–206 Moreover,
although only a few case studies of use in pediatric populations have been reported,216–
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recently published recommendations by the French Group for Pediatric Intensive

Care and Emergencies357 recommends the use of the continuous-wave (CW) NIRS
probes, despite no clear evidence of efficacy and limited physiologic accuracy.
Unfortunately, physiologic interpretation of CW NIRS regional cerebral tissue
oxygen saturation (rSO2) has limitations. Calculations of rSO2 from CW techniques, for
example, require assumptions about baseline status (i.e., tissue optical scattering,
oxygen saturation, total hemoglobin concentration).358 These assumptions are
problematic because age, physiologic condition, and degree of hypoxic insult can be
highly variable from patient-to-patient at the time of CPR initiation.359 In contrast to CW
NIRS, frequency-domain diffuse optical spectroscopy (FD-DOS) is a diffuse optical,
near-infrared technique wherein radio frequency modulation of laser sources provides
additional phase information that permits quantification of tissue scattering, and thereby
ameliorates the need for the baseline assumptions. FD-DOS provides improved
quantitative accuracy,9 and has been used in pediatric populations as a clinical research
tool to quantify absolute values of cerebral oxy- and deoxy-hemoglobin concentrations
([HbO2] and [Hb], respectively), total hemoglobin concentration (THC) and cerebral
tissue oxygen saturation (StO2, %).24,39,242–245,40,105,109,110,112,239–241 However, FD-DOS has
not yet been applied during CPR.
In this work, we endeavored to demonstrate the feasibility of FD-DOS for
continuous, absolute quantification of cerebral hemodynamics during asphyxia,
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ventricular fibrillation, cardiac arrest, cardiopulmonary resuscitation (CPR), and, if
achieved, after return of spontaneous circulation (ROSC). The feasibility study was
carried out in a pediatric swine model of asphyxia-induced cardiac arrest. Our primary
objective was to examine the association between non-invasive, FD-DOS-measured
cerebral hemodynamics during CPR and successful ROSC. A second aim was to
identify those parameters of FD-DOS that offer significantly associated predictors for
ROSC, and a third goal was to explore the feasibility for stable critical decision
thresholds during the first 10 minutes of CPR based on FD-DOS parameters. In total the
research aims to assess and facilitate potential applications of FD-DOS for non-invasive
CPR optimization.

C. Methods
Cerebral hemodynamics were continuously monitored by non-invasive
frequency-domain diffuse optical spectroscopy (FD-DOS) in one-month-old, female
Yorkshire swine (8-10kg) during asphyxia, ventricular fibrillation (VF) to induce cardiac
arrest, and subsequent cardiopulmonary resuscitation. All animal procedures were
approved by the Institutional Animal Care and Use Committee at the Children’s Hospital
of Philadelphia and conducted in strict accordance with the NIH Guide for the Care and
Use of Laboratory Animals.
C.1. Frequency-Domain Diffuse Optical Spectroscopy
FD-DOS is a clinically validated technique for quantification of tissue oxy- and
deoxy-hemoglobin concentrations ([Hb] and [HbO2], respectively. FD-DOS benefits from
the simultaneous measurement of optical absorption and scattering properties (μa and
μs’, respectively).23,109,360 This approach is superior to conventional clinical continuous125

wave (CW) near-infrared spectroscopy (NIRS) systems, because it employs radiofrequency amplitude modulation to generate diffusive waves in tissue, permitting
measurement of both phase and amplitude information from detected light. Together the
changes in amplitude and phase enable unique determination of μa and μs’ at each
source wavelength (λ). Given the known wavelength-specific extinction coefficients (ε) of
oxy- and deoxy-hemoglobin, the absorption coefficient of water (μ

,36 5 ),

20

and an

assumed 75% water volume fraction,257 the cerebral [Hb] and [HbO2] can derived by
solving a system of equations for μ (λ) at multiple wavelengths via the relationship:
μ (λ) = ε3456 (λ)JHbO2L + ε34 (λ)JHbL + 0.75μ

,36 5 (λ).

(4.1)

Compared to CW NIRS systems, which assume normative scattering properties

to resolve absorption properties, FD-DOS permits more accurate, individualized
quantification that takes into account alterations in optical scattering that may result from
profound changes in oxygen saturation,325 metabolic remodeling of cellular membranes
due to ATP depletion,326 changes in red blood cell morphology,361 and variation in tissue
composition.11
C.2. Selection of Animal Model
An asphyxia model was selected to best approximate pediatric in-hospital
arrests, which are predominantly respiratory mediated.126,164 This model also permitted a
clinical scenario wherein the application of a neuromonitoring device early in the
resuscitation period is feasible. Preclinical piglet models have played a critical role in
both the optimization of resuscitation strategies228,362,363 and in the development and
validation of FD-DOS techniques.19,26 One month-old piglets correspond anatomically
and neuro-developmentally with toddler-aged humans,364 which approximates the
median age of pediatric victims of cardiac arrest.119,128
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C.3. Animal Preparation
Animals were initially sedated with ketamine (20 mg/kg IM) followed by 4%
inhaled isoflurane via snout mask until intubation by endotracheal tube was achieved
with confirmation by end-tidal CO2 (EtCO2) capnometry. Subsequently, animals were
mechanically ventilated (Modulus SE, DatexOhmeda; Madison, WI) on room air using a
tidal volume of 10mL/kg, a positive end-expiratory pressure of 6cm H2O, and titration of
respiratory rate to maintain EtCO2 within 38-42mmHg. Anesthesia was maintained using
1-2% inhaled isoflurane with depth of anesthesia monitored via heart rate and blood
pressure and confirmed by toe-pinch reflex at 5-minute intervals. Morphological
measurements of animal weight, length, and anterior-posterior chest diameter were
recorded.
C.4. Physiologic Monitoring
FD-DOS cerebral monitoring was performed using an optical probe with sourcedetector separations ranging from 0.75 - 3 cm (Figure 4.1). The probe was calibrated
using tissue phantoms before each animal measurement.19 Following secure placement
of the probe over the left frontal cortex, absolute absorption and scattering coefficients
(μa and μs’, respectively) at λ=690, 725, 785, and 830nm were continuously quantified
from measurements of amplitude and phase collected at a rate of 10Hz by a commercial
FD-DOS instrument operating at a modulation frequency of 110MHz (Imagent, ISS Inc.,
Champaign, IL). Recorded measures of absorption were used to derive cerebral oxyand deoxy-hemoglobin concentrations ([HbO2] and [Hb], respectively), from which
cerebral tissue oxygen saturation (StO2, %) and total hemoglobin concentration (THC,
+mol/L) were calculated as:
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Figure 4.1. CPR Neuromonitoring Placement: Non-invasive frequency-domain diffuse
optical (FD-DOS) probe was placed over the left frontal cortex. Source-detector
separations ranged from 0.75cm to 3cm. Invasive measurement of PbtO 2 and relative
cerebral blood flow were conducted through two burrs holes over the right cortex.
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Aortic and right atrial pressures were transduced via solid-state, micromanometer-tipped
catheters (4.5-6Fr; Millar Instruments, Houston, TX) inserted through the right femoral
artery and vein, respectively, using ultrasound-guided Seldinger technique. A balloontipped, thermodilution Swan-Ganz catheter (Edwards Lifesciences; Irvine, CA) was
similarly introduced via the left femoral vein and was fluoroscopically directed into the
main pulmonary artery. To prevent subsequent clot formation, 200 units/kg of
unfractionated heparin was administered following cannula placement.
Additional invasive cerebral monitoring was achieved through two burr holes on
the right side of head. This facilitated measurement of relative cerebral blood flow
(rCBF, %) in the cortex via a laser Doppler probe (PeriFlux, PeriMed Inc.; Ardmore, PA)
affixed to the dura matter and measurement of subcortical brain tissue oxygen content
(PbtO2, mmHg) ~1 cm below the cortical surface (Licox CC1-P1, Integra LifeSciences;
Plainsboro, NJ).
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Systemic physiologic and hemodynamic monitoring comprised electrocardiogram
(ECG), aortic pressure (AoP), right atrial pressure (RaP), peripheral saturation (SpO2)
via pulse oximetry, EtCO2, and rectal temperature data. All of these monitoring devices
were sampled at rate of 256Hz and displayed using PowerLab software and interfacing
hardware (ADI Instruments; Colorado Springs, CO). Chest compression depth and
compression rate were captured using a CPR quality monitoring defibrillator (Zoll R
Series Plus, Zoll Medical Corp.; Chelmsford, MA).
Following placement of physiologic monitors, a 20 mL/kg bolus of 0.9% sodium
chloride solution was administered for post-fasting fluid repletion. Continuous recording
of physiologic monitors was initiated 10 minutes prior to asphyxia to establish baseline
values and was discontinued either at the end of CPR for non-survivors, or at 4 hours
following return of spontaneous circulation (ROSC).
C.5. Experimental Protocol
The experimental protocol is summarized in Figure 4.2. Five minutes prior to
asphyxia, analgesia was initiated using continuous syringe-pump infusion of intravenous
fentanyl (1–10 mcg/kg/h); this was sustained through the asphyxial period. Immediately
following confirmation of absence of toe-pinch reflex, asphyxia was induced by clamping
of the endotracheal tube following exhalation and was confirmed by the absence of
EtCO2. After 7 minutes of sustained asphyxia, ventricular fibrillation (VF) was induced
using transcutaneous ventricular pacing. Once VF was confirmed by ECG, the
endotracheal tube was unclamped and mechanical ventilation was restarted with a tidal
volume of 10 mL/kg, a positive end-expiratory pressure of 6cm H2O, 100% fraction
inspired oxygen, and a respiratory rate of 6 breaths per minute. Manual CPR was
immediately initiated with chest compressions administered at a rate of 100
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Figure 4.2. Asphyxia-Induced Cardiac Arrest and CPR Experimental Protocol:
Continuous non-invasive frequency-domain diffuse optical spectroscopy (FD-DOS)
measurements of cerebral hemodynamics were continuously acquired from start of
Baseline, through Asphyxia, CPR, and four-hours post-Return of Spontaneous
Circulation (ROSC).

compressions per minute. Auditory guidance was provided by metronome and visual
feedback provided from the CPR quality monitoring defibrillator. Chest compression
depth and vasopressor dosing was determined according to animal allocation into one of
three treatment groups:
I.

Depth-guided CPR (DG-CPR; n = 14): Chest compressions were delivered
at the guideline-recommended depth of 1/3 of the anterior-posterior chest
diameter, and epinephrine (0.02 mg/kg IV) was administered every four
minutes.

II.

Hemodynamic-directed CPR (HD-CPR): Chest compression depth was
actively titrated to maintain an a priori aortic systolic pressure goal of either
90 mmHg (n = 2) or 110 mmHg (n = 2). Vasopressors were administered only
when coronary perfusion pressure (CoPP) was less than 20 mmHg; this
parameter was automatically calculated and displayed as the difference
between the mid-diastolic aortic pressure and right atrial pressure.
Vasopressor dosing followed a three-stage cycle starting with 0.02 mg/kg of
epinephrine, a repeated 0.02 mg/kg of epinephrine, followed by a switch to
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0.4 units/kg of vasopressin, as indicated by CoPP. Administration continued
cyclically with a minimum interval of one minute after epinephrine doses and
two minutes after a vasopressin dose.
III.

DG-CPR with inhaled nitric oxide (iNO; n = 10): iNO (20 ppm) was
administered beginning one minute into CPR and was continued through the
end of the resuscitation period.

In all animals, chest compressions were paused for cardiac rhythm check (every
two minutes) for a duration of four seconds. Following ten minutes of chest
compressions, animals were externally defibrillated with 5 J/kg, a dose that has had
demonstrated efficacy in this animal model.365 If ROSC was not achieved following
defibrillation, CPR was resumed and defibrillation was re-attempted as indicated during
cardiac rhythm checks at two-minute intervals. CPR concluded immediately, upon
attainment of ROSC, or after the final unsuccessful external defibrillation at 20 minutes
of CPR. Following ROSC, FiO2 was gradually down-titrated from 100% to room air within
10 minutes while maintaining an SpO2 between 94-99%. Inhaled isoflurane was titrated
to absence of toe-pinch reflex. Intravenous epinephrine (0.1 -1 mcg/kg/minute) was
titrated as necessary to maintain a minimum mean aortic pressure of > 45 mmHg.
Animals were euthanized at four hours post-ROSC using intravenous potassium
chloride.
C.6. Statistical Analysis
Our primary analysis examined the association of non-invasive cerebral
hemodynamic measurement values at 10 minutes of CPR and the attainment of ROSC.
Cerebral hemodynamics incorporated absolute values of [HbO2], [Hb], StO2, and THC,
absolute and relative changes of [HbO2], [Hb], StO2, and THC from baseline, and
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absolute and relative changes of [HbO2], [Hb], StO2, and THC from 1 minute into CPR.
The 1-minute time-point was selected for two reasons. First, this corresponds to the
clinical period allotted for chest molding (i.e., conformational adaptation of the chest wall
to the force of compressions), which impacts the efficacy of early chest compressions.
Second, this is a feasible timing window for when non-invasive monitoring could be
placed on the patient after arrest recognition and the initiation of CPR. Non-parametric
Wilcoxon Rank-Sum tests (α = 0.05) were performed to compare values between ROSC
and no-ROSC groups, due to the presence of non-parametric variable distributions
within each group. Supplementary analysis summarizing post-ROSC absolute and
relative changes from baseline at 1-hour intervals was also performed.
Baseline values for each physiologic measure were determined as the mean
value acquired during the 2-minute interval prior to asphyxia. Asphyxia-end values were
calculated as the mean value acquired in the 15-seconds prior to the end (i.e., 7minutes) of asphyxia. In order to allow a full 1 minute of chest molding and time for FDDOS placement, 1-minute CPR values were calculated as the mean of values measured
in the 15 seconds immediately following 1 minute of CPR. The 10-minute CPR values
were calculated as the mean of values measured in the 15 seconds immediately
preceding the 9.5-minute mark of CPR to ensure all subjects were included due to
experimental variability in timing of confirmation of ventricular fibrillation.

Selection of Optimal Predictor and Critical Decision Thresholds
Following identification of the FD-DOS parameters significantly associated with
ROSC, a secondary analysis was performed to identify which parameter was the optimal
predictor for ROSC and to examine the feasibility of stable critical decision thresholds
over time during the first 10 minutes of CPR. Only parameters that could be feasibly
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measured after the start of CPR were included in this analysis. These data were
comprised of absolute values, and absolute and relative changes from 1-minute into
CPR. In our selection of critical thresholds, we chose to separately maximize specificity
(i.e., inverse of false positive rate) or sensitivity (i.e., inverse of false negative rate) to
minimize incidence of false outcomes. Our reasoning is that if it is to be a novel
diagnostic for CPR optimization, then FD-DOS guidance should only impact care if the
prediction is accurate.
For each significant parameter, a ROC curve and two critical thresholds,
maximizing specificity (=1) or sensitivity (=1), were determined at 1-minute intervals from
2-10 minutes of CPR using univariate logistic regression for the outcome of ROSC. The
average value measured within each 1-minute interval was used to determine the ROC
curve, the corresponding AUC, and the critical thresholds whereby the “specificity
threshold” corresponded to the parameter value with highest sensitivity for ROSC while
maintaining a specificity for ROSC equal to 1, and, similarly, the “sensitivity threshold”
corresponded to the parameter value with highest specificity while maintaining sensitivity
equal to 1.
The optimal FD-DOS predictor and overall predictor, including systemic
hemodynamics, was selected based on the highest mean AUC. A stable specificity or
sensitivity threshold was determined to be feasible if the mean threshold had a
specificity or sensitivity >0.9 over all intervals, respectively.

D. Results
ROSC was achieved in 74.2% of subjects (n = 23/31) which included n = 9/14 in
the DG-CPR group who underwent standard-of-care AHA guideline resuscitation, n =
10/10 who received inhaled nitric oxide (iNO) during AHA guideline resuscitation, and n
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= 4/7 who underwent HD-CPR. All animals received a minimum of 10 minutes of CPR,
with resumed resuscitation immediately following unsuccessful defibrillation attempts.
D.1. Association of Cerebral Hemodynamics and ROSC
A summary of pairwise comparisons between cerebral and systemic
hemodynamic measures, presented as median [IQR], in ROSC and no-ROSC groups at
baseline, at the end of asphyxia, and at 10 minutes of CPR, is given in Table 4.1. While
no significant differences are seen between groups at baseline or during asphyxia
(Figure 4.3), significant differences in the absolute values of [HbO2], StO2, and THC,
and significant differences in absolute and relative changes from baseline and 1-minute
of CPR, are seen at 10-minutes of CPR. The most highly significant differences
(p<0.001) were seen in in the absolute and relative change from 1-minute of CPR in
these three parameters (Figure 4.4). No difference between groups was observed in
relative or absolute [Hb] values. This finding suggests that attainment of ROSC and
subsequent survival is largely determined by performing high-quality CPR, which in turn
provides both adequate oxygen and adequate blood volume (clinical analogue of THC)
to the brain.
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Table 4.1. Parameters at Baseline, End-of-Asphyxia and 10-minutes of CPR
ROSC, n=23

No-ROSC, n=8

p-value

33.7 (30.3, 37.3)
30.4 (26.8, 35.5)
52.2 (46.2, 58.0)
66.1 (58.9, 68.9)

36.3 (34.4, 43.1)
30.4 (28.1, 34.4)
54.8 (53.0, 56.3)
69.6 (62.3, 74.5)

0.130
0.769
0.484
0.250

18.3 (11.3, 24.7)
-15.4 (-22.3, -11.3)
50.9 (40.4, 66.3)
48.5 (45.0, 58.8)

23.0 (18.7, 24.7)
-18.2 (-25.0, -13.1)
57.7 (44.4, 62.8)
56.5 (50.3, 58.5)

0.269
0.668
0.542
0.379

29.3 (22.1, 34.6)
-5.5 (-11.7, -1.6)
84.7 (62.2, 94.3)
8.3 (4.2, 10.5)
135.7 (115.8, 148.1)
41.0 (37.3, 47.0)
11.3 (5.6, 14.6)
135.5 (118.8, 152.2)
-4.4 (-9.3, -1.7)
89.5 (81.3, 96.2)
41.9 (33.3, 48.1)
-12.4 (-18.7, -6.2)
76.2 (62.9, 88.2)
8.7 (4.9, 14.8)
126.4 (114.3, 147.6)
68.8 (62.7, 78.0)
6.0 (2.3, 9.6)
109.5 (103.3, 114.5)
1.0 (0.1, 5.0)
101.6 (100.1, 108.1)

18.4 (12.5, 21.8)
-22.9 (-29.6, -13.0)
39.5 (31.8, 64.0)
-5.6 (-11.1, -0.2)
79.2 (57.6, 99.2)
43.8 (38.2, 49.0)
10.0 (6.4, 17.2)
125.5 (122.2, 156.5)
-4.3 (-8.4, -2.5)
90.6 (83.1, 94.0)
27.6 (22.1, 35.1)
-25.7 (-34.2, -19.1)
51.0 (40.6, 64.7)
-1.6 (-7.9, 0.6)
96.2 (77.7, 103.8)
56.4 (55.9, 66.3)
-11.1 (-18.6, -2.2)
84.5 (77.5, 96.2)
-12.7 (-19.9, -3.2)
82.6 (75.2, 95.5)

0.006†
<0.001‡
0.002†
<0.001‡
<0.001‡
0.542
0.839
0.982
0.804
1.000
0.006†
0.006†
0.005†
<0.001‡
<0.001‡
0.020*
<0.001‡
<0.001‡
<0.001‡
<0.001‡

Baseline
[HbO2]§, µmol/L
[Hb], µmol/L
StO2, %
THC, µmol/L

Asphyxia, End
[HbO2], µmol/L
[Hb], µmol/L
StO2, %
THC, µmol/L

CPR, 10 minutes
[HbO2], µmol/L
∆[HbO2] from Baseline
r[HbO2] to Baseline, %
∆[HbO2] from 1min-CPR
r[HbO2] to 1min-CPR, %
[Hb], µmol/L
∆[Hb] from Baseline
r[Hb] to Baseline, %
∆[Hb] from 1min-CPR
r[Hb] to 1min-CPR, %
StO2, %
∆StO2 from Baseline
rStO2 to Baseline, %
∆StO2 from 1min-CPR
rStO2 to 1min-CPR, %
THC, µmol/L
∆THC from Baseline
rTHC to Baseline, %
∆THC from 1min-CPR
rTHC to 1min-CPR, %
Reported as median (IQR).
*p<0.05; †p<0.01; ‡p<0.001; § Abbreviations: [HbO 2], oxy-hemoglobin concentration; [Hb],
deoxy-hemoglobin concentration; StO 2, tissue oxygen saturation; THC, total hemoglobin
concentration; ∆-prefix, absolute change; r-prefix, relative value compared to 100% at
baseline.
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Figure 4.3. Changes in Cerebral Hemodynamics during Asphyxia, ROSC versus
No-ROSC: During the 7-minute asphyxial period, all subjects experienced a decreased
in concentration of oxy-hemoglobin ([HbO 2 ]) and tissue oxygen saturation (StO 2 ) and an
increase in deoxy-hemoglobin concentration ([Hb]) and total hemoglobin concentration
(THC). Data is depicted as median (solid line) and IQR (shaded region between dotted
lines) and colored with respect to outcome group (ROSC, blue; No-ROSC, red). No
significant differences in cerebral hemodynamics distinguish ROSC from No-ROSC
subjects prior to start of CPR.
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Figure 4.4. Changes in Cerebral Hemodynamics during Early CPR, ROSC versus
No-ROSC: For each CPR outcome (i.e., ROSC, in blue, or No ROSC, in red), the
median (solid line) and IQR (shaded region between dotted lines) of the change in
cerebral oxy-hemoglobin concentration (∆[HbO 2 ]; top left), deoxy-hemoglobin
concentration (∆[Hb]; bottom left), total hemoglobin concentration (∆THC; top right) and
tissue oxygen saturation (∆StO 2 ; bottom right) from 1-minute into CPR are plotted over
the first 10-minutes of CPR. Early separation between outcome groups is seen in
∆[HbO 2 ], ∆THC, and ∆StO 2 .
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D.2. Selection of Optimal Predictor and Critical Decision Thresholds

Table 4.2. Mean AUC and Critical Thresholds Over 1-Minute CPR Intervals for
Significant Predictors at 10-Minutes of CPR

Significant Predictors
[HbO2], µmol/L*
∆[HbO2] from 1min-CPR
r[HbO2] to 1min-CPR, %
StO2, %
∆StO2 from 1min-CPR
rStO2 to 1min-CPR, %
THC, µmol/L
∆THC from 1min-CPR
rTHC to 1min-CPR, %

AUC

Sensitivity
Threshold

Specificity
Threshold

0.72 (0.10)
0.91 (0.07)
0.89 (0.06)
0.71 (0.09)
0.90 (0.07)
0.87 (0.08)
0.64 (0.12)
0.85 (0.06)
0.83 (0.07)

10.1 (1.7)
+0.3 (0.8)
101.2 (3.0)
12.6 (2.0)
+1.4 (1.6)
103.8 (4.7)
65.3 (19.8)
-5.3 (1.6)
94.0 (1.7)

30.2 (3.5)
+4.6 (1.8)
126.9 (10.1)
46.5 (4.2)
+5.1 (0.9)
124.2 (10.3)
83.7 (19.0)
+3.3 (1.3)
104.7 (1.4)

Reported as mean (standard deviation).
*Abbreviations: [HbO 2], oxy-hemoglobin concentration; StO 2, tissue oxygen saturation.; THC,
total hemoglobin concentration; ∆-prefix, absolute change; r-prefix, relative value compared
to 100% at baseline.

In Table 4.2 we list the mean AUC, as well as the mean of the critical specificity
and sensitivity thresholds, across all 1-minute intervals from 2-10 minutes of CPR for
each significant parameter (p<0.05) at 10-minutes of CPR. Examination of the mean
AUC values demonstrates a similarity with our comparisons at 10-minutes of CPR,
wherein the best predictors of each hemodynamic parameter (e.g., absolute value,
relative value) were the absolute and relative change from 1-minute of CPR. Overall, the
hemodynamic parameter with the highest mean (SD) AUC of 0.91 (0.07) was absolute
change in [HbO2] from 1min-CPR: (∆[HbO2]CPR; Figure 4.5). The corresponding mean
(SD) sensitivity threshold (i.e., the mean of all thresholds which achieved a specificity of

1 in each 1-min interval) was ∆[HbO2]CPR = +0.3 (0.8) +mol/L. Applying this threshold

across all 1-min intervals achieved an overall sensitivity of 0.98. Similarly, the mean (SD)
specificity threshold was ∆[HbO2]CPR = +4.6 (1.8) +mol/L; it achieved an overall
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specificity of 0.94. Attaining high (>0.9) overall sensitivity or specificity indicates that
these mean threshold values may be suitable for sensitive or specific prediction
applications at any time-point from 2-10 minutes of CPR.

Figure 4.5. Optimal Predictor ∆ [HbO 2 ] CPR Receiver Operating Characteristic (ROC)
Curve Analysis during Early CPR: (left) Computed ROC curves, (center)
corresponding AUCs, and (right) critical sensitivity and specificity thresholds for change
in absolute cerebral tissue oxy-hemoglobin concentration from 1-minute of CPR
(∆[HbO 2 ] CPR ) are shown. The AUC demonstrated a monotonic increase over early CPR
beginning at 0.81 (0.10) after 3 minutes and reaching a maximum value of 0.98 (0.03)
after 10 minutes of CPR. The stability of the maximum sensitivity threshold at
∆[HbO 2 ] CPR ~ 0 indicates animals where no increased in [HbO 2 ] occurred during CPR
did not survive.

D.3. Assessment of Scattering Error Effects on Continuous-Wave (CW) NIRS
The variance in optical scattering (i.e., the reduced scattering coefficient, µs’) at
baseline and changes in optical scattering during asphyxia and CPR were examined in a
supplementary analysis (see Section F. Appendix, Figure 4.A4 and 4.A5) to
characterize the potential errors of CW NIRS physiologic quantification instead of FDDOS. Changes in scattering from baseline and difference between ROSC and no-ROSC
groups were examined by Wilcoxon signed-rank test and by Wilcoxon rank sum test,
respectively, at the end of asphyxia (7th minute) and in the 10th minute of CPR.
At the end of asphyxia, a significant increase in scattering was observed at
785nm with a median [IQR] = +0.11cm-1 [0.01, 0.43] increase from baseline (p = 0.013);
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but no differences were found at 690, 725, and 830nm or between ROSC and no-ROSC
groups. Red blood cells are known to predominate the near-infrared reduced scattering
spectra of whole blood and the reduced scatting spectrum exhibits a monotonic
decrease with wavelength > 600nm; however spectral features are present between 750
and 800nm in the reduced scattering coefficient of plasma.366 The finding of differential
changes in scattering with wavelength may correspond to dynamic changes in
composition of the blood volume probed by near-infrared photons.
At 10-minutes of CPR, no significant changes in scattering from baseline were
observed in subjects who achieved ROSC. However, in the no-ROSC group, we found
significant increases in scattering from baseline at 690nm (median [IQR] = +0.87 cm-1
[0.26, 1.05], p = 0.039), 785nm (median [IQR] = +0.58 cm-1 [0.27, 0.96], p = 0.016) and
830nm (median [IQR] = +0.27 cm-1 [0.03, 0.61], p = 0.016). This represents a
pronounced 7.8-10.4% change in scattering consistent with observed changes in
scattering 17 minutes following euthanasia by pentobarbital in neonatal pigs324 and
during extreme hypoxia (sagittal sinus oxygen saturation < 10%) in piglets.19 Note, 17
minutes was selected for comparison to the combined period of 7-minutes of asphyxia
and 10-minutes of CPR.
Thus, we carried out a simulated assessment of “typical” spatially-resolved CW
NIRS measurement errors using simulated infant and pediatric probes from recent
publications regarding commercial CW NIRS systems. The infant probe contains two
source-detector separations of 0.9 and 2.5cm,227 and, similarly, the pediatric probe,
separations of 1.2 and 4.0cm.29 to assess the effects of varying scattering from the CW
NIRS assumptions of constant scattering from baseline. Using the ‘dc slope’ method of
the spatially-resolved CW NIRS technique,26 the absolute value of optical absorption (+ )

is calculated from a fitted slope (2) and an assumed optical scattering coefficient (+, ′) as:
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+ =

2
.
3+,-

(4.4)

Errors in the CW NIRS calculation of + are equated to 1) errors in the assumption of a

linear “dc slope” relationship (explained below), 2) the assumption of constant scattering
coefficients over time, and 3) the assumptions of a constant scattering power, a
parameter which determines the wavelength-dependence of the assumed scattering

coefficients. The impact of these errors on + and the calculation of [HbO2], [Hb], THC,
and StO2 are examined. As the assumptions underlying the first error incorporate the

second error, these will be examined in unison. Due to normality of baseline scattering
across subjects by Shapiro-Wilk test, the methodology and results of our scattering error
analysis is reported using means, standard deviations, and 95% CIs.
Assumption of Constant Scattering and Source-Detector Separation Linearity
The linear “dc slope” relationship underlying the spatially-resolved CW NIRS
technique can be derived from the CW solution for the detected diffuse reflectance (R, W
cm-2) at a source-detector separation

(cm) with underlying tissue modeled as a semi-

infinite homogeneous medium (Equation 1.24):26
R U• ( ) = ‰ ›|q3+

+,-

1 V
+ }

Mœ•–ž –Ÿ '

¡.

(4.5)

The variable ‰ ≅ 5Ž% /6Z+,- when +,- ≫ + and the index of refraction of the medium is

matched with the index of refraction outside the medium at the semi-infinite boundary. Ž%

is the intensity of the source (measured in W). Given these assumptions, ‰ may be

assumed to remain constant with respect to . Equation 4.5 may be rearranged into the
following expression
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which becomes linear with respect to
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on the right-hand side when q3+ +,- ≫ 1. The

measured diffuse reflectance (R U• ( )) may be fitted by linear regression with respect to
source-detector separations ( ) to derive the slope (2 = −q3+ +,- ). This brings us to the

result of Equation 4.4 which is used to calculate + .

The assumption of linearity and the accuracy of the relationship between the

fitted slope and tissue optical properties (Equation 4.4) requires that q3+ +,- ≫ 1.

While this is generally true, for small source-detector separations or absorption or

scattering coefficients, the accuracy of this assumption becomes diminished. Without
assuming q3+ +,- ≫ 1, for a typical commercial SRS probe geometry with two

separations ( ! ,

), the expression for the fitted slope (2) becomes

−q3+ +,- + ln ¢ £
!

q3+ +,- + 1

! q3+ +, + 1
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−

(4.8)

The error of the SRS-approximated slope is readily given by the second additive term in
the expression. Because

!

and

are necessarily positive, this error term always results

in an increase in the absolute value of the slope. This translates into a fitted 2 that is
always more positive than an 2 calculated from Equation 4.4 using accurate optical

properties. The error becomes smaller as |

−

!|

≫ 0, i.e., the difference in the selected

source-detector separations is large. Also, as observed earlier, when + and +,- increase
and

to 0.

! q3+

+,- and

q3+ +,- both become ≫ 1, the logarithmic error expression reduces
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However, errors are introduced in the calculation of + (Equation 4.4) by both

errors in the slope (2) in the numerator, and errors in the assumption of +,- in the
denominator. Errors in + may be expressed as:
+

,Xš

+

2Xš
+,=|
} - .
2
+,,Xš

(4.9)

Thus, as scattering is over-estimated, absorption becomes under-estimated.

To best quantify potential + errors attributed to the use of a fixed “population-

average” scattering assumption for all subjects, we examine our experimental

measurements of inter-subject variation at baseline and at 10-minutes of CPR. At
baseline, our absolute scattering coefficient at ) = 690j© exhibits a coefficient of
variation of 17.3% across 31 subjects. This is in agreement with optical property

variability in human neonates5 and neonatal pigs.19 At 10-minutes of CPR, the no-ROSC
group demonstrated a +10.8% (SD=8.8%) change in scattering from baseline. Using the
mean +,- () = 690j©) at baseline (11.0 cm-1) as an informed scattering assumption for

CW NIRS, the error in the CW NIRS measurements of + (690j©) at 10-minutes of CPR
is plotted in Figure 4.6 with respect to the error in assumed scattering.

Due to the SRS linearity assumption, even with no error in scattering, estimations

of + exhibit a 5.2% (95% CI: 3.9-7.6) error using the pediatric probe and a 10.5% (95%

CI: 8.1-15.34) error using the infant probe. Given that the 95% CI of FD-DOS measured
scattering values at 10-minutes of CPR ranged from 7.9 to 15.0 cm-1, our analysis
assessed a realistic range of scattering errors (from -26% to +40%) that would be

observed during this critical time-period. This range of error in +,- (690j©) resulted in a

+ (690j©) error ranging from +47% to -18% in the infant probe, and from +41 to -24%

in the pediatric probe. We next observe how these errors in + quantification propagate
into errors in physiologic measurements.
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Figure 4.6. Spatially-Resolved CW NIRS + Measurement Error at 10-Minutes of
CPR is plotted for a typical infant probe (SDS = 0.9 and 2.5cm) and a pediatric probe
(SDS = 1.2 and 4.0cm) with respect to the error of an assumed scattering coefficient
(+, ′) over the 95% CI of measured +, ′(690nm) at 10-minutes of CPR.

Assumption of Constant Scattering Power

In order to translate measurements of + into physiologic properties,

measurements at additional wavelengths are necessary. As a result, CW NIRS systems
also require assumptions regarding the dependence of scattering on wavelength, which
has been shown to be well approximated by Mie scattering using the expression11
MC
)
|
} = +,- ()).
500j©

(4.10)

From the mean of reported scattering coefficient values in neonatal piglets of
comparable size to our population,26 we are able to solve for the normalization factor
+,- (500j©) = 15.3 cm-1 and the scattering power

=

= 1.22. Notably, the scattering power

varied widely, from 0.49 to 1.60, across subjects in this prior report; this identifies yet
another source of error that cannot be determined by CW NIRS methods. Using these

literature-derived parameters, we calculate reasonable CW NIRS assumptions for +,- ())
at 690, 725, 785, and 830nm as 10.4, 9.7, 8.8, and 8.3 cm-1, respectively. For

comparison, the scattering power was also determined from measured scattering
properties across all subjects in the present work, at baseline and in the no-ROSC group
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at 10-minutes of CPR, by linear regression of the linear rearrangement of Equation 4.10

with respect to ln()):

lns+,- ())t = − (ln())) + constant.

(4.11)

With similar variation to the referenced scattering power, the mean (SD) scattering
power at baseline was 1.15 (0.63), and at 10-minutes of CPR, 1.49 (0.79). Scattering
power has been shown to vary greatly both with-in similar tissues as well as across
different types of tissue.11 A shift in scattering power in the no-ROSC group may be
diagnostic of a deleterious change in tissue composition and should be examined in
future investigations.
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Figure 4.7. Physiologic Error Dependency on Scattering Power: The absolute error
in [HbO 2 ], [Hb], THC, and StO 2 are plotted for the infant probe (left) and the pediatric
probe (right) with respect to the absolute error in assumed scattering power ( ) at
baseline. The error in is significantly and positively correlated with error in [HbO 2 ]
(p=0.003) and StO 2 (p<0.001).

Using calculated scattering assumptions from literature, we computed the error in
CW NIRS quantification of StO2 (analogous to rSO2 for CW NIRS), [Hb], [HbO2], and
THC with respect to the error in scattering power at baseline. Note that this error results
from both errors in scattering power as well as the errors in the scattering coefficients.
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To quantify the specific dependency of error on scattering power, we examined the
Pearson’s correlation coefficient (R) between absolute error in measured physiologic
values and error in scattering power (Figure 4.7).
When there is no error in scattering power ( Error = 0), we observe that the
linearity assumption and scattering assumptions (discussed in the previous section)
have predominantly resulted in an overestimation of all physiologic parameters for both
the infant and pediatric probe. The error in scattering power demonstrates a significant
correlation with error in [HbO2] (R=0.51, p=0.003) and error in StO2 (R=0.90-0.94,
p<0.001). When the scattering power is over-estimated ( Error > 0), even greater overestimation of StO2 and [HbO2] result. Notably, the Pearson’s correlation coefficient for
StO2 corresponds to a high coefficient of determination (R2) ranging from 0.81-0.88.
From this finding we conclude that the majority of CW NIRS StO2 quantification error at
baseline in our data is explained by error in the assumed scattering power.
CW NIRS Quantification Error during Asphyxia and CPR
To conclude our error analysis, we examine the physiologic error during asphyxia
and CPR resulting from the assumptions of linearity and constant scattering and
scattering power discussed in the previous two sections. Using the simulated CW NIRS
data, we re-evaluate the significant effects observed in our FD-DOS data to determine if
similar results would have been achieved using CW NIRS techniques.
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Figure 4.8. Error in CW-NIRS Measurement of StO 2 during Asphyxia (left) and CPR
(right): The error (bottom) in the CW NIRS quantification of StO 2 (top), compared to
FD-DOS quantification of StO 2 (middle), is plotted with respect to time. The CW NIRS
StO 2 measurements exhibit greater inter-subject variability and diminished contrast
during asphyxia and CPR. Limited separability between ROSC and No-ROSC groups is
observed using the CW NIRS technique.

The median and IQR of errors in CW NIRS quantification of StO2 and the change
in StO2 (ΔStO2; from baseline during asphyxia, from 1-minute of CPR during CPR) are
plotted in Figure 4.8 and Figure 4.9, respectively. In the absolute value data, during
asphyxia, CW NIRS data exhibits greater variability and over-estimates FD-DOS data at
all time points with a median absolute error ranging from +8.2 to +16%. During CPR,
separate analyses of ROSC and no-ROSC groups reveal a reduction in separability
resulting from a decreasing trend error in the ROSC group with time but increasing trend
in error in the no-ROSC group with time. A comparison of the CW NIRS StO2 and its
change at 10-minutes of CPR, between ROSC and no-ROSC groups (Table 4.3),

demonstrates significant (p<0.05) for absolute StO2, but not ΔStO2 or rStO2. Neither CW

NIRS quantification of THC or [HbO2] was found to significantly differ (p<0.05) between
groups.
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Figure 4.8. Error in CW-NIRS Measurement of Change in StO 2 (Δ2 ‡ ) during
Asphyxia (left) and CPR (right): The error (bottom) in the CW NIRS quantification of
ΔStO 2 (top), compared to FD-DOS quantification of ΔStO 2 (middle), is plotted with
respect to time. The CW NIRS ΔStO 2 measurements exhibits less error compared to
absolute measurements of StO 2 , however, contrast during asphyxia and CPR remains
diminished compared to FD-DOS measurements. Limited separability between ROSC
and No-ROSC groups is observed using the CW NIRS technique.

Identical assessment of the predictive power of CW NIRS StO2 over time (as
described in Section C.6, “Selection of Optimal Predictor and Critical Decision
Thresholds”) resulted in a mean (SD) AUC of 0.70 (0.09). This is comparable in
predictive power and predictive stability to the FD-DOS StO2 AUC result of 0.71 (0.09).
More modest agreement of predictive power and stability is also achieved by CW NIRS
quantification of [HbO2] which exhibits a mean (SD) AUC of 0.64 (0.11) compared to
0.72 (0.10) using FD-DOS. Examination of the identical tabulation of the AUC of the
remaining CW NIRS variables (Table 4.3), as reported in Table 4.2 for FD-DOS
variables, show diminished predictive power by greater than one standard deviation.
These results reveal the limited ability of the CW NIRS technique to accurately quantify
absolute concentrations of [HbO2], [Hb], and THC in tissue; this, in turn, limits the
predictive utility of CW NIRS measurements of these parameters to guide CPR.
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Table 4.3. Simulated CW NIRS Predictors, ROSC Association and Mean AUC
from 2 to 10-Minutes of CPR
CW NIRS Predictors
[HbO2], µmol/L*
∆[HbO2] from 1min-CPR
r[HbO2] to 1min-CPR, %
StO2, %
∆StO2 from 1min-CPR
rStO2 to 1min-CPR, %
THC, µmol/L
∆THC from 1min-CPR
rTHC to 1min-CPR, %

ROSC

No-ROSC

p

Mean AUC

43.9 (38.5, 54.0)
5.2 (0.8, 8.7)
111.8 (101.9, 126.6)
50.3 (45.0, 57.0)
4.4 (0.7, 7.6)
106.9 (101.6, 116.9)
87.7 (72.8, 100.8)
1.2 (-1.3, 6.3)
101.5 (98.4, 109.2)

32.1 (29.9, 38.9)
-4.7 (-15.3, 3.7)
92.7 (72.1, 110.5)
45.7 (38.0, 46.9)
-0.4 (-4.2, 3.6)
99.3 (90.0, 107.9)
82.8 (77.5, 83.4)
-10.3 (-21.3, -0.1)
90.9 (80.2, 99.8)

0.079
0.038
0.109
0.023
0.097
0.153
0.593
0.033
0.033

0.64 (0.11)
0.70 (0.07)
0.65 (0.05)
0.70 (0.09)
0.64 (0.06)
0.62 (0.06)
0.49 (0.11)
0.72 (0.07)
0.72 (0.05)

Reported as mean (standard deviation).
*Abbreviations: [HbO 2], oxy-hemoglobin concentration; StO 2, tissue oxygen saturation.;
THC, total hemoglobin concentration; ∆-prefix, absolute change; r-prefix, relative value
compared to 100% at baseline.

In summary, the CW NIRS quantification of absolute StO2 demonstrates the
potential to achieve similar results to more quantitative diffuse optical techniques during
CPR; however, it fails to comparably quantify the change in StO2 or underlying
physiologic parameters of [HbO2], [Hb], and THC and their changes during CPR. These
parameters yield greater predictive power for ROSC and cannot be accurately assessed
by CW NIRS.

E. Discussion
In this work, the novel application of quantitative, non-invasive frequency-domain
diffuse optical (FD-DOS) monitoring during CPR uncovered significant associations
between measured cerebral hemodynamic parameters and the outcome of ROSC, a
critical step towards survival following cardiac arrest. Further analysis of the predictive
value and stability of prediction for these parameters during the first 10 minutes of CPR
demonstrated the potential utility of non-invasive optical monitoring during CPR for real-
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time optimization of resuscitation outcomes. Specifically, cerebral tissue oxygen
saturation (StO2), oxy-hemoglobin and total hemoglobin concentration ([HbO2] and THC,
respectively), measured using FD-DOS at 10-minutes of CPR, were each significantly
associated with ROSC at 10-minutes of CPR. Across these first 10 minutes, absolute
change in [HbO2] from 1-minute of CPR (∆[HbO2]CPR) was found to be the best predictor
of subsequent ROSC, and stable, high-sensitivity and high-specificity thresholds were
determined. This application of FD-DOS to CPR represents an important advancement
in physiologic quantification over previous clinical applications of CW-NIRS to CPR. By
providing improved physiologic accuracy and ROSC prediction, real-time FD-DOS
guidance of CPR holds tremendous promise to improve neurological outcomes following
pediatric cardiac arrest.
Prior adult and pediatric literature, as well as animal models, describing the use
of non-invasive cerebral optical monitoring during CPR have been limited to reporting of
CW-NIRS measurements of rSO2 (i.e., an analogue of StO2) and either trends or
estimated values of [Hb], [HbO2], and THC. By quantifying absolute scattering and its
change, the present application of FD-DOS permitted the critical examination of absolute
[HbO2], [Hb], and THC during CPR; it also permitted their association with outcome. The
study thus uncovered new insights into the necessary and sufficient requirements for
ROSC in the brain. Measured values of [Hb], or its changes during CPR, did not have an
association with resuscitation outcome. This suggests that the level of extraction of
oxygen and, potentially, the level of persisting metabolic activity of the brain, is not a key
factor for resuscitation. Levels of [HbO2] and THC, and their ratio, StO2, were
significantly associated with ROSC. However, the most significant parameters were not
absolute values, but rather the change from start of CPR. This supports the notion that
significant inter-subject variability exists in the absolute value of these parameters.
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Importantly, a positive increase in [HbO2] and THC in the ROSC group underscores that
the ability of CPR to deliver oxygen and maintain blood volume in the brain is critical to
resuscitation. By the 5th minute of CPR, ∆[HbO2]CPR demonstrated an AUC > 0.90
suggesting neuromonitoring may be used to quickly identify whether or not ongoing CPR
is a viable strategy for the patient or if alternative or supplementary interventions are
necessary.
Existing clinical reports of CW NIRS monitoring were examined for comparability
of trends to explore whether our model mirrored the effects of cardiac arrest and CPR
seen clinically. The absolute value of StO2 after 10-minutes of CPR in the ROSC
(median [IQR] = 41.9% [33.3, 48.1]) versus no-ROSC groups (median [IQR] = 27.6%
[22.1, 35.1]), as well as the difference between group medians (14.3%), is within the
range of mean rSO2 values reported in a recent meta-analysis by Cournoyer et al. of
CW-NIRS monitoring during cardiac arrest and resuscitation in human subjects.201 The
mean values during CPR in individuals who achieved ROSC ranged from 35% to 47.2%,
and in individuals who did not achieve ROSC ranged from 17% to 35.4%, with standard
deviations of both groups ranging from 1.26% to 17.9%. The difference in means
between groups ranged from 6.3% to 23.3%. Another finding corroborated by our
results, is that while minimal differences were seen at initiation of CPR between patients
who would go on to ROSC and those who would not, the administration of CPR had
significant intra-subject variability causing a differentiation in ROSC outcome and
associated changes in cerebral oxygenation. This finding emphasizes that current CPR
administration guidelines are not an effective strategy for everyone, and that noninvasive neuromonitoring of cerebral hemodynamics could provide more individualized
guidance.
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The quantitative agreement with Cournoyer et al. reflects that the assumptions
used for clinical CW-NIRS rSO2 monitors are a reasonable representation of average
physiologic properties. However, in the setting of profound ischemia, changes in
scattering have been shown to become significant.26,324 The Fahraeus effect is a
potential mechanism behind these changes whereby decreased axial alignment at lower
red blood cell flow velocities causes dynamic hemoconcentration within the vessel and,
as a result, an increase in scattering.367 Because the scattering spectra of red blood cells
and tissue slope down with increasing wavelength,11,367 changes in scattering
differentially impact the concentration of deoxy-hemoglobin compared to oxyhemoglobin.
Supplementary analysis was performed to quantify these potential errors in CW
NIRS physiologic measurements resulting from methodologic assumptions. These errors
were calculated with respect to our quantitative FD-DOS measurements of baseline
absorption and scattering properties and their change during asphyxia and resuscitation.
This analysis clearly demonstrated limitations of CW NIRS monitoring. Using a typical
pediatric-sized optical probe, errors in the assumed constant scattering coefficient,
ranging from -26% to +40% at 10-minutes of CPR, resulted in CW NIRS absorption
property errors ranging from +41% to -24%. Notably, nearly 90% of the variation in StO2
error at baseline was explained by the error of the assumed scattering power (i.e., the
wavelength-dependence of scattering assumptions). During asphyxia and CPR, CW
NIRS quantification of StO2 (or, analogously, rSO2) consistently over-estimated the true
StO2 value. While a comparison of CW NIRS StO2 between ROSC and no-ROSC
groups at 10-minutes of CPR remained significant, all other hemodynamic parameters
and their changes no longer discriminated outcome. This evidence reinforces that
absolute hemoglobin concentration measures from CW NIRS instruments should be
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interpreted cautiously. While absolute errors are substantially diminished when
examining changes in hemodynamic parameters, the physiologic impact of hypoxicischemia on scattering causes differential trends in error that confound the interpretation
of CW NIRS measures. Ultimately, CW NIRS was unable to access the predictive power
of changes in hemodynamic parameters. However, the CW NIRS measurement of StO2
had comparable predictive power to the FD-DOS StO2 measurement. Given the
widespread adoption of CW NIRS systems, we are optimistic that this parity may reduce
barriers for clinical translation of non-invasive optical neuromonitoring.
Both Asim et al. and a recent study by Parnia et al. have made significant strides
in demonstrating the clinical feasibility of non-invasive optical neuromonitoring during the
conduct of in-hospital resuscitation in adults.204,368 However, the identified predictors in
both studies were assessed as averages over several minutes and stability throughout
the resuscitation period was not assessed; these issues present prohibitive challenges
for real-time guidance. Using improved FD-DOS quantification of cerebral hemoglobin
concentrations, we have identified ∆[HbO2]CPR as a promising predictor to address these
shortfalls. The advanced application of FD-DOS quantification to the CPR domain offers
improved predictive power and real-time sensitivity by correcting for errors in
assumptions of scattering and linearity (see above, Section D.3) inherent to CW-NIRS
methods. Note, from the perspective of exercising caution when deploying a novel
diagnostic for guidance, we determined critical thresholds with maximized sensitivity and
specificity to minimize false-negatives and false-positives, respectively, with the intent of
minimizing impact to standard-of-care. As such, reported sensitivity thresholds may be
used to identify subjects who would not ROSC and for whom an alternative intervention
should be considered. Similarly, specificity thresholds may be used to identify individuals
where the standard-of-care is sufficient and should not be considered for alternative
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intervention. Ultimately, these thresholds should be evaluated more broadly by including
respective healthcare and patient costs for the given decision outcome.
E.1. Study Limitations
This observational study has determined important associations between
cerebral hemodynamics and ROSC and has established a model for optimal predictor
selection that should be further optimized, as discussed, depending on clinical
application. Furthermore, independent prospective validation is necessary to confirm our
observational findings. Open questions remain regarding appropriate interventions inresponse to deficits in ∆[HbO2]CPR. A multifactorial response using other significant
parameters is likely necessary to determine the most effective strategy. For example, if
both ∆[HbO2]CPR and ∆THCCPR are diminished, this is indicative of limited oxygen supply
as well as oxygen availability. Efforts should be made to both increase brain perfusion
(e.g., increased depth of compressions) as well as oxygenation (e.g., increased rescue
breathing, use of supplemental oxygen); however, if only ∆[HbO2]CPR is diminished and
THC levels are stable or rising, this is indicative of sufficient cerebral preload pressure
(i.e., compressions are getting blood to the brain) but delayed transit through the brain
resulting in critical levels of oxygen depletion that may be ameliorated by drug
administration to decrease central venous pressure (i.e., the “afterload”). The exciting
prospect of non-invasively directing optimized CPR still requires improved understanding
of the impact of such interventions on cerebral hemodynamic parameters such that an
optimal management strategy may be devised and subsequently optimized.
Furthermore, while this large-animal model is a high-fidelity replication of pediatric
resuscitation procedures following respiratory-mediated arrest, generalizability of
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determined thresholds to alternative pediatric populations where the arrest is cardiac in
origin requires additional study.
E.2. Conclusions
Advanced, quantitative diffuse optical neuromonitoring was applied during CPR,
for the first time, to determine significant associations between measured cerebral
hemodynamics and ROSC following asphyxia and cardiac arrest in a pediatric swine
model. Our findings have provided novel insights regarding the cerebral physiology of
resuscitation as well as provided promising predictors of ROSC that may be applied
within the first few minutes of CPR. Rigorous characterization of quantification error due
to assumptions underlying clinical spatially-resolved CW NIRS systems demonstrate the
limited potential of this technique to access our novel diagnostics. Further use of noninvasive hemodynamic neuromonitoring during investigations of cardiac arrest and
resuscitation is needed to improve our understanding of the impact of existing CPR
strategies on cerebral physiology and its association with successful resuscitation
outcomes. It is our earnest hope that the development of novel strategies incorporating
non-invasive, quantitative optical neuromonitoring guidance will facilitate reduction of
mortality and neurological morbidity in children following cardiac arrest.
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F. Appendix
F.1. Supplemental Methods
Comparison of Invasive and Non-Invasive Neuromonitoring
Comparisons between invasive and non-invasive neuromonitoring offer improved
confidence that non-invasive measurements accurately reflect the dynamic physiology of
the brain. Separate linear mixed-effects models including random slope and intercept
effects were used to examine the relationship between relative values (%) of noninvasive and invasive measurements of cerebral oxygenation (i.e., tissue oxygen
saturation, StO2, and brain tissue oxygen content, PbtO2, respectively) and cerebral
blood flow (i.e., diffuse correlation spectroscopy blood flow index, rCBF DCS, and laser
Doppler blood flow, rCBF LD, respectively) during asphyxia and CPR. Results are
shown and discussed in Figure 4.A1 and Figure 4.A2 (see Section F.3).
Recovery of Cerebral Hemodynamics following ROSC
Non-parametric Wilcoxon signed rank tests (α = 0.05) were performed to
compare post-ROSC values to pre-asphyxia baseline values due to the presence of nonparametric distributions of the difference within each parameter. The 1, 2, 3 and 4-hour
post-ROSC values were calculated as the mean of values measured in the 1 minute
immediately preceding each time-point. Results are summarized in Table 4.A1 (see
Section F.2) and plotted in Figure 4.A3 (see Section F.3).
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F.2. Supplemental Tables

Table 4.A1. Cerebral Hemodynamic Recovery following ROSC

[HbO2], µmol/L
r[HbO2] to Baseline, %
∆[HbO2] from Baseline
[Hb], µmol/L
r[Hb] to Baseline, %
∆[Hb] from Baseline
THC, µmol/L
rTHC to Baseline, %
∆THC from Baseline
StO2, %
rStO2 to Baseline, %
∆StO2 from Baseline

Post-ROSC
1 hour

Post-ROSC
2 hour

Post-ROSC
3 hour

Post-ROSC
4 hour

32.3 (28.8, 37.1)
92.5 (90.0, 105.3)
-1.7 (-3.6, 1.6)
32.4 (29.8, 37.6)†
110.5 (101.8, 120.6)
2.5 (0.6, 6.0)
63.5 (60.4, 71.6)
102.8 (95.8, 106.9)
1.7 (-3.1, 4.8)
48.7 (44.3, 52.3)†
94.6 (85.3, 98.7)
-3.0 (-7.0, -0.6)

34.0 (28.3, 36.9)
101.1 (85.9, 112.8)
0.4 (-3.6, 3.5)
32.8 (29.5, 36.9)†
110.9 (104.0, 116.7)
3.2 (1.3, 4.6)
66.3 (61.0, 69.0)
103.5 (97.2, 108.1)
2.1 (-1.9, 4.7)
49.0 (43.3, 53.8)*
95.5 (88.6, 103.3)
-2.5 (-5.3, 1.7)

35.2 (30.7, 41.4)
101.1 (95.0, 125.8)
0.5 (-1.7, 6.2)
30.6 (28.9, 34.9)*
106.1 (98.8, 113.5)
1.6 (-0.4, 3.9)
65.2 (63.1, 70.8)*
105.9 (97.3, 110.7)
3.9 (-1.4, 6.5)
52.8 (47.0, 56.1)
99.6 (94.0, 110.5)
-0.2 (-3.5, 5.1)

37.5 (32.8, 43.1)†
112.8 (98.5, 133.8)
4.2 (-0.5, 10.9)
29.5 (27.7, 32.6)
106.3 (90.4, 113.9)
1.9 (-3.1, 4.0)
67.5 (64.6, 76.4)†
107.5 (100.8, 115.5)
5.3 (0.5, 9.0)
56.5 (49.3, 59.6)
103.1 (97.6, 115.8)
1.7 (-1.2, 7.5)

Reported as Median (IQR)
*p<0.05; †p<0.01; ‡p<0.001; § Abbreviations: [HbO 2 ], oxy-hemoglobin concentration; [Hb],
deoxy-hemoglobin concentration; StO 2 , tissue oxygen saturation; THC, total hemoglobin
concentration; ∆-prefix, absolute change; r-prefix, relative value compared to 100% at
baseline.
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F.3. Supplemental Figures

Figure 4.A1. Comparison of Invasive and Non-Invasive Measures of Cerebral
Oxygenation: During asphyxia (left) and CPR (right), relative StO 2 demonstrates a
strong correlation with relative PbtO 2 . During asphyxia, the modeled linear relationship
exhibited a significant slope (mean [95% CI] = 1.9 [1.6, 2.1]; p<0.001) with a high
coefficient of determination (R 2 = 0.82). Similarly, the relationship during CPR also
exhibited a significant slope (mean [95% CI] = 3.9 [2.3, 5.5]; p<0.001) with a high
coefficient of determination (R 2 = 0.84). These results provide substantial confidence
that changes in non-invasive measurements of StO 2 reflect true changes in cerebral
oxygen content.

Figure 4.A2. Comparison of Invasive and Non-Invasive Measures of Cerebral
Blood Flow: During asphyxia (left) and CPR (right), relative cerebral blood flow
measured by non-invasive diffuse correlation spectroscopy (rCBF DCS, %)
demonstrates a strong correlation with invasive intracranial measures by laser Doppler
(rCBF LD, %). During asphyxia, the modeled linear relationship exhibited a significant
slope (mean [95% CI] = 0.5 [0.5, 0.6]; p<0.001) with a strong coefficient of
determination (R 2 = 0.90). Similarly, the relationship during CPR also exhibited a
significant slope (mean [95% CI] = 0.9 [0.4, 1.3]; p<0.001) with a high coefficient of
determination (R 2 = 0.82). These results highlight that motion during CPR substantially
increases variance in the quantitative relationship between non-invasive and invasive
measurements of cerebral blood flow compared to measurements during asphyxia.
Despite this variation, the high coefficient of determination supports that changes in
non-invasive rCBF DCS value continue to reflect changes in invasive rCBF LD. Further
study is needed to understand and remove the contribution of motion during CPR from
both measurement modalities.
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Figure 4.A3. Changes from Baseline in Cerebral Hemodynamics during 4 Hour
Post-ROSC Recovery: For subjects who achieved return of spontaneous circulation
(ROSC; n=23), the median (solid line) and IQR (shaded region between dotted lines) of
the absolute change in cerebral oxy-hemoglobin concentration (∆[HbO 2 ]; top left),
deoxy-hemoglobin concentration (∆[Hb]; bottom left), total hemoglobin concentration
(∆THC; top right) and tissue oxygen saturation (∆StO 2 ; bottom right) from pre-asphyxia
baseline values for the 4 hours following ROSC are plotted. Three points of inflection
qualitatively define different stages of cerebral hemodynamic recovery comprising an
acute (0 - 10 minutes), subacute (10 – 45 minutes), intermediate (45 – 170 minutes)
and extended (>170 minutes) stage. Significant differences from baseline at 1, 2, 3, and
4 hours post-ROSC are indicated by asterisks (*, p<0.05; **, p<0.01).
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Figure 4.A4. Baseline Optical Reduced Scattering Coefficient (+,- ) and Changes at
End-Asphyxia: The median, IQR and range, excluding outliers (blue circles), of the +,at baseline, and end of asphyxia change from baseline (Δ+,- ), are plotted for each
measured wavelength (horizontal axis) across all subjects (n=31). The asterisk (*)
denotes a significant change from baseline (p=0.013) at the 785nm wavelength at the
end of asphyxia.

Figure 4.A5. Percentage Change in Optical Reduced Scattering Coefficient (Δ+,- )
during Asphyxia and CPR: The median and IQR (shaded), of the “percentage of
baseline” change in +,- are plotted across asphyxia (7 minutes) and the first 10 minutes
of CPR. During CPR, the changes for survivors who achieved ROSC are plotted in red,
and non-survivors plotted in blue.
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CHAPTER 5: CONCLUSIONS AND FUTURE OUTLOOK
In the presented work, non-invasive, quantitative diffuse optical neuromonitoring
has demonstrated the potential to substantially improve the individualization of care in
children who are at risk for hypoxic-ischemic neurological injury. Using this novel clinical
tool, in Chapter 2 and Chapter 3, we quantified the continuous effects of
cardiopulmonary bypass, deep hypothermia, and circulatory arrest (each distinct
intraoperative neurological risk factors) on cerebral oxygen metabolism in a neonatal
swine model of surgical cardiac repair for newborns with severe congenital heart
defects. And in Chapter 4, we determined highly predictive associations of noninvasively measured cerebral hemodynamics with return of spontaneous circulation
(ROSC) in a pediatric model of respiratory-mediated cardiac arrest. In this concluding
chapter, our findings and our future outlook for this innovative clinical modality are
summarized.

A. Mitigating Pediatric Brain Injury During Hypothermic Cardiopulmonary
Bypass
Newborns with complex congenital heart defects (CHD) who must undergo open
heart surgery within the first weeks of life to repair the aortic arch suffer a
disproportionate burden of new or worsened post-operative neurological injury.54
Neurological injury has been associated with the use of extended cardiopulmonary
bypass (CPB), rapid cooling to and rewarming from deep hypothermia (DH), and the use
of deep hypothermic circulatory arrest (DHCA). In our first study, which spanned
Chapter 2 and Chapter 3, we critically examined these risk factors using non-invasive
diffuse optical measurements of cerebral tissue oxy- and deoxy-hemoglobin
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concentration ([HbO2] and [Hb], respectively), total hemoglobin concentration (THC),
oxygen saturation (StO2), blood flow index (BFI), and cerebral rate of oxygen metabolism
(CMRO2). Importantly, our findings identified specific limitations of conventional
temperature guidance of deep hypothermic cardiopulmonary bypass in CHD neonates.
Furthermore, these findings also provide strong evidence for the validity and utility of
non-invasive diffuse optical measurements to address these limitations and lays the
framework for unique diagnostic parameters of cerebral status.
Using unprecedented continuous determination of the temperature-dependence
of cerebral oxygen metabolism in vivo in a neonatal swine model of DH CPB, we found
that the relationship, with respect to non-invasive nasopharyngeal temperature,
demonstrated a significant hysteresis between cooling and rewarming periods. In
contrast, the relationship with respect to invasive intracranial temperature did not
demonstrate hysteresis. This result (Chapter 2) underscores that not only is
nasopharyngeal temperature an inaccurate reflection of intracranial temperature, noninvasive diffuse optical measurement of cerebral oxygen metabolism is better. Second,
we performed an identical analysis of the hysteresis of metabolic temperaturedependence between cooling and rewarming periods in neonatal swine who underwent
deep hypothermia with circulatory arrest (DHCA). In these animals, even when
metabolic temperature-dependence was assessed with respect to intracranial
temperature, a significant hysteresis was found. From this effect, we concluded that
DHCA has a significant impact on cerebral oxygen metabolism that persists beyond the
end of the DHCA into the rewarming period. Furthermore, because this impact cannot be
adequately explained by variability in temperature, it must be independently measured
(Chapter 3); diffuse optics provides this capability.
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Furthermore, continuous measurement of cerebral metabolic parameters during
DHCA provided new physiologic insights and identified novel diagnostic parameters.
First, procedural exsanguination in the first two minutes following DHCA was found to
deplete a disproportionate amount of [HbO2] from cerebral tissue. These two minutes
accounted for 14-21% of the total [HbO2] loss over 40 minutes of DHCA. Strategies to
mitigate this loss should be explored and may permit extended cerebral tolerance to
DHCA. Next, the timing of the stabilization of the [HbO2] depletion rate was found to
agree well with the transition from aerobic to anaerobic metabolism (i.e., substrate
transition from oxygen to glucose). Because this transition rapidly escalates after 50%
depletion of baseline oxygen content, the timing of this transition may prove to be a
useful diagnostic of remaining oxygen availability in cerebral tissue as well as the rate of
depletion. Finally, depletion of THC during DHCA should be examined in combination
with DCS measures of cerebral blood flow as a surrogate for changes in tissue
composition which impact the concentration of tissue hemoglobin; these measurements
may provide additional markers of vascular and cellular injury.
In sum, these findings form a substantial basis for the future investigation of noninvasive diffuse optical guidance of therapeutic hypothermia and deep hypothermic
circulatory arrest. Associations of these parameters with outcomes assessing
neurological injury will permit the development of optimal neuroprotective strategies for
CHD neonates and other similarly vulnerable pediatric populations.

B. Neurological Predictors of CPR Outcome following RespiratoryMediated Cardiac Arrest
Physiological monitoring in the context of resuscitation represents a recent and
ongoing paradigm shift from “rescuer”-centric guidance, which focuses on chest
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compression parameters, to “patient”-centric optimization, where each individual’s realtime physiologic-response to resuscitation is emphasized. Neurological morbidity
remains the primary cause of death in resuscitated children. This stresses the need for
physiologic monitoring of the brain during resuscitation. In Chapter 4, a high-fidelity
pediatric swine model of asphyxial cardiac arrest provided the opportunity to associate
cerebral hemodynamics during cardiopulmonary resuscitation (CPR), measured noninvasively for the first time by quantitative frequency-domain diffuse optical spectroscopy
(FD-DOS), with the critical outcome of return of spontaneous circulation (ROSC).
At 10-minutes of CPR, immediately prior to the first defibrillation attempt, noninvasive FD-DOS measures of [HbO2], THC, and StO2, as well as their change from
baseline and the first minute of CPR, were significantly associated with subsequent
ROSC. FD-DOS measurement of elevated [HbO2] and StO2 in subjects who achieved
ROSC (versus those who did not achieve ROSC) provides improved physiologic
quantification of the oxygenation difference over prior applications of continuous-wave
NIRS techniques in this context. Furthermore, the finding that changes in [HbO2] and
THC from baseline were more significantly associated with ROSC than changes in StO2
from baseline revealed that maintenance of elevated cerebral blood volume is critical.
Thus, monitoring of oxygen saturation alone (i.e., the fraction of oxygenated blood) may
not be sufficient for guidance of resuscitation. Underscoring this limitation, we found that
among associated parameters, the change in [HbO2] during CPR demonstrated the
highest predictive power and stability (mean AUC = 0.91) in the first 10 minutes of CPR.
Importantly, through critical examination of assumptions underlying spatially-resolved
continuous-wave (CW) NIRS, a technique commonly used in clinical cerebral oximeters,
we determined that CW NIRS is unable to sufficiently quantify this diagnostic parameter
for ROSC prediction. The use of more advanced, quantitative diffuse optical techniques
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is necessary to improve accuracy, minimize inter-subject variability, and maximize
predictive power.
This work has determined significant associations between cerebral
hemodynamics and ROSC and identified change in [HbO2] as a promising non-invasive
predictor which may be utilized for guidance in the first few minutes of CPR. Further
optimization is necessary for application in multimodal monitoring schema (e.g., with
arterial blood pressure and/or end-tidal CO2 monitoring), in alternative clinical
populations (e.g., cardiac etiologies) and for specific use scenarios (e.g., to guide use of
pressor interventions, or to determine futility). While independent prospective validation
is also needed to confirm these observational findings, it is our earnest belief that the
use of non-invasive, quantitative diffuse optical neuromonitoring will facilitate the
development of novel CPR optimization strategies that will reduce the devastating
burden of neurological morbidity in children following cardiac arrest.

In Closing
The body of evidence presented in this thesis represents a significant step
towards the clinical realization of diffuse optical neuromonitoring and guidance using
quantitative diffuse optical spectroscopy and diffuse correlation spectroscopy. These
modalities and their application to medicine are borne from a diverse community of
visionary scientists, engineers and healthcare providers who have come together,
across continents and with decades of determination, to improve survival, neurological
outcomes, and subsequent quality of life in these at-risk children. In turn, the unique
simplicity and non-invasive nature of this technology, like the pulse oximeter or a simple
thermometer, has demonstrated ease of use and holds the potential for widespread
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accessibility by diverse patient populations and by individual users with or without
medical training. With this powerful vision in mind, we continue forward.
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